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Abstract 
 
Many therapies prescribed by traditional healers in Southern Africa include plant 
combinations to treat infectious diseases. Artemisia afra is one of the most commonly used 
traditional medicines in African traditional medicine and most often given in combination 
with other plants. This plant‟s popularity coupled with its wide range of uses in combination 
serves as the rationale for the bases of this study. In this study, combinations of A. afra 
(essential oils and plant extracts), which are commonly used for the treatment of respiratory 
diseases were studied from an antimicrobial perspective in order to determine if a scientific 
basis exists for their combined use. The plants used often in double or triple combination with 
A. afra in the treatment of respiratory tract infections are Lippia javanica, Osmitopsis 
asteriscoides, Agathosma betulina, Eucalyptus globulus, Allium sativum, Leonotis randii, 
Tetradenia riparia and Zanthoxylum capense. 
 
Essential oils from plant samples were analysed using gas chromatography coupled to mass 
spectroscopy (GC-MS). Compounds found in highest concentrations were camphor (41.0%) 
in A. afra, linalool (70.7%) in L. javanica, 1,8-cineole (59.0%) in O. asteriscoides, 
isomenthone (31.4%) in A. betulina, 1,8-cineole (63.0%) in E. globulus and β-caryophyllene 
(32.4%) in T. riparia.  
 
Dichloromethane: methanol extracts and aqueous extracts were prepared for each plant using 
the dried ground plant material collected. The antimicrobial activities of each sample as well 
as each combination (including essential oils) were tested using the minimum inhibitory 
concentrations (MIC) assay against a panel of respiratory tract organisms. The highest 
sensitivities observed for the essential oils were that of E. globulus against Cryptococcus 
neoformans with a MIC value of 0.6 mg/ml. The dichloromethane: methanol extracts showed 
the most activity with E. globulus against Moraxella catarrhalis (MIC value of 0.01 mg/ml). 
The aqueous extracts showed the best activity with Z. capense against Streptococus 
agalactiae with a MIC value of 0.4 mg/ml. 
 
The 1:1 fractional inhibitory concentration (∑FIC) values of the combinations of A. afra with 
L. javanica, A. afra with O. asteriscoides, A. afra with A. betulina, A. afra with E. globulus 
and A. afra with Z. capense were calculated from the MIC data. Synergy, additivity, 
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indifference and antagonistic interactions within the combinations were then interpreted. The 
most significant interactions of the double combinations with synergistic ∑FIC values of 0.2 
were the combination of the dichloromethane: methanol extracts of A. afra with O. 
asteriscoides against Streptococcus pyogenes and the combination of the aqueous extracts of 
A. afra with E. globulus against Streptococcus pneumoniae. Significant antagonism was 
noted with the combination of the dichloromethane: methanol extracts of A. afra with E. 
globulus against Enterococcus faecalis.  
 
The ∑FIC results of the combinations of A. afra with L. javanica, O. asteriscoides, A. 
betulina, E. globulus or with Z. capense were used to calculate ratios and plotted on to an 
isobologram. The isobolograms were interpreted with regard to any synergy, antagonism, or 
additive interactions present in the combination. Isobolograms revealed the most significant 
activity with the combination of the aqueous extracts of A. afra with E. globulus against C. 
neoformans with all the ratios tested being synergistic. The most prominent antagonism (five 
ratios) noted was in the combination (dichloromethane: methanol extracts) of A. afra with E. 
globulus against M. catarrhalis.  
 
The triple combinations analyzed for their antimicrobial activity were the combinations of A. 
afra with O. asteriscoides and E. globulus, A. afra with L. randii and E. globulus, A. afra 
with A. sativum and Z. capense and the combination of A. afra with T. riparia and salt. The 
most significant synergistic activity was noted for the combination of the essential oils A. 
afra with T. riparia and salt against Mycobacterium smegmatis with a ∑FIC value of 0.2. The 
combination of A. afra with O. asteriscoides and E. globulus of (dichloromethane: methanol 
extracts) displayed the most antagonistic activity against M. catarrhalis. 
 
When analysing the combinations that include A. afra, it was noted that adjuncts are an 
important combination ingredient in the traditional method of preparation. These were also 
tested for their activity. The combinations that include adjuncts i.e. honey, salt, vinegar, 
brandy and milk showed mainly indifferent interactions. This indifference noted supports the 
use of these adjuncts by traditional healers as it serves to verify that these adjuncts are at least 
not hindering the activity of the plant itself, which is a positive direction for future 
investigations.  
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Traditional medicine, with regard to A. afra, as prescribed by traditional healers, has 
commonly employed the use of combinations of more than one plant to treat respiratory 
conditions. When the antimicrobial activities in combination were examined from a scientific 
viewpoint, there is evidence of some bases for their traditional use. The results obtained from 
the testing of the essential oils validate its traditional use as an inhalant. The 
dichloromethane: methanol extracts showed results varying from synergy to antagonism 
while the aqueous extracts showed good antimicrobial activity. It is recommended that future 
studies should be conducted into these interactions to determine the benefits of these 
combinations for possible use in the commercial and primary health-care sectors. 
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Glossary 
 
Extracts:  liquid, powdered or viscous crude mixtures of chemical compounds, extracted from 
plant material using water or organic solvents e.g. alcohol (ethanol). (van Wyk and Wink, 
2004). Thus, the extract contains only the soluble portion of the plant material and the non-
soluble (fibrous) residues are discarded. (van Wyk and Wink, 2004).  
 
Infusion: (infusum) this refers to a preparation that is made by adding boiling water to the 
required amount of drug. This preparation is then allowed to steep for five to ten minutes 
before it is strained. An infusion is sometimes referred to as a “tea”. (van Wyk and Wink, 
2004) 
 
Decoction:  (decoctum) this refers to a preparation that is made by adding cold water to the 
required amount of drug. It is then heated to boiling and allowed to simmer for five to ten 
minutes, thereafter it is strained. (van Wyk and Wink, 2004)  
 
Tincture:  (tincture) this refers to an alcoholic solution (usually containing 30 to 70% water) 
prepared from medicinal plant material. This herbal mixture is extracted for a specified 
period, after which it is pressed and/or strained to separate the liquid and solid material. A 
mother tincture is often prepared by using 70% ethanol, and the solution is then diluted with 
clean water to a predetermined yield. (van Wyk and Wink, 2004) 
 
Ointments, pastes or gels:  these are semisolid preparations intended for external application 
that contain medicinal substances in a suitable carrier substance (water or oily solvents). (van 
Wyk and Wink, 2004) 
 
Inhalations: they are liquid preparations containing volatile ingredients which when vaporised 
in a suitable manner, are intended to be brought into contact with the lining of the respiratory 
tract. The ingredients must be volatile at room temperature, where they might be inhaled from 
an absorbent pad on which they have been placed, or they may need to be added to water 
heated to about 65°C, but not boiling water, and the vapour inhaled for 5-10 minutes. (van 
Wyk and Wink, 2004). 
 
xxviii 
 
Snuffs:  they are preparations of finely powdered, dried medicinal plants that can be drawn up 
into the nostrils through inhalation. (van Wyk and Wink, 2004). 
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May God have mercy on those who lead the way 
and those who come behind, and those who fulfil their vows, 
and those who seek to fulfil them, 
with His Grace and bounty, His great benefits and favours! 
For He is the best object of petition and the noblest object of hope; 
And God is the best protector and the most merciful of those who show mercy, 
* 
and the best of friends and the best of heirs 
and the best replacer of what has been consumed 
and provider for those devoted 
who sow and till the soil of good works. 
And God bless Muhammad and all the Prophets and Messengers! 
Amen, O Lord of created beings! 
 
                                                                                              [Mathnâwi IV, Prologue] in Jewels 
of Rememberance, Rumi. 
 
 
*
 Qur‟an: Surah Yusuf (Joseph), 12:64. 
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Chapter 1 
Introduction 
 
1.1 Traditional medicine 
Approximately 80% of the world‟s population is dependent on traditional medicine (Owalabi 
et al., 2007; van Wyk et al., 2009). The World Health Organisation (WHO, 2002) has 
described traditional medicines as “diverse health practices, approaches, knowledge and 
beliefs incorporating plant, animal and/or mineral based medicines, spiritual therapies, 
manual techniques and exercises applied singularly or in combination to maintain well-being, 
as well as to treat, diagnose or prevent illness” (WHO, 2002). This definition encompasses 
traditional medicine throughout the world and indicates that the use of medicinal plants is 
only a small component of a more integrated and holistic approach to health care. However, a 
general definition does not adequately explain the importance and scope that traditional 
medicine and traditional healers have on the African continent.  
 
From comparisons between Chinese medicines and Ayurvedic treatment, it is evident that 
many practices have been exchanged between each of these methods of healing (Swerdlow, 
2000). These methods have been used for generations and over time have evolved with 
contributions that can be found in Sri-Lanka, Thailand and Africa (Swerdlow, 2000). These 
two systems include using one plant for many conditions or many plants to treat just one 
ailment and remedies are still the mainstay of treatment in the less commercialized and 
developed areas of India and China, where they continue to show their worth as becoming 
more popular in the western world (Swerdlow, 2000). The successes that these two ancient 
medicinal practises have had are not unique as the same principles are applied to traditional 
healers in Africa. This system has also survived through many generations and has been 
passed on by teachers, parents and mentors.  
 
Traditional healers are widely referred to as medicine men or “shaman”. These terms are used 
to denote a person who is skilled in the use of plants and other natural substances and in the 
rituals of medicine and healing (Swerdlow, 2000). In South Africa, traditional healers are 
known, most commonly, as “inyanga” and “isangoma” (Zulu), “ixwele” and “amaquira” 
(Xhosa), “nqaka” (Sotho), “bossiedokter” and “kruiedokter” (Afrikaans) (Eloff and McGaw 
in Ahmad et al., 2006). There are an estimated 200 000 indigenous traditional healers in 
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South Africa and approximately 60% of the population consult these healers (van Wyk et al., 
2009). This may be due to their large numbers and accessibility as well as the familiarity they 
have with their patients. As in Western medicine, the variety of different ailments and 
treatments lends itself to the need for specialization. Thus, under the label of traditional 
healer, there are herbalists, herb sellers, traditional birth attendants, bone setters, diviners, 
faith healers, traditional surgeons, spiritualists and many others (Evans, 2002). The fact that 
traditional healers are an important source of primary health care in Southern Africa is 
supported by the WHO (2002). The cultural importance and high botanical density in the 
region are the most likely reasons why the demand is so high (McGaw et al., 2005; Light et 
al., 2005; Lewu and Afolayan, 2009). Despite the well known fact that traditional medicine is 
a diverse and often intricate form of health care, its basis is that of holistic healing. All 
traditional healers treat the psychological as well as physical aspects of each patient. This 
ensures an all round state of health and wellbeing. The physical symptoms are treated using 
various medicinal plants alone and in combination. Different parts of these plants may have 
different effects as they often contain different active ingredients, therefore sometimes the 
whole plant may be used while at other times only a specific part (van Wyk and Wink, 2004). 
 
1.2 Medicinal plants 
The traditional medicines that are generally used by the majority of the patients are mostly 
administered by traditional healers and largely consist of crude plant material and extracts 
(Reid et al., 2005). In South Africa, as in other developing countries of the world, traditional 
medicine still forms the backbone of healthcare (Light et al., 2005). The indigenous 
population, specifically, rely on traditional medicine for all aspects of primary health care 
(Grierson and Afolayan, 1999; Kelmanson et al., 2000; van Wyk et al., 2009).The use of 
medicinal plants by the people of South Africa dates back to the early settlement of the native 
Hottentots. They used many plant species to treat different diseases, (Stone, 1764; Maclagan, 
1876; Neuwinger, 2000; Lewu and Afolayan, 2009).   
 
Medicinal plants tend to normalize physiological function and correct underlying causes of a 
disorder instead of temporarily alleviating symptoms (Murray and Pizzorno, 1999; Vermani 
and Garg, 2002). Generally, medicinal plants are used in two ways. They are sources of 
biologically important or active compounds (pure, chemically defined active principles) or as 
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an element in complex mixtures containing a broad range of constituents e.g. essential oils, 
tinctures, or extracts (Hamburger and Hostettman, 1991; Neuwinger, 2000). 
 
The modes of administration as well as preparation methods need to be taken into account 
when studying these medicines. This includes the quantities, the addition of solvents, as well 
as preparation procedures such as boiling or burning (van Wyk et al., 2009). These vary 
widely as different parts of the plant are eaten, drunk as teas, or mashed in water for 
compresses or poultices when freshly harvested. Dried herbs can be soaked in liquids for the 
same use but are frequently crushed to powder and made into ointments by mixing with fats. 
These can be massaged into skin scratches or wounds (von Koenen, 2001). 
 
1.3 Combination therapy 
Even though efficacies between extracts (Kang et al., 1992), essential oils (Lachowicz et al., 
1998), and combinations of medicinal plants with conventional antimicrobials (Scott et al., 
1995; Shin, 2003; Filoche et al., 2005) have been studied, these have not been done in great 
depth. Williamson (2001), in a synergy review, has stressed the need for further interactive 
investigations. This is important in the study of plants such as A. afra as most remedies using 
such plants are prepared using one or two others together and if studied could prove to have a 
synergistic effect. 
 
Moreover, evidence for synergy or antagonism between three or more plant combinations is 
sparse (van Vuuren and Viljoen, 2011). Thirty years ago Rahal, (1978) mentioned this fact 
and until today, not much information has been gathered. When considering all the traditional 
health systems it becomes apparent that an enormous gap exists between where we are 
currently looking for new remedies (synthesizing new entities) and where we should be 
looking i.e. to the tried and tested remedies of old. 
 
“Synergy is what happens when you take two components, combine them and the resulting 
combination is more potent than the individual components. The result is not just double but 
many times their singular effect” (Dugmore and van Wyk, 2008). Synergy is defined as the 
result of the combined action of constituents being greater than expected from a collection of 
individual contributions (Williamson, 2001). It is important to distinguish between synergy 
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and polyvalent action as the latter is merely the various effects that multiple active 
constituents produce when used in combination (Williamson, 2001). 
 
One of the main reasons for the interest in synergy, by combining two or more plants with 
antimicrobial activity together, is the need to delay or prevent the increasing emergence of 
resistant strains of highly pathogenic micro-organisms. The rational for this is that the 
likelihood of micro-organisms to develop resistance to all the antimicrobials in a combination 
is low. An example of this in conventional medicine is when treating Tuberculosis; a multiple 
drug therapy is used to reduce the risk of infection with resistant strains. Another contributing 
factor is that many antimicrobials produce an unacceptable level of toxicity when used in 
high doses. Thus, the use of multiple low dose antimicrobial agents is beneficial in reducing 
the side effects of single high dose compounds (Eliopoulos and Moellering, 1996). Other 
advantages include the treatment of broad spectrum infections. Among them are Gram-
positive, Gram-negative, mycobacterium, yeasts and moulds, all of which can be targeted at 
the same time.  
 
In the ethnobotanical studies of various plants, many publications have noted that synergy is 
often dependant on the organism tested as well as the doses that are used (Kamatou et al., 
2006; van Vuuren et al., 2009; Suliman et al., 2010).Wagner and Ulrich-Merzenich (2009) 
are of the opinion that whole plant extracts have improved effectiveness as compared to the 
single constituent isolated from the plant, but due to the complexity of the constituents, it is 
difficult to identify which component/s are responsible for their synergy (Williamson, 2001). 
Traditional medical disciplines such as South African traditional healers, Chinese medicine, 
and Ayurveda, use combinations of different plants to treat various ailments. It is important, 
therefore, to establish whether the various plants used by traditional healers act in synergy, 
additively or antagonistically when combined. 
 
It is known that medicinal plants have been used since antiquity (Bodeker et al., 1999; Rios 
and Recio, 2005) to treat common infectious diseases and it has been long acknowledged that 
essential oils exhibit antimicrobial properties (Finnemore, 1926; Al-Bayati, 2008). Moreover, 
when using a mixture or combination of plants many more compounds are present and may 
act at multiple target sites, and therefore may act synergistically to increase effectiveness 
(Adwan et al., 2006; Al-Bayati, 2008).  
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The major aim of many in vitro testing procedures with traditional medicinal plants is that the 
focus is on the identification of a single compound. Traditional healers, however, are of the 
opinion that this is a “reductionist” approach. They argue that this approach misses the 
synergism or interactive effects of the multiple ingredients in a complex mixture (Bodeker et 
al., 1999). Combinations are frequently used in traditional medicine because of the suspected 
synergism that takes place among the phytochemicals used (Mythilypriya et al., 2008) as well 
as the aim at curing several diseases simultaneously (Abu-Shanab et al., 2004).  
 
Plants may be combined with other components such as animal or insect parts (Reyneke, 
1971; Louw et al., 2002), other medicinal plants (Watt and Breyer-Brandwijk, 1962; 
Hutchings et al., 1996; Felhaber, 1997), and adjuncts such as milk, salt, honey, vinegar, or 
brandy (Watt and Breyer-Brandwijk, 1962). These combinations are used in order to yield 
more potent and safer medicines (Reyneke, 1971;; Shin, 2003; Pyun and Shin, 2006). These 
adjuncts are still used in traditional medicine today, although combinations with other plants 
have proved to be the most valuable in the treatment of ailments (Louw et al., 2002). 
 
The rationale for using plant combinations is the desire to produce a combination that has 
multiple mechanisms of action, and that the expected action of the combination would be 
greater than the sum total of the individual or known and unknown chemical components 
(Harris, 2002). The possibility of other interactions i.e. additivity, indifference or antagonism 
should also be considered (van Vuuren and Viljoen, 2011). 
 
Different plant species in combinations have been scientifically validated. Examples include 
the commercially marketed combination of Ginkgo biloba with Echinacea wherein 
synergistic interactions are present (Williamson, 2001). In another study, the combination of 
Cinnamomum cassia with Allium tuberosum and Cornus officinalis was tested in different 
ratios. The ratio 8:1:1 (C. officinalis: C. cassia: A. tuberosum) possessed antimicrobial 
efficacy over a wide range of micro-organisms (Hsieh et al., 2001). Eucalyptus dives and 
Coriandrum sativum were combined to determine the food preservation efficacy against 12 
organisms (Delaquis et al., 2002). Synergy was obtained against Yersinia enterocolitica. 
Another study combining the essential oils of tea tree with lavender and tested against two 
dermatophytes. Various ratios of the combination were tested and isobolograms were plotted. 
The results demonstrated antimycotic activities (Cassella et al., 2002). Kamatou et al. (2006) 
investigated the combination of the extracts of Salvia chamelaeagnea with Leonotis leonurus 
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to treat respiratory infections. Synergy was observed against the Gram-positive bacteria while 
antagonism, synergy and/or additive interactions were observed against the Gram-negative 
bacteria. Rosemary and clove essential oils were combined in the study wherein MIC assays 
as well as time-kill assays were employed (Fu et al., 2007). Additive interactions were noted 
using MIC ratios against Staphylococcus epidermidis, Staphylococcus aureus, Bacillus 
subtilis, Escherichia coli, Proteus vulgaris and Pseudomonas aeruginosa. Time-kill studies 
revealed only concentrations twice that of the MIC values produced a cidal effect. The 
traditional use of the combination of A. afra with L. javanica essential oil used in traditional 
African medicine to treat K. pneumoniae related respiratory tract infections was validated by 
utilising a time-kill assay (van Vuuren, 2007). Al-Bayati, (2008) tested the essential oils and 
the methanol extracts of the combination of Thymus vulgaris with Pimpinella anisum (Iraqi 
folk medicine) against nine pathogens. Additive interactions were noted for this combination. 
Gutierrez et al. (2009) tested the essential oils of Origanum vulgare with Thymus vulgaris 
and found additivity against food spoilage bacteria. These studies provide some credibility 
towards the uses of plant combinations for enhanced antimicrobial efficacy.   
 
1.4 Respiratory tract conditions  
It is commonly noted that traditional healers prescribe the use of plants singularly and in 
combinations for respiratory infections (Watt and Breyer-Brandewijk, 1962). Therefore, in an 
effort to improve efficacy of traditional medicines, this study was undertaken in order to 
establish a scientific basis for the use of the medicinal plants in combination for the treatment 
of respiratory infections. Respiratory Gram-positive pathogens responsible for infections 
include Bacillus cereus, Enterococcus faecalis, Mycobacterium smegmatis, Staphylococcus 
aureus and Streptococcus pyogenes. Gram-negative pathogens associated with respiratory 
infections include Klebsiella pneumoniae, P. aeruginosa, and Moraxella catarrhalis. Some 
fungi that cause respiratory infections are Cryptococcus neoformans, Aspergillus niger and 
Alternaria alternate (van Vuuren, 2007). Details of some the most frequently used test 
pathogens in this study are given as follows. 
 
M. catarrhalis is Gram-negative diplococci and is considered an important cause of upper 
and lower respiratory tract infections in children and adults. It is reported to be the single 
cause of sinusitis, otitis media, tracheitis, bronchitis and pneumoniae in children (Verduin et 
al., 2002). M. catarrhalis is also a common cause of nosocomial infections and causes 
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laryngitis, bronchitis and pneumoniae (Verduin et al., 2002). It is the third most common 
pathogen after Haemophilus influenza and Streptococcus pneumoniae causing lower 
respiratory tract infections in adults (Nicotra et al., 1986; Chin et al., 1993). 
 
Klebsiella pneumoniae is a Gram-negative encapsulated bacteria, an opportunistic pathogen 
and causes septicaemia, pneumonia, urinary tract infection, as well as soft tissue infections. It 
is a prominent nosocomial pathogen causing respiratory tract infections (Podschun and 
Ullmann, 1998; Brisse et al., 2009). It is one of the leading causes of community-acquired 
pneumoniae in some countries like South Africa (Ko et al., 2002; Yu et al., 2007; Brisse et 
al., 2009). 
 
E. faecalis is a Gram-positive pathogen and causes up to 90% of enterococcal infections in 
humans (Kayaoglu and Ørstavik, 2004). It most commonly infects the urinary tract, 
endocardium causing endocarditis and the abdomen (Boyd and Hoerl, 1981; Jett et al., 1994). 
It can also infect the lungs, soft tissues, paranasal sinuses and the ears (Rantz and Kirby, 
1943; Horvitz and von Graevenitz, 1977; Berk et al., 1983; Maki and Agger, 1988; Doyle and 
Woodham, 1991; Graninger and Ragette, 1992; Bonten et al., 1993; Jett et al., 1994) 
 
Cryptococcus neoformans is an encapsulated yeast, which enables it to reduce size in certain 
environments, which is thus then ideal for alveolar deposition following inhalation of the 
pathogen. It is a major pathogen in the immune-compromised patient (causing 
cryptococcosis) with underlying conditions such as Acquired Immune Deficiency Syndrome 
(AIDS), lymphoma and patients undergoing corticosteroid therapy (Nielson et al., 1977; 
Perfect, 1989; Levitz, 1991; Cherniak and Sundstrom, 1994; Diamond, 1995; Hogan et al., 
1996; Nosanchuk et al., 2000). It causes asymptomatic pulmonary infections followed by 
meningitis. When limited to the lungs it causes pneumonia (King and DeWitt, 2009 
 
S. pneumoniae is an alpha haemolytic Gram-positive cocci. Acute respiratory tract infections 
are often caused by S. pneumoniae, the main aetiological agent.  It is exclusive to humans and 
is one of the most common community-acquired respiratory tract infections requiring 
antimicrobial therapy. It is also a leading cause of bacterial pneumoniae (File, 2000; Bessen, 
2009; WHO, 2009; Farrel et al., 2010). S. pneumoniae causes diseases such as bacteremia, 
meningitis, pharyngitis, rhinitis, otitis, sinusitis, arthritis and pneumonia (Demachy et al., 
2001; Warda et al., 2009).  
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S. pyogenes is referred to as the large colony-forming beta-haemolytic group (Bessen, 2009). 
It is the causative agent of the “strep” throat representing pharynhitis and tonsillitis 
infections. It is also a cause of non-bulbous impetigo in children in underdeveloped countries. 
Invasive S. pyogenes causes an autoimmune disease Rheumatic fever, with serious cardiac 
manifestations (Carapetis et al., 2005; Bessen, 2009). 
  
Streptococcus agalactiae is a Gram-positive group B streptococcus and is a commensal 
normal colonizer of the vagina, gastrointestinal and upper respiratory tract of healthy humans. 
It causes severe disease such as pneumonia, skin and soft tissue infections, septic arthritis and 
meningitis in immuno-compromised animals and humans (Bessen, 2009; Woods and Levy, 
2010).   
 
M. smegmatis is a Gram-positive, rapidly growing mycobacterium. It was selected for this 
study due to its genetic similarity to Mycobacterium tuberculosis and its lack of virulence as 
an infectious organism (Mitscher and Baker, 1998). M. smegmatis has been associated with 
soft tissue or wound infections as well as respiratory tract infections (Vonmoos et al., 1986; 
Newton et al., 1993; Cox et al., 1994; Pennekamp et al., 1997; Ergan et al., 2004).  
 
1.5 Plants used in treating respiratory tract infections 
Focussing on combinations used for respiratory infections, numerous ethnobotanical 
remedies are administered. Many of these have not been validated scientifically. A 
compilation of the ethno-botanical uses of the combinations used for respiratory infections in 
Southern Africa has been reported and some are summarised in Table 1.1.  
 
On examination of these combinations, it is clear that A. afra is predominantly administered 
in combination. Hence, this study focuses on validating the antimicrobial efficacy of those 
combinations containing A. afra.   
 
Table 1.1 Plant combinations used for the treatment of respiratory infections. 
Plants in combination Uses Administration Reference 
A. afra with Eucalyptus 
globulus 
Respiratory 
complaints
 
 
Crushed leaves or 
steam from infusions 
are inhaled or 
decoctions are taken 
Watt and Breyer-
Brandwijk, (1962); 
Hutchings et al. 
(1996). 
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Plants in combination Uses Administration Reference 
A. afra with Agathosma 
betulina 
Respiratory 
complaints 
Herbal wine 
Watt and Breyer-
Brandwijk, (1962). 
A. afra with Zanthoxylum 
capense 
The Europeans and 
Africans use it in 
febrile conditions, 
and it is used as a 
treatment for colds 
A decoction and an 
infusion of the leaf is 
used 
Watt and Breyer-
Brandwijk, (1962). 
A. afra with Osmitopsis 
asteriscoides 
Respiratory 
complaints 
Tincture 
Watt and Breyer-
Brandwijk, (1962). 
A. afra, Eucalyptus globulus 
with Leonotis microphylla 
Fever, chest 
infections and 
digestive 
disturbances 
Infusion 
Watt and Breyer-
Brandwijk, (1962). 
A. afra, Zanthoxylum 
capense 
with Allium sativum 
Respiratory 
complaints 
Decoction 
Watt and Breyer-
Brandwijk, (1962). 
A. afra with 
Lippia javanica 
Fevers, respiratory 
complaints, 
measles and as a 
prophylactic 
against lung 
inflammations 
Infusion, taken with 
milk 
Watt and Breyer-
Brandwijk, (1962). 
A. afra, Osmitopsis 
asteriscoides with Eucalyptus 
globulus 
Respiratory 
complaints 
Infusion, tincture 
Watt and Breyer-
Brandwijk, (1962); 
van Wyk et al. 
(2009). 
A. afra with Tetradenia 
riparia and salt 
Coughs Decoctions 
Hutchings et al. 
(1996). 
A. afra with Alepidea 
amatymbica 
Colds and flu 
Leaves and 
root/rhizome 
Jäger, 2003. 
A. afra with Warburgia 
salutaris 
Acute bronchitis, 
coughs from colds 
or flu, fever 
Leaves and bark
 
 
Felhaber, (1997); 
Jäger, (2003). 
A. afra, Alepidea 
amatymbica with Leonotis 
leonurus 
Asthma 
Leaves, root and 
leaves 
Felhaber, (1997). 
A. afra, Warburgia salutaris 
with Acorus calamus 
Chronic bronchitis 
and emphysema 
Leaves, bark and 
rhizome 
Felhaber, (1997). 
A. afra, Ruta graveolens with 
Pteronia divaricata 
Fever and colds Unknown Hulley et al. (2010). 
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Plants in combination Uses Administration Reference 
Cheilanthes hirta with 
Mohria cafforum 
Colds and sore 
throats in restless 
children 
Burned together and 
taken in as an 
inhalation 
Hutchings et al. 
(1996). 
Phoenix reclinata, Euclea 
natalensis, Capparis 
tomentosa with Maytennus 
heterophylla
 
Pleurodynia and 
pleurisy
 
Steam from the 
decoction is blown 
into the wound
 
Hutchings et al. 
(1996); Bryant, 
(1966). 
Cannabis sativa with 
Warburgia salutaris
 Dry cough, asthma 
Powdered bark of 
Warburgia salutaris 
and leaves of 
Cannabis sativa are 
mixed and smoked 
Hutchings et al. 
(1996); Bryant, 
(1966). 
Nymphaea nouchali with 
Tulbaghia species 
Coughs and colds Decoctions 
Hutchings et al. 
(1996). 
Ranunculus multifidus with 
Helichrysum nudifolium 
Severe coughs and 
sore throats 
Milk infusions of 
roots 
Hutchings et al. 
(1996). 
Capparis brassii, 
Zanthoxylum capense, 
Capparis tomentosa with 
what is reported to be 
Cyrtanthus obliquus but is 
probably a Eucomis species 
Chronic coughs Decoction 
Hutchings et al. 
(1996); Bryant, 
(1966). 
Ozoroa paniculosa with 
Berchemia zeyheri 
Acute 
inflammatory 
conditions of the 
chest 
Taken by mouth 
Hutchings et al. 
(1996). 
Pterocelastrus echinatus with 
Alepidea amatymbica 
Respiratory 
ailments
 Decoction
 
Hutchings et al. 
(1996); Pujol, 
(1990). 
Cucumis hirsutus with Aster 
bakeranus 
Chronic coughs Decoctions 
Hutchings et al. 
(1996); Bryant, 
(1966). 
Berkheya raphontica with 
Athrixia phylicoides
 
Dry hacking 
coughs 
Decoctions 
Watt and Breyer-
Brandwijk, 1962; 
Hutchings et al. 
(1996). 
Eucalyptus globulus, 
Corbichonia decumbens with 
Acorus calamus
 
Blocked nose
 
Boiled infusion
 
Felhaber, (1997). 
Warburgia salutaris with 
Acorus calamus
 Pneumonia
 
Infusion
 
Felhaber, (1997). 
Lippia javanica with Aloysia 
triphylla 
Colds, fever, 
asthma 
Herbal teas 
van Wyk and Wink, 
(2004). 
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1.6 Artemisia afra (previous studies) 
A. afra is known to be widely used for medicinal purposes as well as being one of the oldest 
medicinal plants used in South African traditional medicine (Mangena and Muyima, 1999; 
Thring and Weitz, 2006). It is considered a future flagship of traditional medicine due to its 
broad spectrum of activity (Mangena and Muyima, 1999; Liu et al., 2009; van Wyk et al., 
2009).  
 
A. afra has been documented in the literature for its chemistry, cultivation, toxicology, and 
quality control. As depicted in Figure 1.1, the bioactivity (53%) of A. afra has been the focus 
of a majority of studies. Antioxidant (Graven et al., 1992; Burits et al., 2001), antimalarial 
(Weenen et al., 1990; Kraft et al., 2003; Clarkson et al., 2004; Gathirwa et al., 2007), anti-
nematodal (McGaw et al., 2000), cardiovascular (hypotensive) (Guantai and Addae-Mensah, 
1999), cytotoxic (Jenett-Siems et al., 2002) and sedative (Nielsen et al., 2004; Stafford et al., 
2005) effects have been demonstrated and well documented (van Wyk, 2008a).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 The relative percentage of research by topic published on A. afra. 
 
Furthermore, Figure 1.2, which examines the literature pertaining specifically to the 
biological activity, shows that most of the literature thus far available regarding A. afra‟s 
biological activities have focussed on antimicrobial aspects. 
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Figure 1.2 The relative percentages of research by bioactivity published on A. afra. 
 
Some studies conducted on the antimicrobial activity of A. afra include Graven et al. (1992),  
Gundidza, (1993); Bruneton, (1995); Rabe and van Staden, (1997); Mangena and Muyima, 
(1999); Huffman et al. (2002); Muyima et al. (2002); Jäger, (2003); Motsei et al. (2003); van 
Vuuren and Viljoen, (2006); Viljoen et al. (2006b), Vagionas et al. (2007); van Vuuren, 
(2007). A. afra combinations, however, have been neglected. Further information regarding 
the botanical description, medicinal uses, geographical locality, chemistry of A. afra and 
other plants examined in this study may be found in Appendix A3. 
 
1.7 A. afra in combination 
When examining the research undertaken on A. afra using the Google search engine, 
“Artemisia afra” gave 16000 results (7/01/2011). When examining this more closely by using 
the terminology “combination”, 1860 results emerged http://www.google.co.za/search?hl=en 
&biw=1280&bih=683&q=Artemisia+afra&as_q=combination&btnG=Search%C2%A0withi
n%C2%A0results). A Pubmed search on “Artemisia afra” yielded 24 results. Limiting the 
search to “Artemisia afra in combination” yielded zero results. Using ScienceDirect, a search 
on “Artemisia afra” alone yielded 148 articles and when limited to “Artemisia afra in 
combination”, 65 were identified. On Scopus, 70 results were found for “Artemisia afra” 
alone and for “Artemisia afra in combination”, only nine results were obtained. (6/01/2011). 
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This lack of information shows that there is a need for scientifically valid research on this 
subject. 
 
Some instances where plants have been combined with A. afra for the treatment of microbe 
related infections have been documented in the ethnobotanical literature and are included in 
Table 1.1. Accounts of the administration of L. javanica with A. afra to treat respiratory 
disorders have been reported (Hutchings et al., 1996; Watt and Breyer-Brandewijk, 1962). A. 
afra has also been noted to be used either alone or in combination with the leaves of 
Eucalyptus spp. by the Xhosa, as an influenza remedy (Watt and Breyer-Brandewijk, 1962). 
Watt and Breyer-Brandewijk, (1962) sites many examples in which A. afra has been used in 
combinations with common household herbs e.g. ginger, thyme, rosemary, mint and 
chamomile. More specialised to traditional healers, as they are widely available and 
indigenous to the country of South Africa, are combinations involving species such as O. 
asteriscoides and E. globulus (Watt and Breyer-Brandewijk, 1962). Decoctions of the leaves 
of A. afra and Agrimonia bracteata are used for colds and decoctions of T. riparia and A. 
afra with salt are used to treat coughs in Southern Africa (Hutchings et al., 1996; Liu et al., 
2009). These combinations sometimes involve two or sometimes three plants. Other 
examples of combinations with A. afra is the use of A. afra, R. graveolens and P. divaricata, 
to treat fever and colds (Hulley et al., 2010) other examples include, A. afra leaves and W. 
salutaris bark for the treatment of cough from cold or flu as well as acute bronchitis 
(Felhaber, 1997). A combination of A. afra leaves and A. amatymbica root is drunk for colds 
and flu. Similarly, steam inhalation therapy is used with the combination of A. afra and A. 
amatymbica rhizome. Asthma is treated with a combination, which is drunk, of A. afra 
leaves, A. amatymbica root and L. leonurus leaves (Felhaber, 1997). A combination of A. afra 
leaves, W. salutaris bark, and A. calamus rhizome is used to treat chronic bronchitis and 
emphysema (Felhaber, 1997).  
 
A. afra in combination with other plants in double combination and in triple combinations 
were analyzed in this study to determine the antimicrobial interactions present. Figure 1.3 
shows the double combinations that are tested along with the method of administration. 
Figure 1.4 shows the triple combinations of A. afra that are evaluated.  
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Artemisia afra 
Root/leaf infusions b, c 
Leaf decoctions (with sugar or 
honey) c 
Alcohol extract e 
Steam inhalation c 
Agathosma 
betulina 
Herbal wine a 
 
Eucalyptus 
globulus 
Steam inhalation 
Decoctions a and b 
Osmitopsis 
asteriscoides 
Tincture a 
Infusionh 
Lippia javanica 
Infusions with milk 
or water a and b 
 
Zanthoxylum 
capense 
Decoction 
Infusion of leaves a 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 A. afra in double combinations. (Watt and Breyer-Brandewijk, 1962
a
; Hutchings 
et al., 1996
b;
 van Wyk et al, 2009
c
; van Wyk and Wink, 2004
d
; von Koenen, 2001
e
; Felhaber, 
1997
f
; Moolla, 2006
g
; Scott and Springfield, 2004
h
). 
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Figure 1.4 A. afra in triple combinations. (Watt and Breyer-Brandewijk, 1962
a
; Hutchings et 
al., 1996
b;
 van Wyk et al, 2009
c
; van Wyk and Wink, 2004
d
; von Koenen, 2001
e
; Felhaber, 
1997
f
; Moolla, 2006
g
). 
 
1.8 Aims and objectives of the study 
This study was undertaken with the aim of finding a scientific rationale for the antimicrobial 
use of A. afra in combination. A further breakdown of objectives for this study is as follows: 
 
1. To identify plants used in combination with A. afra by examination of the 
ethnobotanical literature.  
2. To extract (dichloromethane: methanol and aqueous extracts) and distil collected 
plant material. 
3. To perform gas chromatography coupled with mass spectrometry (GC-MS) on the 
essential oils obtained from hydrodistillation. 
4. To perform thin layer chromatography analysis on the plants essential oils 
independently and in combination with A. afra. 
Artemisia afra  
Root/leaf infusions b,c 
Leaf decoctions (with 
sugar or honey) c 
Alcohol extract e 
Steam inhalation c 
Zanthoxylum 
capense and 
Allium 
sativum 
Decoctions a 
Eucalyptus 
globulus and 
Leonotis 
randii 
Infusions a 
Tetradenia 
riparia and 
salt 
Decoction b 
 
Eucalyptus 
globulus and 
Osmitopsis 
asteriscoides 
Infusions 
Tincture c 
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5. To carry out antimicrobial screening using minimum inhibitory concentration 
(MIC) assays on essential oils and extracts. 
6. To perform interactive combination studies comparing data obtained from the 
initial screening antimicrobial studies i.e. with combinations utilizing fractional 
inhibitory concentration (∑FIC) studies and isobologram interpretation. 
7. To investigate the use of adjuncts in combination with A. afra using MIC and 
∑FIC assays. 
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Chapter 2 
Materials and Methods 
 
2.1 Collection of plant material 
Plant species (Table 2.1) were collected (Figure 2.1) at various localities during the summer 
months between the periods January 2007-April 2007. All plant identities were confirmed by 
a qualified botanist, either Andrew Hanky or Professor Alvaro Viljoen. The various species 
and their collection localities are shown in Table 2.1. Voucher specimens are deposited in the 
Department of Pharmacy and Pharmacology, University of the Witwatersrand. 
 
Table 2.1 Collection data of the plants studied.  
Voucher Species Locality 
Material 
distilled (g) 
Essential oil 
yield (%w/v) 
SFVV13 
Agathosma 
betulina 
Landmeterskop, 
Middelberg 
(Mpumalanga) 
955 0.9 
SFVV14 
A. afra 
Klipriviersburg 
(Gauteng) 
5902.7 0.6 
SFVV67 
SFVV33 
E. globulus Cresta (Gauteng) 3823.4 0.8 
SFVV74 
SFVV46 L. randii 
Walter Sisulu Botanical 
Gardens, Johannesburg 
(Gauteng) 
117.6 No oil 
SFVV8 
L. javanica Fairlands (Gauteng) 2893.3 0.2 
SFVV70 
SFVV23 O. asteriscoides Hermanus, Cape Town 2233.2 0.8 
SFVV47 
T. riparia 
Walter Sisulu Botanical 
Gardens (Gauteng) 
6871.7 0.1 
SFVV62 
SFVV72 
SFVV76 
SFVV48 Z. capense 
Walter Sisulu Botanical 
Gardens (Gauteng) 
262.2 No oil 
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2.2 Sample preparation 
2.2.1 Dichloromethane: methanol extracts 
Extracts were prepared by submerging the dried macerated plant material (±50 g) in a 1:1 
mixture of dichloromethane and methanol (CH2Cl2: MeOH) (Merck). This was heated to 
37°C for 24 hrs in a water bath. Thereafter, the solution was filtered using cotton wool. The 
filtered solution was then evaporated by air-drying in a fume hood. The resulting extract was 
then stored at 4°C for antimicrobial analysis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 Collection of A. afra in Klipriviersburg. 
 
2.2.2 Aqueous extracts  
Aqueous extracts were prepared by submerging macerated plant material (±50 g) in sterile 
distilled water, which was then kept in a water bath at 37°C overnight. Thereafter, it was 
filtered using Wattman
®
 No 1 filter paper and stored at -80°C for 48 hrs before lyophilisation 
(van Vuuren and Viljoen, 2006).  
 
2.2.3 Distillation of plant material 
For the aromatic plants, the essential oils were isolated by conventional hydro-distillation in a 
Clevenger-type apparatus. A round bottomed flask was packed with fresh leaf material 
(±1000 g) (Figures 2.2 and 2.3) and ±500 ml of distilled water was added. The flask was then 
sealed and the cooling system was set up. Thereafter the apparatus was heated using an 
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electric heating mantle. The essential oils were then collected in the condenser and were 
decanted after three hours. The samples collected were then stored in amber vials and 
refrigerated for antimicrobial analysis. 
 
Figure 2.2 Fresh leaf materials being 
packed into the apparatus. 
 
 
Figure 2.3 Clevenger apparatus being set 
up. 
 
2.2.4 Adjunct preparation 
Salt, powdered skim milk, as well as powdered full cream milk was purchased from the local 
Checkers
®
 supermarket. The different types of honey used i.e. orange blossom honey, wild 
blossom honey and blue gum honey were purchased from Woolworths
®
. The milk powder 
was made up according to the instructions indicated on the container by the manufacturer. 
(25.0 mg/ml). The milk was autoclaved and then allowed to cool before analysis. 
 
The honey, brandy and vinegar were made up to a concentration of 64.0 mg/ml. The volume 
of acetone or water to be added was calculated according to Equation 2.2. Honey was also 
tested at 100% or undiluted. Salt was prepared to a concentration of 4% and diluted with 
water. 
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2.3 Chromatographic techniques 
2.3.1 Thin layer chromatography 
Thin layer chromatography (TLC) was done as an initial screening process to visualise the 
chromatographic profile of each plant. Furthermore, combinations of the plants were done in 
order to qualitatively determine any increase or decrease in compounds when combined.  
 
2.3.1.1 Initial TLC screening 
A preliminary screening of the plants essential oils, dichloromethane: methanol extracts and 
the aqueous extracts were performed in order to visualize any compounds present using TLC. 
In this study for the essential oils, the mobile phase in which the plates were developed 
comprised of toluene: ethyl acetate (93:7). The mobile phase for development of the 
dichloromethane: methanol extracts was methanol: water: ethyl acetate (16.5: 13.5: 100) and 
for the aqueous extracts methanol: water: acetone: ethyl acetate: chloroform (10:8: 30: 40: 
12) was the best choice. Compounds resolved on the plate were visualized using either 
general or specific methods. Ultraviolet light (UV) indicates fluorescent compounds. They 
are examined at 365 nm (long) and at 254 nm (short) wavelength UV light (Evans, 2002). 
Alternatively, following development colourless compounds required a chemical reaction in 
order to visualize their location (Smith and Seakins, 1976). Thus, a spray reagent to produce 
coloured derivatives was used. For the essential oils, the plates were sprayed with an 
anisaldehyde-acetic-acid reagent (van Vuuren, 2007) or a vanillin-sulphuric acid reagent 
(Wagner and Bladt, 1996), as shown in Table 2.2. Similarly, for the extracts, vanillin-
sulphuric acid reagent or natural products reagent (Table 2.2) was used (Wagner and Bladt, 
1996). This required subsequent heating of the plate to approximately 110°C for 5 min to 
enable visualization of the compounds (Wagner and Bladt, 1996). 
 
Table 2.2 Reagents used and its composition. 
Reagent Composition 
Anisadehyde-acetic-acid 
0.5 ml anisaldehyde + 10 ml glacial acetic acid + 85 ml 
methanol 
Vanillin-sulphuric acid 
(100 ml ethanol + 1 g vanillin) + (100 ml ethanol + 10 
ml sulphuric acid) 
Natural products-
polyethylene glycol 
1% methanolic diphenylboric acid + 5% ethanolic poly-
ethylene glycol-4000 
(Adapted from Wagner and Bladt, 1996). 
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2.3.1.2 High performance thin layer chromatography (HPTLC) 
After troubleshooting in the initial screening of TLC and optimizing the solvents for the 
elution of the compounds of the essential oils, dichloromethane: methanol extracts and the 
aqueous extracts were determined, an automatic TLC system was used. This was performed 
at the Tshwane University of Technology with the assistance of co-supervisor Professor A.M. 
Viljoen and Joanet Maree. The plates were then developed in a CAMAG twin trough glass 
tank pre-saturated with the mobile phase using the CAMAG Automatic Development 
Chamber (ADC2). The tank was saturated for 10 min in advance and enhanced by keeping 
filter paper along one wall of the chamber. Each TLC plate was developed to a height of 80 
mm (Paramasivam et al., 2009). All TLC runs were carried out under laboratory conditions of 
approximately 25°C and 39.5% relative humidity.  
 
Sample application was performed using the CAMAG Automatic TLC Sampler 4 (ATS4) as 
shown in Figure 2.4 on pre-activated silica gel HPTLC plates (60GF 254, 20 × 10 cm). 
Samples were applied as 10 mm wide bands with N2 flow at 15 µl/sec, positioned 10 mm 
from the bottom of the plate and 15 mm from the side of the plate (Paramasivam et al., 2009).  
 
 
 
 
 
 
 
 
 
Figure 2.4 Process of HPTLC using the CAMAG Automatic TLC Sampler 4 (ATS4)
a
, 
CAMAG Automatic Development Chamber (ADC2)
b
, CAMAG Reprostar (Repro3)
c
, 
CAMAG Chromatogram Immersion Device III
d
 and the CAMAG TLC Plate Heater III
e
. 
(http://www.hptlc.us/v/products/application/ats4.html
a
; 
http://www.camag.com/v/products/development/adc2.html
b
; 
a b c 
d e 
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http://www.camag.com/v/products/assemblies/herbal_kits5.html
c
; 
http://www.camag.com/v/products/derivatation/derivatization.html
d
). 
 
After development, plates were dried for five minutes, viewed, and photographed with the 
CAMAG Reprostar (Repro3). Plates were viewed at 254 nm and 365 nm. Images and full 
analysis reports are housed in the CAMAG library at Tshwane University of Technology. In 
order to view the individual compounds, the plates were dipped in vanillin-sulphuric acid 
reagent (as in Table 2.2) using a CAMAG Chromatogram Immersion Device III and then 
heated on a CAMAG TLC Plate Heater III at 104°C for 3-5 min. The plates were then 
photographed using the CAMAG Reprostar (Repro3).  
 
2.3.1.3 Gas chromatography coupled to mass spectroscopy (GC-MS) 
Essential oil samples were analyzed in order to detect the constituents present. Gas 
chromatography is considered an efficient method for the characterisation of essential oils 
(Bakkali et al., 2008; Anwar et al., 2009; Hussain, 2009). The use of gas chromatography 
coupled with mass spectroscopy (GC-MS) is regarded as a rapid and reliable method in order 
to identify individual essential oil components (Yadegarinia et al., 2006; Gulluce et al., 2007; 
Anwar et al., 2009; Hussain, 2009).  
 
The oils were analysed by GC–MS (Agilent 6890N GC system coupled directly to a 5973 
MS). A volume of 1 µl was injected using a split ratio (200:1) with an autosampler at 24.79 
psi and an inlet temperature of 250°C. The GC system equipped with a HP-Innowax 
polyethylene glycol column 60 m×250 μm i.d. ×0.25 μm film thickness was used. The oven 
temperature program was 60°C for the first 10 min, rising to 220°C at a rate of 4°C/min and 
held for 10 min and then rising to 240°C at a rate of 1°C/min. Helium was used as carrier gas 
at a constant flow of 1.2 ml/min. Spectra were obtained on electron impact at 70 eV, scanning 
from 35 to 550 m/z. The percentage compositions of the individual components were 
obtained from electronic integration measurements using flame ionization detection (FID, 
250°C). n-Alkanes were used as reference points in the calculation of relative retention 
indices (RRI). Component identifications were made by comparing mass spectra and 
retention indices. Library searches were carried out using NIST
®
, Mass Finder
® 
and Flavour
®. 
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2.4 Antimicrobial assays 
2.4.1 Media and culture preparation 
When undertaking microbial susceptibility testing, the cultures used i.e. S. pneumoniae, S 
pyogenes, S. agalactiae, M. smegmatis, E. faecalis, M. catarrhalis, K. pneumoniae and C. 
neoformans as well as the media used play an important role in the accuracy of results 
obtained. The culture medium selected for in vitro susceptibility testing must be able to 
support good growth of the organism to be tested. In addition, it should not have any effect 
on the action of the antimicrobial agent being tested (McGinnis and Rinaldi in Lorian, 1991). 
Table 2.3 lists the media used in the culturing of the bacteria or fungi as well as the strain 
numbers and characterization of the type of micro-organism. All microbiological techniques, 
culture and media preparation were followed as in CLSI (2003) guidelines. 
 
Table 2.3 Media used in this study to grow bacteria and fungi. 
  
The following strains of micro-organisms were obtained from the National Health Laboratory 
Services (NHLS); E. faecalis ATCC 29212, M. catarrhalis ATCC 23246, K. pneumoniae 
NCTC 9633, C. neoformans ATCC 90112, S. pneumoniae ATCC 49619, S. pyogenes ATCC 
8668, S. agalactiae ATCC 55618 and M. smegmatis (clinical strain). 
  
Micro-organism strain 
number 
Characterization 
of type of micro-
organism 
Media 
S. pneumoniae ATCC 49619 Gram- positive 
Mueller Hinton (Oxoid) + 2.5% sheep‟s blood 
(National Health Laboratory Services (NHLS) 
S. pyogenes ATCC 8668 Gram-positive 
Mueller Hinton (Oxoid) + 2.5% sheep‟s blood 
(NHLS) 
S. agalactiae ATCC 55618 Gram-positive 
Mueller Hinton (Oxoid) + 2.5% sheep‟s blood 
(NHLS) 
M. smegmatis (clinical strain) Gram-positive 
Middlebrook–7H9-Broth (DifcoTM)  + glycerol 
+ Middlebrook ADC Enrichment supplement 
(BBL
TM
) 
E. faecalis ATCC 29212 Gram-positive Tryptone Soya broth/agar (Oxoid) 
M. catarrhalis ATCC 23246 Gram-negative Tryptone Soya broth/agar (Oxoid) 
K. pneumoniae NCTC 9633 Gram-negative Tryptone Soya broth/agar (Oxoid) 
C.  neoformans ATCC 90112 Yeast Tryptone Soya broth/agar (Oxoid) 
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2.4.2 Minimum inhibitory concentration (MIC) studies 
Microbiological assays are performed in order to determine the potency or concentration of a 
test substance e.g. essential oil or extract to be able to determine its effects on the growth of a 
micro-organism (Hewitt and Vincent, 2003). A fundamental principle to these assays is that 
they depend on the comparison of the effect of a standard reference substance e.g. an 
antibiotic such as ciprofloxacin, and a sample whose potency is to be determined on a 
“biological system” e.g. a culture of micro-organisms. The comparison is between the 
reference standard and the sample of unknown potency i.e. differences in antimicrobial 
activity can be seen between a known antimicrobial agent and a sample that has never been 
tested before (Hewitt and Vincent, 2003). 
 
One of the simplest and widely preferred techniques used to analyse the effectiveness of an 
antimicrobial‟s action is to determine the minimum inhibitory concentration (MIC) (Eloff, 
1998; Hewitt and Vincent, 2003). The minimum inhibitory concentration is the lowest 
concentration of an antimicrobial that completely inhibits the growth of an organism 
(Bannister et al., 2000). It is based on the principle of contact of a test organism to a series of 
dilutions of test antimicrobial/substance (van Vuuren, 2007).  
 
Two main methods are used, depending on the substrate used, agar dilution, and the broth 
dilution method (Hewitt and Vincent, 2003). In the agar, dilution method a serial dilution of 
the antimicrobial is prepared in molten agar and then plates are poured. The plates are then 
inoculated uniformly with about 20 µl of an overnight broth culture containing 10
5 
Colony 
Forming Units (CFU) of a suitable test organism. After incubation the level with no growth 
or very few colonies are taken to be the MIC. Controls, e.g. agar plates not containing any 
antimicrobial as well as a reference antimicrobial with known sensitivity to the micro-
organism, must be included in the study (Hewitt and Vincent, 2003). 
 
The broth dilution method involves the growth of an organism in a liquid nutrient medium 
and test solutions at a series of concentrations, from reference standards as well as test 
substance (Hewitt and Vincent, 2003). A starting concentration of the antimicrobial is made 
up in broth and then two fold dilutions are serially prepared. Each test tube is then inoculated 
with the micro-organism of about 10
5 
Colony Forming Units (CFU). After incubation, the 
tubes are assessed for any microbial growth. The first clear tube after turbidity is recorded as 
the MIC i.e. the highest dilution of the antimicrobial preventing growth is the MIC of the test 
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organism (Hewitt and Vincent, 2003). This technique requires large quantities of test 
substance, is very time consuming and when testing extracts, precipitation of the green colour 
made it difficult to determine the MIC (Eloff, 1998). Thus, a “sensitive” and “quick” method 
specifically developed to obtain MIC values for plant extracts against micro-organisms was 
developed by Eloff (1998). This microplate or microdilution method is not expensive, 
approximately 30 times more sensitive than any other method found in literature and it 
requires small quantities of test substance. It can be used for a large number of samples as 
well as a variety of different micro-organisms. Controls can be performed on the same plate 
at the same time and does not require a long time i.e. it is a quick and efficient method (Eloff, 
1998).  
 
All bacterial cultures were sub-cultured from stock agar plates and grown in the respective 
broth as shown in Table 2.3 for 24 hrs. The yeast (C. neoformans ATCC 90112) was 
incubated for 48 hrs. These were prepared using a 1:100 dilution, yielding an approximate 
inoculum size of 1×10
6 
colony forming units (CFU)/ml). Thus, 500 µl of test organism was 
placed into 50 ml of sterile broth. The culture was prepared immediately before use.  
 
2.4.2.1 Essential oil/extract and antimicrobial control preparation  
Stock solutions of each of the essential oils were made to a starting concentration of 128.0 
mg/ml using acetone as a diluent, and extracts were made to a concentration of 64.0 mg/ml. 
The volume of acetone to be added was calculated using Equation 2.1. 
 
                                
  
                                            
                                              
       
        Equation 2.1 
 
Positive controls i.e. ciprofloxacin (Sigma-Aldrich) for the bacteria and amphotericin B 
(Sigma-Aldrich) for the yeasts were also prepared. A starting stock solution of ciprofloxacin 
was made up with distilled water to a concentration of 0.01 mg/ml. Amphotericin B was 
diluted with dimethyl sulfoxide (DMSO) initially to a concentration of 1.0 mg/ml. Thereafter 
distilled water was used to make up a starting stock solution of 0.1 mg/ml. 
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2.4.2.2 Micro-titre plate preparation 
Under aseptic conditions (laminar flow unit), 100 µl of sterile water was added to each well 
of a 96 well micro-titre plate. A negative control (a) i.e. 100 μl of sterile water was added in 
row A12 (Figure 2.6) and 100 µl of conventional antimicrobial (b) (ciprofloxacin for the 
bacteria and amphotericin B for the yeasts) was placed into well A1 (as shown in Figure 2.5), 
as positive controls. One hundred micro-litres of each of the prepared test plant samples 
dissolved in water/acetone were placed in the respective wells in row A. These wells were 
labeled as depicted in Figure 2.5. Serial dilutions were then done in a vertical orientation, 
from A to H, using a multi-channel pipette. Thereafter, micro-titre plates were removed from 
the laminar flow unit and 100 µl of prepared culture was placed into each if the 96 wells. 
Micro-titre plates were sealed with sterile adhesive sealing film (AEC Amersham) to prevent 
evaporation of the essential oils. The remaining prepared culture was incubated along with 
another negative control, which was a streak plate of the culture used in the assay. This was 
carried out in order to determine the purity of the culture by the identification of single 
identical colonies. The micro-titre plates were also incubated with the other samples. 
Additionally, another negative control, to determine if the media used was sterile whereby the 
media was left overnight on the desk at 25°C. Incubation was set at 37ºC for the bacterial 
cultures for 24 hrs while the yeast was incubated at 37ºC for 48 hrs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5 A typical micro-titre plate. (a) – negative control; (b) – positive control. 
Negative 
control (a) 
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control (b) 
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Microbial growth or inhibition was detected by using a 0.04% solution of INT (Sigma-
Aldrich). An amount of 0.04 g was weighed and added to 100 ml sterile water to make up the 
required stock solution. INT is insoluble in cold water therefore for optimum solubility. It 
was placed in a water bath at approximately 55ºC for 30 min. Once dissolved, the INT 
solution was stored at 4°C and used within 2-3 days (Begue and Kline, 1972).  
 
After relevant incubation periods, 40 µl of prepared INT solution was added to each of the 96 
wells. For the bacteria, results were recorded six hrs later and for the yeast (C. neoformans) 
results were recorded 24 hrs later. All tests were performed in duplicate and on separate 
occasions to ensure accuracy and reproducibility of the results. 
 
MIC values were interpreted using the classification adapted from Fabry et al. (1998) 
Aligiannis et al. (2001) and van Vuuren (2007 and 2008). Fabry et al. (1998) indicated that 
extracts having an MIC value of ≥8.0 mg/ml have some antimicrobial activity. Aligiannis et 
al. (2001), and Duarte et al. (2005), classified the interpretation of MIC values for plant 
materials, essential oils and extracts whereby strong inhibitors are those samples that have 
MIC values up to 0.5 mg/ml. Moderate inhibitors have MIC values between <0.5-1.5 mg/ml 
and weak inhibitors have MIC values above 1.6 mg/ml. Gibbons (2004) and Rios and Recio, 
(2005), as described in van Vuuren (2008), have interpreted the MIC value for any natural 
product below 1.0 mg/ml to have noteworthy antimicrobial activity and an MIC value below 
0.1 mg/ml to be “very interesting”. After extensive reviewing of the literature, van Vuuren 
(2008) proposed that essential oils with MIC values of 2.0 mg/ml or lower could be 
considered noteworthy. Thus incorporating all these interpretations, in this study, MIC values 
are interpreted as follows; an extract having an MIC value below 8.0 mg/ml will be 
considered to have some antimicrobial activity, but below 1 mg/ml is noteworthy. Any 
essential oil with an MIC of 2.0 mg/ml or lower will be considered as having noteworthy 
activity.  
 
Furthermore, they can be divided into very strong inhibitors: MIC values less than 0.1 mg/ml; 
strong inhibitors: MIC values up to 0.5 mg/ml; moderate inhibitors: MIC values between 0.6-
1.5 mg/ml; and weak inhibitors: MIC values above 1.6 mg/ml (Fabry et al., 1998; Aligiannis 
et al., 2001; Duarte et al., 2005; Rios and Recio, 2005; van Vuuren, 2008). A summary of the 
classification of antimicrobial activity used in this study is provided in Table 2.4. 
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2.4.3 Combination studies 
In the testing of combinations of two or more plant essential oils or extracts, in order to assess 
whether synergy, antagonism or additive interactions are present, three general methods are 
used (Acar, 2000; Cassella et al., 2002). They are the chequerboard method, time-kill curves 
and disk diffusion methods (Acar, 2000). Results with killing curves and disk diffusion 
studies are qualitative assessments of interactions, while the micro-titre-plate method is 
expressed more quantitatively using the Fractional inhibitory concentration (FIC) method as 
well as the isobologram method (Acar, 2000). For the purposes of this study, combinations 
were tested using the micro-titre-plate method as it allows many different combinations and 
concentrations to be tested (Eliopoulos and Moellering, 1996; Acar, 2000). 
 
Table 2.4 Classification of antimicrobial activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Adapted from Fabry et al., 1998; Aligiannis et al., 2001; Gibbons, 2004; Duarte et al., 2005; 
Rios and Recio, 2005; van Vuuren, 2007 and 2008).  
 
2.4.4 Fractional inhibitory concentration (FIC) determination 
The ∑FIC is expressed as the interaction of two plant essential oils or extracts, wherein the 
concentration of each agent in combination is expressed as a fraction of the concentration that 
would produce the same effect when used independently (Berenbaum, 1978; van Vuuren and 
Viljoen, 2008). It is often used to analyze potential antimicrobial interactions. It does 
however, have certain limitations i.e. the MIC end points are required for each agents being 
tested (Stergiopoulou et al., 2008). If the MIC end point is not determined at the highest 
concentration tested, a ∑FIC cannot be calculated and thus for the purpose of this study it is 
Type of 
sample 
MIC value 
(mg/ml) 
Classification 
Extracts 
<8.0 Some antimicrobial activity 
< 1.0 Noteworthy antimicrobial activity 
Essential oils 
≤2.0 Noteworthy antimicrobial activity 
>2.0 - <8.0 Some antimicrobial activity 
Essential oils 
and extracts 
<0.1 
Very interesting antimicrobial activity/ 
Very strong inhibitors 
0.1 - 0.5 Strong inhibitors 
0.6 – 1.5 Moderate inhibitors 
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indicated as “not determined (1)”. However, results are interpreted by comparing the MIC 
values obtained for the plant essential oil or extracts alone and in combination. For all 
combinations where the MIC values were determined, the ∑FIC values were calculated 
according to Equation 2.2 and Equation 2.3 (Berenbaum, 1978; Davidson and Parish, 1989; 
O‟Shaughnessy et al., 2006).  
     
                                      
                    
 
Equation 2.2 
 
     
                                     
                    
 
Equation 2.3 
 
a and b represent the two plants. The sum of the FIC, known as the mean ∑FIC index was 
calculated using Equation 2.4 
 
                          
Equation 2.4 
 
The ∑FIC index has been adapted from Berenbaum (1978), Odds (2003) and modified to 
include an additive interpretation (Schelz et al., 2006; Iten et al., 2009; van Vuuren and 
Viljoen, 2011). It is used to determine the correlation between the two plants and may be 
classified as either synergistic (≤0.5), additive (0.5 - 1.0), indifferent/non-interactive (>1.0 - 
4.0) or antagonistic (≥4.0). FIC determination was carried out on all the combinations 
associated with A. afra. This includes all the double and triple combinations of A. afra with 
other plants, as well as its combinations with adjuncts such as honey, salt, vinegar, brandy 
and milk. These combinations were tested and ∑FIC values determined against the pathogens 
used in this study i.e. S. pneumoniae, S. pyogenes, S. agalactiae, M. smegmatis, E. faecalis, 
M. catarrhalis, K. pneumoniae and C. neoformans,  except where an endpoint MIC value was 
not noted. This was carried out as a preliminary determination of the presence of interactions 
within a combination for all pathogens. Thereafter four pathogens i.e. K. pneumoniae, M. 
catarrhalis, E. faecalis and C. neoformans were selected to further investigate interactions 
present, using isobologram construction studies.  
 
Isobologram construction was undertaken, as it may be a more sensitive method to determine 
the in vitro pharmacodynamic interactions between combinations (Tallarida, 2006; 
59 
 
Stergiopoulou et al., 2008). An advantage over FIC determination is that a number of ratios 
can be tested and plotted out at the same time, in order to detect the interactions at different 
concentrations of the combination. 
 
2.4.5 Isobologram construction 
Isobolograms are used to characterize the nature of an interaction between combinations e.g. 
between plant essential oils or extracts, antibiotics or even between plants and antibiotics 
(Gennings et al., 1990). An isobol is a level curve, on the surface of an interaction among a 
combination of plant product extracts or essential oils. The surface is 3-dimensional, wherein 
the horizontal axes (x and y), represents the individual drug concentrations, and the vertical 
axes represent the effect of the combination. An isobol is thus the collection of all the points 
on the surface that lie at a particular effect (Boucher and Tam, 2006). An isobologram is a 
convenient graphical way of representing the results of a combination study and is useful in 
visualizing combination data (Tallarida and Raffa, 1995). These different types of 
interactions have been demonstrated and introduced by Fraser (1870-1871, 1872) and their 
approach has been extended by Loewe and Muischnek (1926), Loewe (1953) and Berenbaum 
(1981) (Gennings et al., 1990). More recently, they have been utilized in the combination 
study between antibiotics and commonly used essential oils by van Vuuren et al. (2009) and 
by Suliman et al. (2010) to determine the interactions between the essential oil of A. afra with 
other essential oils commonly used in traditional medicine in South Africa.  
 
The isobologram ratio method (Berenbaum, 1978; Williamson,
 
2001)  involves combining 
the two plants in nine ratios i.e. 9:1; 8:2; 7:3; 6:4; 5:5; 4:6; 3:7; 2:8; 1:9. The MIC was 
determined for all ratios and the plant samples independently. Micro-titre plates were then 
prepared as in Section 2.4.2. Ratios were calculated using Equations 2.5 and 2.6 and then 
plotted onto Microsoft Excel
©
 as is demonstrated in Figure 2.6. 
 
   
                                                 
                                  
 
       Equation 2.5 
 
  
                                                 
                                  
 
        Equation 2.6 
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MIC values (mg/ml) of plant samples in combination relative to the independent MIC were 
plotted on an isobologram, using GraphPad Prism
®
 version 5
 
software, as a ratio, allowing for 
a graphical representation of the interaction of the various combinations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6 Example of the ratios for essential oils and how they were presented in Microsoft 
Excel 
©
. 
 
The isobologram can be interpreted by examining the data points of the ratios where the MIC 
for each concentration is determined in relation to the independent MIC‟s (shown as a 
straight line) and extrapolating synergy (≤0.5), additivity (>0.5 – 1.0), indifference (>1.0 – 
≤4.0) and antagonism (>4.0) as shown in Figure 2.7. Tests were undertaken at least in 
duplicate. Conventional antimicrobials were included in all repetitions as positive controls. 
Negative controls were also included in the testing as described in Section 2.4.2. 
 
 
 
 
Well 
no 
Concentrations 
(mg/ml) 
MIC values 
obtained 
Ratio values 
Plant 
X 
Plant 
Y 
Plant 
X 
Plant 
Y 
Plant 
X 
Plant 
Y 
1 32 0 8.00 0.00 1.00 0.00 
2 28.8 3.2 7.20 0.80 0.90 0.10 
3 25.6 6.4 6.40 1.60 0.80 0.20 
4 22.4 9.6 5.60 2.40 0.70 0.30 
5 19.2 12.8 4.80 3.20 0.60 0.40 
6 16 16 4.00 4.00 0.50 0.50 
7 12.8 19.2 3.20 4.80 0.40 0.60 
8 9.6 22.4 2.40 5.60 0.30 0.70 
9 6.4 25.6 1.60 6.40 0.20 0.80 
10 3.2 28.8 0.80 7.20 0.10 0.90 
11 0 32 0.00 8.00 0.00 1.00 
 
Ratio values as calculated  
100% test substance 
(plant X) 
 
Well 
no 
Concentrations 
(mg/ml) 
MIC values 
obtained 
Ratio values 
Plant 
X 
Plant 
Y 
Plant 
X 
Plant 
Y 
Plant 
X 
Plant 
Y 
1 32 0 8.00 0.00 1.00 0.00 
2 28.8 3.2 7.20 0.80 0.90 0.10 
3 25.6 6.4 6.40 1.60 0.80 0.20 
4 22.4 9.6 5.60 2.40 0.70 0.30 
5 19.2 12.8 4.80 3.20 0.60 0.40 
6 16 16 4.00 4.00 0.50 0.50 
7 12.8 19.2 3.20 4.80 0.40 0.60 
8 9.6 22.4 2.40 5.60 0.30 0.70 
9 6.4 25.6 1.60 6.40 0.20 0.80 
10 3.2 28.8 0.80 7.20 0.10 0.90 
11 0 32 0.00 8.00 0.00 1.00 
 100% test 
substance (plant X) 
100% test substance 
(plant Y) 
 
100% test substance 
(plant Y) 
Ratios ranging 
from 9:1 to 1:9 
 
Ratios ranging 
from 9:1 to 1:9 
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Figure 2.7 Example of an isobologram showing synergy (   ), additivity (   ), indifference (   ) 
and antagonistic (   ) pharmacological interactions. 
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Chapter 3 
The antimicrobial efficacy of Artemisia afra Jacq. ex Willd and 
Lippia javanica (Burm. f.) Spreng. in combination 
 
 
3.1 Introduction 
A. afra is combined with many different plants in South African traditional medicine, but 
most notably and consistently of all, with Lippia javanica. (Watt and Breyer-Brandwijk, 
1962; Neuwinger, 2000; Huffman et al., 2002). A decoction of L. javanica is generally mixed 
with a decoction of wormwood and used for colds and influenza (Smith, 1895). Likewise, an 
infusion made with A. afra and L. javanica, is given to treat fevers, influenza (Hutchings et 
al., 1996), measles and used as a prophylactic against lung inflammations (Smith, 1895; Watt 
and Breyer-Brandwijk, 1962). 
 
Although there has been much citation in literature regarding the use of the combination of 
these two plants, there is very little scientific evidence to support the traditional use in 
combination. Only one other study for the combination of A. afra and L. javanica has been 
researched by van Vuuren (2007). Time-kill assays were utilized to access the ethnobotanical 
use of A. afra essential oil (0.25%) alone, L. javanica essential oil (0.25%) alone and the 1:1 
combination of A. afra (0.125%) with L. javanica (0.125%) essential oils. Time-kill on the 
two independent plants was carried out on three pathogens i.e. K. pneumoniae, C. neoformans 
and B. cereus. The time-kill using the combination was carried out against K. pneumoniae. 
Results on the combination study found that a bactericidal effect was achieved within an hour 
of exposure and that this cidal effect was maintained for the full 48 hrs of testing. The study 
concluded that A. afra interacts synergistically with L. javanica against K. pneumoniae thus 
validating the traditional use of the combination (van Vuuren, 2007) 
 
The aims of this study included studying the essential oil composition of A. afra and L. 
javanica using GC-MS, TLC screening on the plants essential oils, dichloromethane: 
methanol extracts and the aqueous extracts independently and in combination (1:1) and 
testing of the antimicrobial activity, of A. afra and L. javanica independently as well as in 
combination using MIC microplate assays. Combinations were made by mixing different 
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ratios of A. afra with L. javanica. Nine ratios in total were carried out with either A. afra or L. 
javanica varying in mixed ratios. Additionally, not only the essential oils, but also the 
dichloromethane: methanol extracts as well as the aqueous extracts were tested. ∑FIC 
determination as well as isobologram studies were then done in order to determine the 
efficacy of A. afra with L. javanica in combination and identify any interaction between the 
two. 
 
3.2 Results and discussion 
3.2.1 Chromatographic techniques 
3.2.1.1 Essential oil composition of A. afra 
Thirty compounds were identified, making up 92.8% of the total composition (Table 3.1) in 
the essential oil of A. afra. The major compounds present were camphene (4.0%), 1, 8-
cineole (17.0%), artemisia ketone (6.4%), β-thujone (6.0%), camphor (41.0%) and borneol 
(8.6%)  
 
Table 3.1 GC-MS results of A. afra. 
RRI* Compounds Area (%) 
1016 α-Pinene 0.5 
1057 Camphene 4.0 
1104 β-Pinene 0.4 
1193 α-Terpinene 0.1 
1202 1,8-Cineole 17.0 
1232 (Z)-β-Ocimene 0.4 
1242 γ-Terpinene 0.1 
1250 (E)-β-Ocimene 0.1 
1281 Terpinolene 0.1 
1350 Artemisia ketone 6.4 
1441 β-Thujone 6.0 
1488 α-Copaene 0.1 
1501 Artemisia alcohol 0.2 
1511 Chrysantenone 0.1 
1521 Camphor 41.0 
1573 Pinocarvone 0.5 
1588 Bornyl acetate 0.5 
1602 Terpinen-4-ol 1.7 
1628 cis-p-Menth-2-en-1-ol 0.5 
1639 Myrtenal 0.5 
1653 trans Pinocarveol 1.0 
1672 γ-Terpineol 0.2 
1679 trans Piperitol 0.3 
1701 α-Terpineol 0.3 
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*RRI:  Relative retention indices calculated against n-alkanes.  
% calculated from TIC data. 
 
Numerous studies have reported on the composition of the essential oil of A. afra (Appendix 
A). The sample of A. afra from this study is rich in camphor at 41.0% and β – thujone makes 
up only 6.0% of the total composition of the oil and α- thujone was absent. In the study by 
van Vuuren (2007), the essential oil of A. afra was collected from Klipriviersberg (the same 
location as this sample) and analysed. The major compounds detected in this study and that of 
van Vuuren (2007) were mostly the same except α-thujone (18.8%) was the major compound 
in van Vuuren (2007) and camphor (41.0%) was the major constituent in this study. As 
discussed in Section 3.4.2, the differences in the major compound composition of the oils are 
clearly noticed. This is not surprising, as studies conducted have concluded that A. afra 
shows immense chemical variation from individual plant-to-plant samples to collective plant 
samples (Graven et al., 1992; Chagonda et al., 1999; Mangena and Muyima, 1999; Viljoen et 
al., 2006b).   
 
3.2.1.2 Essential oil composition of L. javanica 
The GC-MS results for L. javanica showed twenty-one compounds (Table 3.2) making up 
96.3%. The major compounds are 1, 8-cineole (2.3%), p-cymene (3.4%), trans-linalool oxide 
(4.5%), cis-linalool oxide (4.0%), linalool (70.7%) and caryophyllene oxide (6.9%).  
 
Viljoen et al. (2005) as well as van Vuuren (2007) studied the chemical composition of L. 
javanica essential oil from Fairlands in the North of Johannesburg, the same locality as the L. 
javanica used in this study. Adequate comparison of the differences in the major compounds 
can thus be made. In Viljoen et al. (2005), linalool (65.19%) was found to be the major 
compound followed by (Z)-β-ocimene (12.97%) and (E)-β-ocimene (6.21%). van Vuuren 
(2007) found the major compounds to be (Z)-β-ocimene (13.0%) and linalool (65.2%). 
Comparing these samples with that of L. javanica essential oil in this study, it is clear that 
RRI* Compounds Area (%) 
1709 Borneol 8.6 
1715 Germacrene D 0.9 
1739 Piperitone 0.3 
1741 Bicyclogermacrene 0.4 
1745 Piperitol 0.3 
1857 Myrtenol 0.3 
Total 92.8 
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linalool is the main or dominant compound, with the composition of linalool alone in all three 
samples greater than 65.0%. A slight difference that is noted is the absence of (Z)-β-ocimene 
in the sample tested in this study. In van Vuuren (2007), (Z)-β-ocimene was only found as a 
major constituent in the Fairland population and was not a main constituent in the other 
populations tested. Thus, the absence of this constituent, in the sample used in this study, is 
notable although variations may exist between and within natural populations (Viljoen et al., 
2005). 
 
Table 3.2 GC-MS results of L. javanica. 
RRI* Compounds Area (%) 
1016 α-Pinene 0.1 
1057 Camphene 0.2 
1117 Sabinene 0.1 
1193 Limonene 0.5 
1202 1,8-Cineole 2.3 
1270 p-Cymene 3.4 
1441 trans-Linalool oxide 4.5 
1464 α-Longipinene 1.2 
1471 cis-Linalool oxide 4.0 
1488 α-Copaene 0.3 
1511 Chrysanthenone 0.1 
1521 Camphor 0.4 
1546 Linalool 70.7 
1575 d-Terpineol 0.1 
1596 β-Caryophyllene 0.3 
1602 Terpinen-4-ol 0.2 
1701 α-Terpineol 0.1 
1709 Borneol 0.8 
1728 α-Amorphene + α-muurolene 0.1 
2010 Caryophyllene oxide 6.9 
Total 96.3 
*RRI:  Relative retention indices calculated against n-alkanes  
% calculated from TIC data 
 
3.2.1.3 Thin layer chromatography  
TLC fingerprint studies were carried out as an initial screening process singularly and in 
combination, in order to determine and visualise the locality of the various compounds by 
using Rf values. Figure 3.1, 3.2 and 3.3 show respectively the TLC results for essential oils, 
dichloromethane: methanol extracts and aqueous extracts of A. afra, L. javanica alone and in 
combination.  
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In Figure 3.1, compounds not visible under UV light of 254 nm or UV of 365 nm or white 
light are then seen when the TLC plate has been derivatized. Several compounds in A. afra 
essential oil were detected under 254 nm of UV light. 
 
 
 
Figure 3.1 TLC of the essential oils of A. afra, L. javanica individually and in combination 
under UV light of 254 nm, UV light of 365 nm and visualized with vanillin-sulphuric acid 
reagent. Aa - A. afra; Lj - L. javanica; Aa + Lj -A. afra with L. javanica. 
 
The combination of A. afra and L. javanica essential oil showed a mixture of the components 
of each of the oils, although to a lesser degree. Under UV light of 365 nm, compounds at the 
starting point for all three lanes were visible. A single compound, red in colour with Rf = 
0.35, was visible in L javanica alone, as well as in the combination with A. afra. After 
derivatization with vanillin-sulphuric acid reagent, many compounds not previously visible 
were observed.  
 
The dichloromethane: methanol extracts (Figure 3.2) showed good separation of the 
constituents of each plant under UV light of 254 nm. The combination of A. afra with L. 
javanica also showed very clearly the compounds that are visible singularly. The derivatized 
plate also demonstrated good separation with a greenish-yellow coloured major compound 
found in L. javanica (Rf = 0.45). This compound was also clearly visible in the combination 
wherein A. afra was combined with L. javanica.  
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Figure 3.2 TLC of the dichloromethane: methanol extracts of A. afra, L. javanica 
individually and in combination under UV light of 254 nm, under UV light of 365 nm, 
visualized under white light and visualized with vanillin-sulphuric acid reagent. Aa - A. afra; 
Lj - L. javanica; Aa + Lj -A. afra with L. javanica. 
 
The TLC chromatograms of the aqueous extracts (Figure 3.3) of A. afra, L. javanica and their 
combination showed many compounds at 254 nm and 365 nm. After derivatization, 
compounds in L. javanica that were present in the dichloromethane: methanol extract were 
noted in the aqueous extracts of L. javanica and in the combination with A. afra at Rf = 0.45. 
 
The HPTLC chromatograms show the complexity of the different plants. This is increased 
when the plants are combined. Thus, the individual components of the plants singularly and 
in combination with other plants would be very difficult to identify.  
 
The presence of a greater number of bands in the combination TLC shows that combining 
plants together creates complex phytochemical pools and therefore more possibilities for 
synergistic interactions between the compounds that are now in contact with each other. 
There are also increased opportunities for antimicrobial interaction against bacteria as 
different compounds may inhibit microbes using different mechanisms thus resulting in 
synergy. 
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Figure 3.3 TLC of the aqueous extracts of A. afra, L. javanica individually and in 
combination under UV light of 254 nm, under UV light of 365 nm, visualized under white 
light and visualized with vanillin-sulphuric acid reagent. Aa - A. afra; Lj - L. javanica; Aa + 
Lj -A. afra with L. javanica. 
 
3.2.2 Antimicrobial analysis 
3.2.2.1 MIC assays and FIC determination  
MIC values obtained for the negative controls, ciprofloxacin and amphotericin B, against the 
micro-organisms used in the study are shown in Table 3.3. MIC values were interpreted and 
classified according to Table 2.4, Chapter 2. The negative control, acetone, was noted 
immediately when checking the results of the experiment and where problems were 
experienced tests were repeated.  
 
Table 3.3 MIC values obtained for controls (μg/ml) 
 
 
 
 
 
 
 
 
 
 
Micro-organism 
Controls 
Ciprofloxacin/Amphotericin B 
M. catarrhalis ATCC 23246 6.3 
K. pneumoniae NCTC 9633 0.2 
E. faecalis ATCC 29212 0.6 
C. neoformans ATCC 90112 3.1 
S. pneumoniae ATCC 49619 0.3 
S. pyogenes ATCC 8668 0.6 
S. agalactiae ATCC 55618 1.3 
M. smegmatis (clinical) 0.2 
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Culture purity and signs of contamination were checked by streaking out a loopful of culture 
onto agar and incubating as necessary and checked immediately after completion of 
incubation. Where antimicrobial controls did not reflect consistent expected ranges the entire 
experiment was repeated and the result deleted from the data set. Generally, the MIC values 
for A. afra and L. javanica were in the moderate range and showed good consistency from 
sample to sample. 
 
3.2.2.1.1 Essential oil 
A. afra has a broad spectrum of activity (Mangena and Muyima 1999) The MIC results of the 
essential oils of A. afra (Table 3.4) showed poor antimicrobial activity against K. 
pneumoniae, M. catarrhalis and E. faecalis with mean MIC values at 8.0, 8.7 and 8.7 mg/ml 
respectively. Some antimicrobial activity was seen against C. neoformans (3.8 mg/ml), S. 
pneumoniae (3.3 mg/ml) and S. agalactiae (4.8 mg/ml).  
 
Table 3.4 MIC and ∑FIC values of A. afra, L. javanica essential oils alone and in 
combination against different pathogens (mg/ml).  
* Values in bold indicate noteworthy activity. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail 
regarding control values. 
 
Noteworthy antimicrobial activity was seen against S. pyogenes and M. smegmatis whereby 
mean MIC values of 1.7 and 1.5 mg/ml were obtained. Thus A. afra essential oil was the 
Micro-organism 
MIC (mg/ml) ∑FIC 
A. afra L. javanica 
A. afra with 
L. javanica 
A. afra with L. 
javanica (1:1) 
Interpretation 
K. pneumoniae 
NCTC 9633 
8.0 8.0 8.0 1.0 Additive 
M. catarrhalis 
ATCC 23246 
8.7 8.0 8.0 1.0 Additive 
E. faecalis  
ATCC 29212 
8.7 8.0 8.0 1.0 Additive 
C. neoformans 
ATCC 90112 
3.8 1.5 2.0 0.9 Additive 
S. pneumoniae 
ATCC 49619 
3.3 2.0 2.0 0.8 Additive 
S. pyogenes 
ATCC 8668 
1.7 1.4 1.0 0.7 Additive 
S. agalactiae 
ATCC 55618 
4.8 4.0 4.0 0.9 Additive 
M. smegmatis 
(clinical) 
1.5 2.0 2.0 1.2 Indifferent 
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most active in inhibiting the growth of M. smegmatis and can be considered a moderate 
antimicrobial inhibitor.  
 
The antimicrobial activity of A. afra essential oil has been widely studied using the disc 
diffusion method or the MIC micro-titre plate method. In order to further substantiate the 
results obtained by disk diffusion and the MIC assays, time-kill studies were employed. In a 
disc diffusion study by Graven et al. (1992), A. afra essential oil was found to be active 
against Acinetobacter calcoaceticus, Beneckea natriegens, Brevibacterium linens, 
Citrobacter freundii, Klebsiella pneumoniae, E. faecalis, Moraxella spp. and Serratia 
marcescens.  
 
 A. afra also exhibits known fungicidal activity as described in the study by Gundidza (1993). 
It was shown that the essential oil has a strong inhibitory effect on Candida albicans, 
Aspergillus niger, Alternia alternate, Aspergillus ochraceus, Geotrichum candidum, 
Penicillium citrium and Aspergillus parasiticus. A later study by Mangena and Muyima 
(1999) using the disc diffusion assay on the essential oil of A. afra indicated that it had a 
broad spectrum antimicrobial activity. Among the most sensitive pathogens to the oil were S. 
pyogenes, Listeria monocytogenes and Acinetobacter johnsonii. S. pyogenes was used in this 
study as well and noteworthy antimicrobial activity was also seen with A. afra essential oil 
with a mean MIC value of 1.7 mg/ml. Due to the different methods used to assess the 
antimicrobial activity, direct comparisons cannot be made. However, the antimicrobial 
activity noted in this study and the one by Mangena and Muyima (1999) serves to confirm the 
inhibitory effect of A. afra on S. pyogenes which is a common cause of respiratory related 
conditions (Khan et al., 2009b). In 2002, Muyima et al. conducted a study on the 
antimicrobial activity of A. afra essential oil. Results found using the disc diffusion assay 
showed a high level of sensitivity of A. afra towards E. coli, S. aureus, Candida albicans and 
Ralstonia pickettii. 
 
Huffman et al. (2002) examined the antimicrobial activity of the essential oil of A. afra using 
the microplate method and minimum inhibitory percentages were determined. Candida 
albicans and C. neoformans gave minimum inhibitory percentages of 0.25%. In 2006, van 
Vuuren and Viljoen conducted a study on the antimicrobial activity of the essential oil of A. 
afra using the MIC micro-titre plate and the time-kill method. The essential oil was tested 
against ten pathogens including S. aureus, S. epidermidis, B. cereus, B. subtilis, E. coli, P. 
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aeruginosa, E. faecalis, K. pneumoniae, C. albicans and C. neoformans. A. afra exhibited 
MIC values of 5.7, 10.1 and 8.0 mg/ml against E. faecalis, K. pneumoniae and C. 
neoformans, respectively. These results are in congruence with those attained in this current 
study. Time-kill studies were performed against S. aureus, K. pneumoniae and C. albicans. 
The time-kill study performed against S. aureus and C. albicans revealed bactericidal 
efficacy after four hours of exposure to the essential oil of A. afra (0.5%). However, against 
K. pneumoniae, regrowth was noted after one hour of exposure.  
 
In another time-kill study by Viljoen et al. (2006b) carried out on A. afra essential oil, A. afra 
was tested against K. pneumoniae and C. neoformans over time to determine if a bactericidal 
effect was apparent in order to validate the traditional use for respiratory conditions. Against 
K. pneumoniae a bactericidal effect was noted at 0.75% within 10 min of the test. A 
bactericidal effect was noted for 1.0% of A. afra against C. neoformans within 60 min. Thus, 
the traditional use of A. afra essential oil was validated for the treatment of respiratory 
conditions. 
 
It is important to note that A. afra essential oil, to my knowledge, has never been tested 
before using the MIC micro-titre plate method against S. pyogenes, S. agalactiae and S. 
pneumoniae. This is somewhat surprising as these are key pathogens in the causes of 
respiratory conditions in South Africa and in the world. Furthermore, activities found for S. 
pyogenes were one of the best of all pathogens tested. 
 
L. javanica essential oil showed poor antimicrobial activity against K. pneumoniae, M. 
catarrhalis and E. faecalis with mean MIC values of 8.0 mg/ml. Against S. agalactiae, some 
antimicrobial activity was noted with a mean MIC value of 4.0 mg/ml. Against S. 
pneumoniae and M. smegmatis, noteworthy activity was seen, both giving a mean MIC value 
of 2.0 mg/ml. The best antimicrobial activity of L. javanica essential oil was seen against C. 
neoformans and S. pyogenes that gave mean MIC values of 1.5 and 1.4 mg/ml respectively. 
L. javanica essential oil can be further classified as a moderate inhibitor of C. neoformans 
and S. pyogenes. The noteworthy antimicrobial activity seen against C. neoformans, S. 
pneumoniae, S. pyogenes and M. smegmatis therefore supports the traditional use of L. 
javanica.  
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Antimicrobial efficacies for L. javanica essential oil has been demonstrated against E. coli, S. 
aureus, Salmonella gallnarum, Klebsiella pneumoniae, Candida albicans  P. aeruginosa, S. 
epidermidis, E. cloacae  (Mwangi et al., 1992; Chagonda et al., 1993; Ngassapa et al., 2003; 
Subramoney, 2003; Manenzhe et al., 2004). 
 
Samie et al. (2005) conducted a study testing the essential oil of L. javanica using the disc 
diffusions assay as well as the micro-dilution method. Disk diffusion showed activity against 
B. pumilus, B. subtilis, E. faecalis, E. cloacae, E. coli, P. mirabilis and K. pneumoniae. The 
micro-dilution method revealed activity against B. cereus, B. pumilus, B. subtilis, S. aureus, 
E. faecalis, E. cloacae, E. coli, P. agglomerans, P. aeruginosa, S. flexneri, A. hydrophila P. 
mirabilis, K. pneumoniae and S. cholera-suis. The MIC values obtained by Samie et al. 
(2005) against E. faecalis and K. pneumoniae were 3.0 mg/ml. These were lower than that 
noted in this current study where MIC values of 8.0 mg/ml were noted. Different 
geographical locations for collection of L. javanica could be the reason behind the differences 
in MIC values. It is known that L. javanica essential oil exhibits chemical variation with 
respect to geographical distribution (Viljoen et al., 2005) and this may contribute to the 
varied antimicrobial effects noted. 
 
Time-kill studies by Viljoen et al. (2005) against K. pneumoniae showed bactericidal effect 
within 30 min for all the concentrations tested. Against C. neoformans, the killing rate at 1% 
concentration was within one hour for L. javanica. No bactericidal effect was noted against 
B. cereus over a 24 hr period. These results validated the use of L. javanica in African 
traditional healing to treat the symptoms of colds and flu (Viljoen et al., 2005). 
 
van Vuuren and Viljoen (2006) tested the antimicrobial activity of L. javanica essential oil 
from the same locality against S. aureus, S. epidermidis, B. cereus, B. subtilis, E. coli, P. 
aeruginosa, E. faecalis, K. pneumoniae, C. albicans and C. neoformans. MIC values obtained 
against E. faecalis were 13.5 mg/ml, K. pneumoniae, 7.6 mg/ml and C. neoformans, 2.4 
mg/ml. Congruency between results of the present study was noted. A time-kill study was 
also performed by van Vuuren and Viljoen (2006) using 0.5% essential oil of L. javanica 
against S. aureus, K. pneumoniae and C. albicans. Against S. aureus a 50% reduction in 
CFU/ml was noted over 24 hrs however, no bactericidal activity was noted against K. 
pneumoniae. Against C. albicans, bactericidal activity was only noted after 24 hrs of 
exposure. These differences in activities seen between Viljoen et al. (2005), and van Vuuren 
73 
 
and Viljoen (2006), wherein the samples of L. javanica was from the same locality, are 
possibly due to the qualitative and quantitative variation seen between and within the 
populations of L. javanica. These variations occur where even a minor compound could 
affect the antimicrobial activity of the plant essential oil. This demonstrates that the 
possibilities of synergistic, antagonistic or even additive interactions are not to be ignored 
(Nakatsu et al., 2000; van Vuuren and Viljoen, 2006). 
 
The combination of A. afra with L. javanica essential oils showed poor antimicrobial activity 
against K. pneumoniae, M. catarrhalis and E. faecalis giving mean MIC values of 8.0 mg/ml. 
No increase in the MIC value, as compared to the individual oils, was noted. Some 
antimicrobial activity was seen against S. agalactiae with a mean MIC value of 4.0 mg/ml. 
Noteworthy antimicrobial activity was noted against C. neoformans, S. pneumoniae and M. 
smegmatis with mean MIC values of 2.0 mg/ml. However, against S. pyogenes a mean MIC 
value of 1.0 mg/ml was noted. The combination is thus classified as a moderate inhibitor of S. 
pyogenes. This was the most sensitive pathogen to the combination of the essential oils of A. 
afra with L. javanica.  
 
∑FIC values calculated from the combination of A. afra with L. javanica essential oil against 
K. pneumoniae, M. catarrhalis, E. faecalis, C. neoformans, S. pneumoniae, S. pyogenes and 
S. agalactiae ranged from 0.7-1.0. This indicates that the combination showed additive 
interactions against these pathogens. Only one pathogen i.e. M. smegmatis showed indifferent 
interactions for the combination with a ∑FIC value of 1.2. It is important to note that no 
antagonism against the pathogens tested was noted for the combination. 
 
The combination of A. afra with L. javanica essential oils has been tested against one 
pathogen  using a time kill assay (van Vuuren, 2007), as mentioned in Section 3.1. There 
have been numerous citations on the use of the combination in traditional African medicine 
(Smith, 1895; Watt and Breyer-Brandwijk, 1962; Hutchings et al., 1996; Neuwinger, 2000; 
Huffman et al., 2002). L. javanica is cited to be used in combination with Aloysia triphylla as 
an herbal tea for the treatment of colds, fever and asthma (van Wyk and Wink. 2004).  
 
However, scientific validation of the efficacy of the combination is nowhere to be found. 
Even though van Vuuren (2007) has studied the combination, different methodologies were 
not used in order to assess the presence of various interactions and against different micro-
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organisms. Since no previous studies on the combination have been done, comparisons 
cannot be made. However, it should be noted that no antagonism was seen in the combination 
against any of the pathogens tested. Mostly additive interactions were prominent and where 
additivity was absent, indifference was evident. Further interactive efficacies are elaborated 
on in Section 3.2.2.2. 
 
3.2.2.1.2 Dichloromethane: methanol extracts 
The MIC values observed for the dichloromethane: methanol extracts, as shown in Table 3.5, 
of A. afra showed some antimicrobial activity against K. pneumoniae (6.3 mg/ml), M. 
catarrhalis (4.7 mg/ml), E. faecalis (6.3 mg/ml), C. neoformans (1.2 mg/ml), S. pyogenes 
(1.1 mg/ml), S. agalactiae (3.0 mg/ml) and M. smegmatis (1.7 mg/ml). The antimicrobial 
activity of A. afra against C. neoformans and S. pyogenes (MIC values of 1.2 and 1.1 mg/ml) 
can further classify A. afra dichloromethane: methanol extract as a moderate inhibitor of 
these two pathogens. Noteworthy and probably the best antimicrobial activity were seen for 
A. afra against S. pneumoniae where a mean MIC value of 0.5 mg/ml was obtained. A. afra 
dichloromethane: methanol extract can thus be further classified as being a strong inhibitor of 
S. pneumoniae. 
 
A. afra methanol extracts were tested for antimicrobial activity using the disc diffusion assay 
by Rabe and van Staden (1997) and activity was noted against S. aureus and B. subtilis. 
McGaw et al. (2000) later performed disc diffusion assays as well as MIC dilution assays to 
determine the antimicrobial activity of A. afra. The hexane extract and the ethanol extracts 
were tested. No activity against the pathogens at the concentration tested (12.5 mg/ml) was 
seen with the hexane extracts. The ethanol extracts however, showed activity against B. 
subtilis and S. aureus when using both antimicrobial assays. Braithwaite et al. (2008) studied 
the methanol and the acetone extracts of A. afra to validate smoke inhalation therapy to treat 
some microbial infections. The MIC micro-titre plate assay was used and noteworthy activity 
(<1.0 mg/ml) was seen only for the acetone extracts against S. aureus (MIC value = 0.25 
mg/ml), B. cereus (MIC value = 0.25 mg/ml) and C. neoformans (MIC value = 0.75 mg/ml). 
Some antimicrobial activity was noted with the acetone extract of A. afra against K. 
pneumoniae with an MIC value of 2.0 mg/ml. Results obtained in this study vary slightly 
compared to previous studies mentioned. However, direct comparisons are difficult as the 
type of extracts and the pathogens tested are different.   
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Table 3.5 MIC and ∑FIC values of A. afra and L. javanica dichloromethane: methanol 
extracts alone and in combination against different pathogens (mg/ml).  
Micro-organism 
MIC (mg/ml) ∑FIC 
A. afra L. javanica 
A. afra with L. 
javanica 
A. afra with 
L. javanica 
(1:1) 
Interpretation 
K. pneumoniae 
NCTC 9633 
6.3 16.0 6.0 0.7 Additive 
M. catarrhalis 
ATCC 23246 
4.7 6.0 6.0 1.1 Indifferent 
E. faecalis  
ATCC 29212 
6.3 2.5 4.7 1.3 Indifferent 
C. neoformans 
ATCC 90112 
1.2 3.5 2.0 1.1 Indifferent 
S. pneumoniae 
ATCC 49619 
0.5 0.4 0.6 1.4 Indifferent 
S. pyogenes 
ATCC 8668 
1.1 0.4 1.5 2.6 Indifferent 
S. agalactiae 
ATCC 55618 
3.0 2.2 1.1 0.4 Synergy 
M. smegmatis 
(clinical) 
1.7 1.5 2.5 1.6 Indifferent 
* Values in bold indicate noteworthy activity. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail 
regarding control values. 
 
When Mativandlela et al. (2008) tested the ethanol extracts of A. afra against M. smegmatis; 
an MIC value of 1.56 mg/ml was obtained. This result is in congruence with the findings in 
this study where the mean MIC value obtained against M. smegmatis was 1.7 mg/ml. This 
report by Mativandlela et al. (2008) together with the results from this study provides 
evidence to support the use of A. afra against certain respiratory pathogens.  
 
L. javanica dichloromethane: methanol extract displayed very poor antimicrobial activity 
against K. pneumoniae with a mean MIC value of 16.0 mg/ml. MIC values ranging from 2.2 -
6.0 mg/ml, showing some antimicrobial activity, were obtained against S. agalactiae, E. 
faecalis, C. neoformans and M. catarrhalis. Moderate inhibition was obtained against M. 
smegmatis with a MIC value of 1.5 mg/ml. Noteworthy activity with strong inhibition was 
noted for L. javanica against S. pneumoniae and S. pyogenes with mean MIC values of 0.4 
mg/ml.  
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L. javanica methanol, acetone and hexane extracts have been tested for their antimicrobial 
activity (Samie et al., 2005) using the disc diffusion and the MIC micro-titre plate method. 
The methanol extract of the leaves were active against B. cereus, B. subtilis, E. faecalis, E. 
cloacae, E. coli, S. flexneri, A. hydrophila and S. cholera-suis with MIC values ranging 
between 1.5-6.0 mg/ml. Against K. pneumoniae poor activity was noted with an MIC value 
of 12.0 mg/ml. Against E. faecalis, some antimicrobial activity was evident where a MIC 
value of 3.0 mg/ml was noted. This correlates with the results found in this study wherein 
MIC values against K. pneumoniae and E. faecalis were 16.0 and 2.5 mg/ml respectively. 
The acetone extracts exhibited similar activities to the methanol extracts with MIC values of 
6.0 mg/ml against E. faecalis and 12.0 mg/ml against K. pneumoniae. The hexane extracts 
exhibited less activity against the tested pathogens with poor antimicrobial activity against E. 
faecalis and K. pneumoniae (12.0 mg/ml).  
 
The methanol extracts of L. javanica were similarly tested against four pathogens i.e. S. 
aureus, E. faecalis, E. coli and P. aeruginosa (Shikanga et al., 2010). Noteworthy activities 
were noted with all the MIC values below 1.0 mg/ml. Relevant to the current study, was the 
MIC value obtained against E. faecalis of 0.14 mg/ml. This denoted very strong inhibition 
and very interesting activity. However, this was not a result that was demonstrated in the 
current study where the MIC value obtained was 2.5 mg/ml. This difference could be due to 
the differing collection localities and/or the chemical variations between and in natural 
populations (Viljoen et al., 2005).   
 
Samie at el. (2010) tested the acetone and the hexane extracts of the leaves of L. javanica 
against three fungal organisms. Antifungal activity was noted for the acetone extracts against 
Candida krusei (MIC value of 1.88 mg/ml). The hexane extracts showed activity against C. 
albicans and C. krusei, both with MIC values of 3.75 mg/ml. No activity against C. 
neoformans (MIC value of >7.5 mg/ml) at the highest concentration tested was noted for 
either the acetone or the hexane extracts. However, in the current study some activity (MIC 
value = 3.5 mg/ml) was noted against C. neoformans. Again, geographical and chemical 
variations may be a contributing factor. 
 
L. javanica dichloromethane: methanol extracts have not previously been tested against S. 
pneumoniae and S. pyogenes (where best activities were noted in this study). This is 
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surprising as Streptococcus spp are well known respiratory organisms and the traditional use 
of L. javanica is for the treatment of just such infections. The results obtained in this study, 
however, serve to validate the use of L. javanica in the treatment of S. pneumoniae (bacterial 
pneumoniae) and S. pyogenes (“strep” throat) related infections. 
 
The combination of A. afra with L. javanica dichloromethane: methanol extracts showed 
some antimicrobial activity against K. pneumoniae, M. catarrhalis, E. faecalis, C. 
neoformans and M. smegmatis with MIC values ranging from 2.0-6.0 mg/ml. Moderate 
inhibition was noted against S. pyogenes and S. agalactiae. The best antimicrobial activity 
with noteworthy inhibition was found against S. pneumoniae with an MIC value of 0.6 
mg/ml. 
 
∑FIC values calculated showed indifferent interactions for all the pathogens tested with the 
exception of K. pneumoniae and S. agalactiae. An additive interaction was noted against K. 
pneumoniae with a ∑FIC value of 0.7. A synergistic interaction of the combination of A. afra 
with L. javanica was seen with ∑FIC = 0.4 against S. agalactiae.  
 
The particular combination of A. afra with L. javanica dichloromethane: methanol extracts 
have also not been studied previously. From this study, the ∑FIC results did not show any 
antagonistic interactions. In fact, additivity was noted against K. pneumoniae (∑FIC value of 
0.7). Synergy was observed for S. agalactiae (∑FIC value of 0.4). As K. pneumoniae is a 
leading cause of nosocomial pneumoniae (Ko et al., 2002; Yu et al., 2007; Brisse et al., 2009) 
in South Africa; this may prove to be a useful discovery. 
 
3.2.2.1.3 Aqueous extracts 
The aqueous extracts of A. afra (Table 3.6) showed generally poor antimicrobial activity 
against the pathogens tested with some antimicrobial activity against C. neoformans (4.0 
mg/ml) and S. pyogenes (5.3 mg/ml). The best activity of A. afra aqueous extract was seen 
against S. agalactiae giving weak antimicrobial activity with a mean MIC value of 1.7 
mg/ml. poor antimicrobial activity was noted against M. catarrhalis, S. pneumoniae and M. 
smegmatis, all yielding mean MIC values of 8.0 mg/ml while against E. faecalis a MIC value 
of 7.0 mg/ml was obtained. Very poor activity was seen against K. pneumoniae where a mean 
MIC value of 12.0 mg/ml was noted. 
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Table 3.6 MIC and ∑FIC values of A. afra, L. javanica aqueous extracts alone and in 
combination against different pathogens (mg/ml).  
* Values in bold indicate noteworthy activity. 
ND
1 
No ∑FIC value could be calculated as no MIC end point for L. javanica was obtained at 
the highest concentration tested. 
2
 Tentative interpretation according to MIC data. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail 
regarding control values. 
 
The aqueous extracts of A. afra were tested by Rabe and van Staden (1997) and no activity at 
the concentration tested (100.0 mg/ml) was noted when using the disc diffusion method for 
antimicrobial assessment. McGaw et al. (2000) also tested A. afra aqueous extracts and found 
no antimicrobial activity using the disc diffusion method as well as the MIC micro-titre plate 
method. Aqueous extracts have been known to exhibit poor to no antimicrobial activity 
(Jäger, 2003; Abu-Shanab et al., 2004; van Vuuren, 2008). This is in contrast to the 
traditional method of preparation of plants where most often the infusion or the decoctions 
are used.  
 
L. javanica aqueous extract showed some antimicrobial activity against C. neoformans, S. 
pneumoniae, S. pyogenes and M. smegmatis with mean MIC values ranging between 3.0-6.0 
mg/ml. Against K. pneumoniae and M. catarrhalis, L. javanica was not active at the highest 
Micro-organism 
MIC (mg/ml) ∑FIC 
A. afra L. javanica 
A. afra with 
L. javanica 
A. afra with L. 
javanica (1:1) 
Interpretation 
K. pneumoniae 
NCTC 9633 
12.0 ≥16.0 12.0 ND1 Additive2 
M. catarrhalis 
ATCC 23246 
8.0 ≥16.0 8.0 ND1 Additive2 
E. faecalis  
ATCC 29212 
7.0 12.0 8.0 0.9 Additive 
C. neoformans 
ATCC 90112 
4.0 3.5 3.0 0.8 Additive 
S. pneumoniae 
ATCC 49619 
8.0 4.0 8.0 1.5 Indifferent 
S. pyogenes 
ATCC 8668 
5.3 3.0 4.0 1.0 Additive 
S. agalactiae 
ATCC 55618 
1.7 0.5 0.8 1.0 Additive 
M. smegmatis 
(clinical) 
8.0 6.0 8.0 1.2 Indifferent 
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concentration tested while very poor activity was seen against E. faecalis with a mean MIC 
value of 12.0 mg/ml. Interestingly, noteworthy strong antimicrobial inhibition was noted 
against S. agalactiae where a mean MIC value of 0.5 mg/ml was obtained. 
 
Thembo et al. (2010) tested the aqueous extracts of L. javanica and found no activity against 
some mycotoxigenic fungi. However, results from the current study provided an exception 
against S. agalactiae wherein strong inhibitory activity (MIC value of 0.5 mg/ml) was noted. 
S. agalactiae is a respiratory tract pathogen and causes pneumonia in healthy humans. The 
use of L. javanica infusions and decoctions in traditional medicine may have solid scientific 
support due to the inhibition observed in this study. Shikanga et al. (2010) tested the 
methanol extracts of L. javanica as a substitute of the aqueous extracts as the extract 
compositions were similar and the methanol extracts are easier to dry. The study was 
performed to determine the antioxidant and antibacterial activity of L. javanica infusions. 
Results were promising with noteworthy activities recorded.  
 
When A. afra was combined with L. javanica aqueous extract very poor antimicrobial 
activity was noted against the pathogen K. pneumoniae (MIC value of 12.0 mg/ml) and low 
activity was noted against M. catarrhalis, E. faecalis, S. pneumoniae and M. smegmatis 
(mean MIC values of 8.0 mg/ml). Some antimicrobial activity was seen against C. 
neoformans and S. pyogenes with mean MIC values of 3.0 and 4.0 mg/ml. Noteworthy 
activity was again noted against S. agalactiae, with a mean MIC value of 0.8 mg/ml. 
 
∑FIC values for the combination of A. afra with L. javanica against K. pneumoniae and M. 
catarrhalis could not be calculated, as the end point MIC value of L. javanica was not 
determined. However, based on the MIC values a tentative interpretation is made. Thus 
against K. pneumoniae and M. catarrhalis the combination of A. afra with L. javanica 
aqueous extracts additive interactions are apparent. Additivity is also evident against E. 
faecalis, C. neoformans, S. pyogenes and S. agalactiae from the calculated ∑FIC values. 
Indifferent interactions were noted against S. pneumoniae and M. smegmatis.  
 
The combination of A. afra with L. javanica aqueous extract has not been studied previously. 
In this study, low to poor activity was noted when testing this combination. ∑FIC values 
showed the combination was additive for most of the pathogens while some were indifferent. 
Interestingly S. agalactiae was the most sensitive pathogen to the combination. Thus, this 
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combination would be ideal in the treatment of S. agalactiae and S. pyogenes related 
respiratory infections.  
 
3.2.2.2 Isobologram interpretation 
A. afra, tested with L. javanica essential oils in combination against M. catarrhalis at 
different ratios were plotted on isobolograms. Results display additive interactions with all 
points on the line (Figure 3.4). The dichloromethane: methanol extracts of the same 
combination also yield additive interactions with two exceptions. The exceptions, are two 
points (ratios 2:8 (Figure 3.4, point a) and 1:9 (Figure 3.4, point b), below ∑FIC = 0.5, 
wherein L. javanica is in the majority. These two combinations display synergistic 
interactions. The 1:1 ratio of the combination is represented by a square (  ) in the 
isobologram. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 Isobologram of the combination of A. afra with L. javanica essential oils (   ) and 
the dichloromethane: methanol extracts (  ) against M. catarrhalis (a – ratio 2:8; b – ratio 
1:9);        1:1 combination. 
 
The aqueous extracts have not been included in the isobologram as the end point for L. 
javanica was not determined at the highest concentration tested, thus an isobologram could 
not be constructed. However, a bar graph as depicted in Figure 3.6 shows the MIC values of 
the different ratios compared to the MIC values of A. afra independently (8.0 mg/ml) and L. 
javanica (≥16.0 mg/ml) alone against M. catarrhalis. The MIC values of the combination of 
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A. afra with L. javanica at ratios 9:1 and 8:2 were consistent at 8.0 mg/ml. At the ratio of 7:3, 
the MIC value went up to 16.0 mg/ml and at 6:4, the MIC value noted was 12.0 mg/ml.  
 
Against K. pneumoniae (Figure 3.5) the combination of A. afra with L. javanica essential oils 
yielded additive interactions for all the ratios tested. The dichloromethane: methanol extracts 
of the combination showed additive interactions for all ratios. The aqueous extracts could not 
be included in the isobologram as the end point of L. javanica could not be determined.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 Isobologram of the combination of A. afra with L. javanica essential oils (   ) and 
the dichloromethane: methanol extracts (   ) against K. pneumoniae;        1:1 combination. 
 
The bar graph of the MIC values obtained for the different ratios tested are shown in Figure 
3.6. This shows that at higher concentrations of A. afra, between ratios 9:1, 8:2 and 6:4, the 
MIC values (6.0 mg/ml) of the combination is lower than that of A. afra alone or L. javanica 
alone. The MIC value of the ratio 7:3 was the same as A. afra, 8.0 mg/ml. When combined in 
equal ratios, the activity of the combination is the same as that of A. afra alone. However, 
when L. javanica is in the majority, the MIC of the combination was higher than the 
concentration of the combination that was tested i.e. ≥16.0 mg/ml. Where A. afra (aqueous 
extract) is present in higher concentrations, better antimicrobial activity is noted against K. 
pneumoniae (Figure 3.6). 
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Figure 3.6 The MIC values of the different ratios of the combination of A. afra with L. 
javanica aqueous extracts against M. catarrhalis and K. pneumoniae.  
 
In the combination of A. afra with L. javanica against E. faecalis (Figure 3.7), the essential 
oils showed additive pharmacological interaction for all the ratios tested. The 
dichloromethane: methanol extracts showed additive interactions as well for most of the 
ratios with the exception of two ratios. The ratio 2:8 (Figure 3.7, point c) showed additivity 
and the ratio 1:9 (Figure 3.7, point d) was synergistic. This suggests that an ideal combination 
of A. afra with L. javanica dichloromethane: methanol extracts would be with one part of A. 
afra and nine parts of L. javanica. The aqueous extracts showed additive interactions for all 
the ratios tested with one ratio i.e. 9:1, was found on the 1:0 and 0:1 line of the isobologram. 
A. afra was the majority plant in this combination.   
 
Isobologram interactions of the combination of A. afra with L. javanica essential oils against 
C. neoformans (Figure 3.8) resulted in additive interactions. The dichloromethane: methanol 
extract also gave additivity at the ratios tested. Two ratios however, showed indifference 
when combined. These were the ratios 7:3 (Figure 3.8, point e), where A. afra was in the 
majority and 1:9 (Figure 3.8, point f), where L. javanica was dominant. When the aqueous 
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extracts of A. afra and L. javanica were combined in nine ratios, additive interactions were 
also noted 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7 Isobologram of the combination of A. afra with L. javanica essential oils (   ),     
dichloromethane: methanol (  ) and aqueous extracts (  ) against E. faecalis (c – ratio 2:8; d – 
ratio 1:9);       1:1 combination. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 Isobologram of the combination of A. afra with L. javanica essential oils (   ) 
dichloromethane: methanol (   ) and aqueous extracts (   ) against C. neoformans (e – ratio 
7:3; f – ratio 1:9);       1:1 combination. 
 
The 1:1 combination of A. afra with L. javanica essential oil and dichloromethane: methanol 
extracts of the isobolograms (Figure 3.4 and 3.5) and the ∑FIC values showed good 
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correlation and congruency against M. catarrhalis and K. pneumoniae (Table 3.4 and 3.5). 
Against E. faecalis and C. neoformans, similarities were apparent for the combination of the 
essential oils and the aqueous extracts. Partial congruency was noted with the differences in 
the dichloromethane: methanol extracts where additivity was seen in the isobolograms and 
indifference was seen in the ∑FIC values. One possible explanation for this variability is the 
possibility of disparate mechanisms of interaction due to the differing methods of testing 
(Beale and Sutherland, 1983; van Vuuren, 2007). 
 
3.3 Conclusions 
 The major constituents of the essential oil of A. afra were camphene (4.0%), 1,8-
cineole (17.0%), artemisia ketone (6.4%), β-thujone (6.0%), camphor (41.0%) and 
borneol (8.6%), representing 83.0% accumulatively.   
 The major compounds of the essential oil of L. javanica are 1,8-cineole (2.3%), p-
cymene (3.4%), trans-linalool oxide (4.5%), cis-linalool oxide (4.0%), linalool 
(70.7%) and caryophyllene oxide (6.9%), representing accumulatively 91.8%. 
 The TLC studies for A. afra and L. javanica essential oils, dichloromethane: methanol 
extracts and the aqueous extracts showed visible bands under different wavelengths 
and gave a unique fingerprint of the plants independently and in combination used in 
this assay.  
 The dichloromethane: methanol extracts of A. afra indicated better antimicrobial 
activity (MIC values between 0.5-6.3 mg/ml) than that of A. afra essential oil (MIC 
values between 1.5-8.7 mg/ml) followed by the aqueous extracts with MIC values 
ranged from 1.7-12.0 mg/ml. The best activity for the dichloromethane: methanol 
extracts of A. afra was against S. pneumoniae with a MIC value of 0.5 mg/ml. 
 The highest efficacy, using the ∑FIC determination method, in the combination study 
of A. afra with L. javanica was noted with the dichloromethane: methanol extracts 
against S. agalactiae (∑FIC value of 0.4) which was synergistic. 
 Synergistic interactions in the isobologram study of the combination of A. afra with L. 
javanica were noted with the best activity noted in two ratios for the dichloromethane: 
methanol extracts against M. catarrhalis. One ratio against E. faecalis was also found 
to be synergistic 
 No antagonism for the combination was noted against any of the pathogens tested. 
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 The efficacies shown against the pathogens tested, using the MIC micro-titre plate, 
∑FIC determination and the isobologram methods give credence and provide 
evidence to support the traditional use of A. afra with L. javanica in combination for 
the treatment of M. catarrhalis, E. faecalis, and S. agalactiae related respiratory tract 
infections. It should, however, be noted that further toxicity and in vivo studies are 
needed to confirm safety and efficacy.  
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Chapter 4 
The antimicrobial efficacy of Artemisia afra Jacq. Ex Willd and 
Osmitopsis asteriscoides (L.) Cass. In combination. 
 
 
4.1 Introduction 
The plants A. afra and O. asteriscoides have been mentioned in the ethnobotanical literature 
for their use in combination. Traditionally, a tincture of this combination has been used for 
the treatment of respiratory complaints (Watt and Breyer-Brandewijk, 1962). The aim of the 
study of this combination was to determine if any increase, decrease or non-inhibitory effect 
was noted when the two plants were combined. A monograph (medicinal uses, botanical 
description, geographical distribution and locality) for O. asteriscoides can be found in 
Appendix A7. 
 
4.2 Results and discussion 
4.2.1 Chromatographic techniques 
4.2.1.1 Essential oil composition of O. asteriscoides 
GC-MS results revealed a total of 32 compounds with the major compound as 1,8-cineole 
(59.0%). As shown in Table 4.1, camphor and α-terpineol were also present at 8.2 and 7.2% 
respectively. The major compounds accumulatively make up 74.4% of the total composition 
of the oil (91.6%). 
 
In the study by Viljoen et al. (2003), where O. asteriscoides was collected from a population 
near Betty‟s Bay in the South Western Cape region of South Africa, the two major 
compounds found in the pooled sample of plants from the population were 1,8-cineole and 
camphor, representing 59.9% and 12.4% respectively of the total oil. Other minor compounds 
were also found. These included α-pinene, camphene, ρ-cymene, longipinene, and α-
terpineol. In the current study the percentage of 1,8-cineole is congruent (59.0%) with that of 
Viljoen et al. (2003) and cited in van Vuuren and Viljoen (2006). The percentage of α-
terpineol in this study (7.2%) is congruent with that of Viljoen et al, (2003) which contained 
7.8% of the total essential oil. The percentage of camphor (8.2%) is slightly different to 
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Viljoen et al. (2003) which made up 12.4% of the total composition of oil. These differences 
in chemical composition are most likely due to the different collection sites.  
 
Table 4.1 GC-MS profile of O. asteriscoides. 
RRI* Compounds Area (%) 
1016 α-Pinene 2.0 
1019 α-Thujene 0.1 
1057 Camphene 1.1 
1104 β-Pinene 0.5 
1117 Sabinene 1.2 
1159 Myrcene 0.1 
1193 α-Terpinene 0.3 
1184 2,3-Dehydro-1,8-cineole 0.2 
1193 Limonene 0.1 
1202 1,8-Cineole 59.0 
1242 γ-Terpinene 0.5 
1270 p-Cymene 0.7 
1281 Terpinolene 0.1 
1382 (z)-Hex-3-en-1-ol 0.1 
1441 trans-Linalool oxide 0.1 
1456 trans Sabinene hydrate 0.2 
1464 α-Longipinene 2.7 
1479 α-Ylangene 0.1 
1511 Chrysanthenone 0.4 
1521 Camphor 8.2 
1546 Linalool 0.4 
1562 Terpineol-4-ol-acetate 0.2 
1573 Pinocarvone 0.2 
1586 β-Elemene 0.1 
1602 Terpinen-4-ol 2.3 
1675 d-Terpineol 0.4 
1701 α-Terpineol 7.2 
1709 Borneol 1.1 
1745 Piperitol 0.1 
1876 cis Carveol 0.1 
2010 Caryophyllene oxide 0.4 
2122 γ-Bicyclofarnesol 1.4 
Total 91.6 
*RRI:  Relative retention indices calculated against n-alkanes.  
% calculated from TIC data. 
 
4.2.1.2 Thin layer chromatography  
The thin layer chromatography of the essential oils (Figure 4.1) of O. asteriscoides 
individually (Figure 4.1, lane 2) and the combination with A. afra (Figure 4.1, Lane 3) at 254 
nm showed some polar compounds. Compounds in A. afra alone (Figure 4.1, lane 1) are 
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visible in the combination as well. After derivatization, many more compounds were visible. 
Major bands at Rf = 0.2, 0.25, 0.4 and 0.45 were evident. 
 
 
 
 
Figure 4.1 TLC of the essential oils of A. afra, O. asteriscoides individually and in 
combination at 254 nm, 365 nm and visualized with vanillin-sulphuric acid reagent. Aa – A. 
afra; Oa – O. asteriscoides; Aa + Oa – A. afra with O. asteriscoides. 
 
The dichloromethane: methanol extracts showed that good separation was achieved as shown 
in Figure 4.2. Many compounds were visible under 254 nm. Under 365 nm, the highly 
fluorescent compounds at Rf = 0.3 and 0.35 (blue in colour) found in A. afra were also 
visible.  
 
 
 
Figure 4.2 TLC of the dichloromethane: methanol extracts of A. afra, O. asteriscoides 
individually and in combination 254 nm, 365 nm, visualized under white light and visualized 
with vanillin-sulphuric acid reagent. Aa – A. afra; Oa – O. asteriscoides; Aa + Oa – A. afra 
with O. asteriscoides. 
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Scott et al. (2004), studied the dichloromethane extracts of O. asteriscoides and found four 
bands when derivatized at Rf = 0.25 (yellow), 0.39 (yellow), 0.58 (purple) and 0.73 (light 
purple. Similar bands were detected in this study with an extra major band at Rf = 0.8. 
 
The aqueous extracts showed poor separation for O. asteriscoides and the combination with 
A. afra. A major band was visualized after derivatization at Rf = 0.9 for O. asteriscoides and 
the combination.   
 
 
Figure 4.3 TLC of the aqueous extracts of A. afra, O. asteriscoides individually and in 
combination at 254 nm; 365 nm; visualized under white light; visualized with vanillin-
sulphuric acid reagent. Aa – A. afra; Oa – O. asteriscoides; Aa + Oa – A. afra with O. 
asteriscoides. 
 
4.2.2 Antimicrobial analysis 
4.2.2.1 MIC assays and FIC determination  
4.2.2.1.1 Essential oils 
The MIC values of O. asteriscoides essential oils individually and in combination with A. 
afra are given in Table 4.2. Even though the MIC values of A. afra essential oil have been 
discussed and evaluated in Chapter 3, Section 3.2.2.1, they have been shown in Table 4.2 for 
the sake of completeness. MIC values for O. asteriscoides essential oil ranged from as low as 
1.0 mg/ml to 8.0 mg/ml. Noteworthy activity was seen against C. neoformans (MIC value = 
2.0 mg/ml), S. pyogenes (MIC value = 1.7 mg/ml) and against M. smegmatis (MIC value = 
1.3 mg/ml). The best MIC value of 1.0 mg/ml was obtained for O. asteriscoides against S. 
pneumoniae.  
 
254 nm 
 
A 
White light 
 
C 
365 nm 
 
B 
Derivatized 
 
D 
Aa       Oa     Aa + Oa    Aa       Oa     Aa + Oa      Aa      Oa     Aa + Oa         Aa       Oa      Aa + Oa   
90 
 
Table 4.2 MIC (mg/ml) and ∑FIC values of A. afra and O. asteriscoides essential oils alone 
and in combination. 
*Values given in bold indicate noteworthy activity. 
Shaded area: results previously discussed in Chapter 3 but included here for reference 
purposes. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail 
regarding control values. 
 
Viljoen et al. (2003) investigated the antimicrobial activity of O. asteriscoides essential oil 
using the disk diffusion, MIC and time-kill studies. MIC results for E. faecalis showed no 
activity at the highest concentration tested and an MIC value of 8.0 mg/ml against C. 
neoformans was obtained. The antimicrobial activity of O. asteriscoides is said to be mostly 
due to the high percentage of 1,8-cineole, which has been shown to have a broad spectrum of 
antimicrobial activity (Pattnaik et al., 1997). Historically cineole rich essential oils have been 
used in the treatment of respiratory conditions (Silvestre et al., 1999; Viljoen et al., 2003). 
Camphor, which is also a major compound found in O. asteriscoides, is known to be an 
antiseptic and a decongestant (Bruneton, 1995). Viljoen et al. (2003) tested the antimicrobial 
activity of 1,8-cineole and camphor independently and in combination and compared it to O. 
Micro-organism 
MIC (mg/ml) ∑FIC 
A. afra O. asteriscoides 
A. afra with  
O. asteriscoides 
A. afra with  
O. asteriscoides 
(1:1) 
Interpretation 
K. pneumoniae 
NCTC 9633 
8.0 8.0 8.0 1.0 Additive 
M. catarrhalis 
ATCC 23246 
8.7 8.0 8.0 1.0 Additive 
E. faecalis  
ATCC 29212 
8.7 8.0 8.0 1.0 Additive 
C. neoformans 
ATCC 90112 
3.8 2.0 2.0 0.8 Additive 
S. pneumoniae 
ATCC 49619 
3.3 1.0 1.0 0.7 Additive 
S. pyogenes 
ATCC 8668 
1.7 1.7 1.5 0.9 Additive 
S. agalactiae 
ATCC 55618 
4.8 4.7 7.0 1.5 Indifferent 
M. smegmatis 
(clinical) 
1.5 1.3 1.5 1.1 Indifferent 
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asteriscoides essential oil and found that the two compounds act synergistically to enhance 
the overall activity of the oil. 
 
O. asteriscoides essential oil was tested by van Vuuren and Viljoen (2006) using the MIC 
micro-titre plate method and time-kill studies. MIC values were determined against S. aureus, 
S. epidermidis, B. cereus, B. subtilis, E. coli, P. aeruginosa, E. faecalis, K. pneumoniae, C. 
albicans and C. neoformans. Comparable pathogens, E. faecalis, K. pneumoniae and C. 
neoformans gave MIC values of 7.0, 11.9 and 1.0 mg/ml respectively. These results are in 
alignment with those obtained in the present study. Time-kill studies revealed bactericidal 
activity against S. aureus after 24 hrs. Against K. pneumoniae cidal activity was noted within 
one hour of exposure; however, regrowth occurred after four hours. Cidal effects were noted 
against C. albicans with four hours of exposure to the essential oil.  
 
In the study by van Vuuren (2007), MIC assays were performed on O. asteriscoides essential 
oil against ten pathogens. Two of these i.e. E. faecalis and C. neoformans, can be compared 
to the results obtained in this study. MIC values obtained by van Vuuren (2007) were 8.0 
mg/ml for both pathogens. The results of this study are comparable with that of van Vuuren 
(2007) for the pathogen E. faecalis. However, for C. neoformans, the MIC determined in this 
study was much lower (2.0 mg/ml) . A possible explanation could be the difference in the 
chemical composition of the samples an due to the fact that the localities for sample 
collection were different, thus producing a different MIC. 
 
In the combination of O. asteriscoides with A. afra, noteworthy antimicrobial activity was 
noted against the same pathogens as was for O. asteriscoides i.e. C. neoformans (2.0 mg/ml), 
S. pneumoniae (1.0 mg/ml), S. pyogenes (1.5 mg/ml) and M. smegmatis (1.5 mg/ml). The 
MIC values of the combination against K. pneumoniae, M. catarrhalis and E. faecalis 
remained constant for the essential oils independently and in combination. Thus, the ∑FIC 
values showed additive interactions when A. afra was combined with O. asteriscoides against 
these pathogens (∑FIC = 1). Other ∑FIC values of note were against C. neoformans, S. 
pneumoniae and S. pyogenes with values of 0.8, 0.7 and 0.9 respectively. Indifferent 
interactions were noted against S. agalactiae and M. smegmatis. No antagonism was noted 
for the combination against any of the pathogens tested. 
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4.2.2.1.2 Dichloromethane: methanol extracts 
The O. asteriscoides dichloromethane: methanol extract was active against all the pathogens 
tested (Table 4.3) with at least some antimicrobial activity noted (MIC values between 0.3 - 
4.0 mg/ml). Activities for S. pneumoniae and S. pyogenes showed noteworthy sensitivity both 
with MIC values of 0.4 mg/ml, indicating O. asteriscoides is a strong inhibitor against these 
pathogens. The best activity was noted against C. neoformans where an MIC value of 0.3 
mg/ml was obtained. 
 
Table 4.3 MIC and ∑FIC values of A. afra and O. asteriscoides dichloromethane: methanol 
extracts alone and in combination. 
*Values given in bold indicate noteworthy activity. 
Shaded area: results previously discussed in Chapter 3 but included here for reference 
purposes. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail 
regarding control values. 
 
For the combination with A. afra, some antimicrobial activity was noted against K. 
pneumoniae, M. catarrhalis, E. faecalis and S. agalactiae (MIC values between 1.0 - 6.0 
mg/ml). Noteworthy activity was seen against C. neoformans, S. pneumoniae, S. pyogenes 
and M. smegmatis. A. afra with O. asteriscoides in combination were strong inhibitors 
against these four pathogens with MIC values ranging at 0.1 - 0.5 mg/ml.  
Micro-organism 
MIC (mg/ml) ∑FIC 
A. afra O. asteriscoides 
A. afra with 
O. 
asteriscoides 
A. afra with 
O. asteriscoides 
(1:1) 
Interpretation 
K. pneumoniae 
NCTC 9633 
6.3 4.0 6.0 1.2 Indifferent 
M. catarrhalis 
ATCC 23246 
4.7 4.0 4.0 0.9 Additive 
E. faecalis  
ATCC 29212 
6.3 2.0 4.0 1.3 Indifferent 
C. neoformans 
ATCC 90112 
1.2 0.3 0.3 0.7 Additive 
S. pneumoniae 
ATCC 49619 
0.5 0.4 0.1 0.3 Synergy 
S. pyogenes 
ATCC 8668 
1.1 0.4 0.1 0.2 Synergy 
S. agalactiae 
ATCC 55618 
3.0 1.3 1.0 0.6 Additive 
M. smegmatis 
(clinical) 
1.7 1.4 0.5 0.3 Synergy 
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∑FIC values then calculated showed synergistic interactions with the combination against S. 
pneumoniae, S. pyogenes and M. smegmatis with values of 0.3, 0.2 and 0.3 respectively. 
Additive interactions were observed against M. catarrhalis, C. neoformans and S. agalactiae. 
Thus against all the pathogens tested for this combination, either synergy or additivity was 
noted with the exception of K. pneumoniae and E. faecalis which were indifferent.  
 
The dichloromethane: methanol extracts of O. asteriscoides have not to this date been tested 
for their antimicrobial activity. This study demonstrates for the first time the antimicrobial 
activity, using MIC methodology, of the dichloromethane: methanol extracts of O. 
asteriscoides independently and in combination. It is surprising that no studies have been 
done on the extracts as the traditional method of administration of O. asteriscoides is as a 
tincture. It is thus important that the alcohol extracts be tested for their activity in treating 
respiratory tract diseases. 
 
4.2.2.1.3 Aqueous extracts 
The antimicrobial analysis of the aqueous extracts (Table 4.4) of O. asteriscoides yielded 
MIC values between 0.5 - 9.0 mg/ml against the pathogens tested. The lowest MIC value was 
against C. neoformans, with a value of 0.5 mg/ml. Moderate inhibition was also noted for O. 
asteriscoides against S. pneumoniae and S. agalactiae with values of 1.5 mg/ml. Against S. 
pyogenes the MIC value obtained was 1.8 mg/ml. 
 
For the combination of A. afra with O. asteriscoides some antimicrobial activity was 
obtained against S. pneumoniae and S. agalactiae with MIC values of 2.0 mg/ml, and 4.0 
mg/ml against M. smegmatis. Moderate antimicrobial activity was recorded for S. pyogenes 
with an MIC value of 1.5 mg/ml. Strong noteworthy inhibitory activity and the lowest MIC 
value (0.5 mg/ml) was obtained against C. neoformans.  
 
∑FIC values obtained for the combination of A. afra with O. asteriscoides aqueous extracts 
showed additive interactions against K. pneumoniae, M. catarrhalis, E. faecalis, C. 
neoformans, S. pneumoniae, S. pyogenes and M. smegmatis. It is interesting to note none of 
the interactions of A. afra with O. asteriscoides yielded antagonistic effects. 
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Table 4.4 MIC and ∑FIC values of A. afra and O. asteriscoides aqueous extracts alone and 
in combination. 
*Values given in bold indicate noteworthy activity. 
Shaded area: results previously discussed in Chapter 3 but included here for reference 
purposes. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail 
regarding control values. 
 
Scott et al. (2004) performed disc diffusion assays on the aqueous extracts of O. 
asteriscoides. Pathogens tested included S. aureus, P. aeruginosa, C. albicans and M. 
smegmatis. In their study, no activity of the aqueous infusion was noted against any of the 
pathogens tested.  
 
4.2.2.2 Isobologram interpretation 
The isobologram of the combination of A. afra with O. asteriscoides essential oils, 
dichloromethane: methanol extracts and aqueous extracts against M. catarrhalis is shown in 
Figure 4.4. The essential oils show additive interactions for all the ratios tested. The 
dichloromethane: methanol extracts showed additive interactions for most of the ratios tested 
with two points as exceptions. These two points are synergistic and they are the ratios 1:9 
(Figure 4.4, a) and 2:8 (Figure 4.4, b).  
Micro-organism 
MIC (mg/ml) ∑FIC 
A. afra 
O. 
asteriscoides 
A. afra with 
O. asteriscoides 
A. afra with 
O. asteriscoides 
(1:1) 
Interpretation 
K. pneumoniae 
NCTC 9633 
12.0 8.0 8.0 0.8 Additive 
M. catarrhalis 
ATCC 23246 
8.0 8.0 8.0 1.0 Additive 
E. faecalis  
ATCC 29212 
7.0 9.0 8.0 1.0 Additive 
C. neoformans 
ATCC 90112 
4.0 0.5 0.5 0.6 Additive 
S. pneumoniae 
ATCC 49619 
8.0 1.5 2.0 0.8 Additive 
S. pyogenes 
ATCC 8668 
5.3 1.8 1.5 0.6 Additive 
S. agalactiae 
ATCC 55618 
1.7 1.5 2.0 1.3 Indifferent 
M. smegmatis 
(clinical) 
8.0 4.0 4.0 0.8 Additive 
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Figure 4.4 Isobologram of the combination of A. afra and O. asteriscoides essential oils (   ), 
dichloromethane: methanol extracts (   ) and aqueous extracts (   ) against M. catarrhalis (a – 
ratio 1:9; b – ratio 2:8);       1:1combination. 
 
This synergy displayed between A. afra with O. asteriscoides takes place when the ratio of O. 
asteriscoides is in the majority. The aqueous extracts showed additive pharmacological 
interactions for five ratios tested. Four ratios (4:6, 3:7, 2:8 and 1:9) wherein O. asteriscoides 
dominates in the combination were synergistic. The 1:1 combination of the essential oils, 
dichloromethane: methanol extracts and the aqueous extracts are shown and depicted in 
Figure 4.4. 
 
The ∑FIC values obtained for the 1:1 combination of the essential oils (Table 4.2), the 
dichloromethane: methanol extracts (Table 4.3) and the aqueous extracts (Table 4.4) against 
M. catarrhalis correlates with those results obtained in the isobolograms.  
 
The interactions of the combination of A. afra with O. asteriscoides against K. pneumoniae 
are graphically represented in Figure 4.5. The essential oils demonstrate additive interactions 
for all the ratios tested. The dichloromethane: methanol extracts show mainly indifferent 
interactions for six of the nine ratios tested. Three of the ratios i.e. 4:6, 3:7 and 1:9 were 
additive. Thus, when O. asteriscoides is in the majority in the combination, additive 
interactions are found. The aqueous extracts show additive interactions with all the ratios 
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tested except one, which was synergistic. The ratio showing synergy is depicted in Figure 4.5, 
(c) is when A. afra is in the majority at a ratio of 8:2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 Isobologram of the combination of A. afra and O. asteriscoides essential oils (   ), 
dichloromethane: methanol extracts (   ) and aqueous extracts (   ) against K. pneumoniae (c – 
ratio 8:2);      1:1 combination. 
 
The ∑FIC values of the essential oils (Table 4.2), the dichloromethane: methanol extracts 
(Table 4.3) as well as the aqueous extract (Table 4.4) of the 1:1 combination against K. 
pneumoniae correlates well with the isobologram (Figure 4.5).  
 
The essential oils of the combination of A. afra with O. asteriscoides against E. faecalis are 
shown in Figure 4.6. All ratios for the combination showed additive interactions. The 
dichloromethane: methanol extracts showed additive interactions for most ratios tested. Two 
ratios tested were indifferent. These were at ratios 6:4 (where A. afra is dominant) and the 1:1 
combination. The aqueous extracts showed additive interactions for all ratios except one 
(ratio 9:1) where A. afra was the dominant plant (Figure 4.6, d). This is interesting to note, as 
this information is not detected in the ∑FIC determination method wherein only 1:1 
combinations are interpreted. ∑FIC data (Table 4.2, 4.3 and 4.4) and isobologram (Figure 
4.6, 4.7 and 4.8) correlation was noted for the essential oils, dichloromethane: methanol and 
the aqueous extracts of the combination against E. faecalis.  
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Figure 4.6 Isobologram of the combination of A. afra and O. asteriscoides essential oils (   ), 
dichloromethane: methanol extracts (   ) and aqueous extracts (   ) against E. faecalis (d – 
ratio 9:1);         1:1 combination.      
 
The interaction of A. afra and O. asteriscoides against C. neoformans is depicted in Figure 
4.7. Results show the essential oil of the combination are additive for all the ratios tested 
except one which was synergistic (∑FIC = 0.5). This was the ratio 8:2 (Figure 4.7, e), where 
A. afra essential oil is the dominant oil in the combination. The dichloromethane: methanol 
extracts displayed a mix of additive and indifferent interactions. The ratios in which 
indifference was noted were at 4:6, 3:7, 2:8 and 1:9. These are all ratios in which O. 
asteriscoides is in the majority. 
 
It is interesting to note that when A. afra and O. asteriscoides dichloromethane: methanol 
extracts are combined in equal parts, the interaction is additive. However, when the ratio of 
O. asteriscoides increases, the combination becomes indifferent. This is important to note as 
the traditional method of administration is a tincture. When traditional healers are mixing the 
combination together and if O. asteriscoides becomes more than A. afra, the administration 
of this combination could become less effective when treating C. neoformans related 
infections. It is reported that O. asteriscoides contains sesquiterpene lactones (Scott and 
Springfield, 2004), which may contribute to the possible toxicity. Thus, the possible harm is 
not due to any antagonism of the combination, but is from the possible toxicity and allergic 
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reactions of the sesquiterpene lactones present in O. asteriscoides (Scott and Springfield, 
2004).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7 Isobologram of the combination of A. afra and O. asteriscoides essential oils (   ), 
dichloromethane: methanol extracts (   ) and aqueous extracts (   ) against C. neoformans (e – 
ratio 8:2);        1:1 combination. 
 
When the aqueous extracts of A. afra and O. asteriscoides were combined against C. 
neoformans, additive and synergistic interactions were noted. Ratios 9:1, 8:2, 6:4, 4:6, 3:7, 
2:8 and 1:9 were the synergistic combinations. It is surprising that the aqueous extracts have 
produced such good synergy and the dichloromethane: methanol extracts have resulted in 
indifferent activity.  
 
The ∑FIC values obtained and the isobologram were congruent for the combination of the 
essential oils, dichloromethane: methanol extracts and the aqueous extracts against C. 
neoformans.  
 
Typically, the alcohol extracts produce better antimicrobial activity than the aqueous extracts. 
However, the combination is also administered as an infusion (Scott and Springfield,  2004) 
and although previous studies (Scott et al., 2004) have found no activity for the aqueous 
extracts, the results obtained in this study serves to validate the use of the combination of A. 
afra with O. asteriscoides in the form if an infusion. 
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4.3 Conclusions  
 The major compounds present in the essential oil of O. asteriscoides were 1,8-cineole 
(59.0%), camphor (8.2%) and α-terpineol (7.2%) making up 74.4% of the total 
composition of the oil (91.6%). 
 The TLC studies of O. asteriscoides (essential oils, dichloromethane: methanol and 
the aqueous extracts) showed visible bands under different wavelengths of light and 
gave a rather characteristic fingerprint of the plants used in this assay.  
 The best antimicrobial activity for the essential oil of O. asteriscoides was obtained 
against S. pneumoniae with a mean MIC value of 1.0 mg/ml. For the 
dichloromethane: methanol extracts, noteworthy inhibitory activity with MIC values 
of 0.33 mg/ml was obtained against C. neoformans, followed by S. pneumoniae and S. 
pyogenes (MIC values = 0.4 mg/ml. The best activity for the aqueous extract of O. 
asteriscoides was obtained against C. neoformans (MIC value of 0.5 mg/ml). 
 The most prominent antimicrobial activity of the combination of A. afra with O. 
asteriscoides essential oils was obtained against S. pneumoniae (MIC value of 1.0 
mg/ml)  For the dichloromethane: methanol extracts, the most interesting and 
noteworthy activity was obtained against S. pneumoniae and S. agalactiae with MIC 
values of 0.1 mg/ml. The combination of the aqueous extracts gave the best 
noteworthy activity against C. neoformans (MIC value of 0.5 mg/ml). 
 In the combination of the essential oils of A. afra and O. asteriscoides, ∑FIC results 
revealed indifferent and additive pharmacological interaction. The dichloromethane: 
methanol extracts ∑FIC results showed synergistic interactions against S. 
pneumoniae, S. pyogenes and M. smegmatis. The aqueous extracts gave various ∑FIC 
results with additivity and indifference.  
 Isobologram results of the combination show mainly additive interactions with the 
essential oils, with one point wherein eight parts of A. afra and two parts O. 
asteriscoides were combined (Figure 4.7, e) was synergistic. 
 Synergistic interactions were found when tested against M. catarrhalis with the 
dichloromethane: methanol extracts at ratios 1:9 and 2:8 (Figure 4.4, a and b). The 
aqueous extracts showed synergy at ratios 4:6, 3:7, 2:8 and 1:9 against M. catarrhalis.  
 Against K. pneumoniae, synergy was noted for one ratio i.e. at eight parts A. afra and 
two parts O. asteriscoides (Figure 4.5, c) of the combination of the aqueous extracts.  
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 The aqueous extracts showed synergy against E. faecalis at nine parts A. afra and one 
part O. asteriscoides (Figure 4.6, d).  
 The best activity was obtained for the combination of A. afra with O. asteriscoides 
aqueous extracts against C. neoformans, where seven of the nine ratios tested were 
synergistic (Figure 4.7). 
 No antagonism was noted for the combination against any of the pathogens tested.  
 The outcomes of this chapter and the testing of the combination of A. afra with O. 
asteriscoides dichloromethane: methanol extracts provides in vitro evidence to 
support the use of a tincture in traditional African healing for the treatment of 
respiratory tract infections. Moreover, the aqueous extracts have also provided in vitro 
evidence of efficaciousness in the traditional use of the combination of A. afra with O. 
asteriscoides.   
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Chapter 5 
The antimicrobial efficacy of Artemisia afra Jacq. Ex Willd and 
Agathosma betulina (P.J. Berguis) Pillans in combination. 
 
5.1 Introduction 
A. betulina is said to be one of the best-known medicinal plants of Southern Africa, which is 
used both locally and internationally for the treatment of various diseases (Moolla et al., 
2007; Moolla and Viljoen, 2008). Traditionally, A. betulina is used in combination with A. 
afra and taken for colds and influenza or as a general tonic (Scott and Springfield, 2004). 
Traditionally 1% (15 mg/ml) of buchu extract is added in combination with A. afra (1.5% (10 
mg/ml) of an extract) to a white sweet wine to make “The South African herbal wine” (Watt 
and Breyer-Brandwijk, 1962). Buchu and African wormwood have been studies extensively 
independently; however, the combination of the plants has never been evaluated 
scientifically. These two plants are widely used individually, generally well-accepted and 
respected plant medicines. Thus the reason of adding this combination to this study.  
 
5.2 Results and discussion 
5.2.1 Chromatographic techniques 
5.2.1.1Essential oil composition of A. betulina 
The essential oil composition of buchu revealed a total number of 30 compounds making up 
97.5% of the total composition (Table 5.1). The major compounds were identified as 
limonene (18.9%), menthone (10.0%), isomenthone (31.4%), pseudodiosphenol (7.5%), and 
diosphenol (8.1%). 
 
Previous studies on the chemical composition of buchu oil are discussed in Appendix A1. In 
brief, Kaiser et al. (1975) identified the main constituent as isomethone (50-60%) of the 
essential oil of buchu. Viljoen et al. (2006a) identified the major compound in commercial 
buchu oil purchased from Afriplex
®
, South Africa as menthone (29.2%). Limonene was also 
present (23.7%). The main constituent found in A. betulina essential oil in this study, was 
isomethone at 31.4%. Smaller quantities of menthone (10.0%) were found. Pulegone, a 
highly toxic compound noted by Viljoen et al. (2006a) at 8.4%, was also found in this study 
but at lower concentrations (4.1%).  
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Table 5.1 Essential oil composition of A. betulina. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*RRI:  Relative retention indices calculated against n-alkanes.  
% calculated from TIC data. 
 
From the literature, there are many other reports on the chemical composition of the essential 
oil of A. betulina (Gentry, 1961; Watt and Breyer-Brandwijk, 1962; Kaiser et al., 1975; 
Simpson, 1998; Lis-Balchin et al., 2001; van Wyk and Wink, 2004; Moolla, 2006; Viljoen et 
al., 2006a; Moolla et al., 2007; Moolla and Viljoen, 2008; van Wyk et al., 2009;). However, 
interest is only recently being directed towards the study of the non-volatile fraction of this 
RRI* Compounds Area (%) 
1016 α-Pinene 0.8 
1104 β-Pinene. 0.3 
1117 Sabinene 0.8 
1159 Myrcene 1.5 
1192 α-Terpinene 0.1 
1193 Limonene 18.9 
1202 1,8-Cineole 1.7 
1242 γ-Terpinene tr 
1250 (E)-β-Ocimene 0.5 
1270 p-Cymene 0.5 
1475 Menthone 10.0 
1468 Fenchyl acetate 0.1 
1496 Isomenthone 31.4 
1546 Linalool 0.5 
1572 Neoisopulegol 0.1 
1577 cis Isopulegone 3.3 
1587 trans Isopulegone 2.8 
1602 Terpinen-4-ol 0.4 
1610 Dihydrocarvone 0.2 
1653 Pulegone 4.1 
1692 Myrtenyl acetate 0.1 
1701 α-Terpineol 0.1 
1715 Germacrene D 0.1 
1739 Piperitone 0.2 
1752 Pseudodiosphenol 7.5 
1825 Diosphenol 8.1 
1873 
trans-8-Mercapto-p-mentha-
3-one 
0.4 
1905 
cis-8-Mercapto-p-mentha-3-
one 
2.3 
2082 Methyl eugenol 0.5 
2188 Eugenol 0.2 
Total 97.5 
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plant (Moolla et al., 2007; Vermaak et al., 2009). The importance of studying a plant in its 
entirety cannot be emphasized enough as the possibility of interactions of volatile and non-
volatile compounds within a plant need to be considered as well as the individual 
contributions of each component (van Vuuren and Viljoen, 2009). 
 
5.2.1.2 Thin layer chromatography  
Thin layer chromatography analysis of the essential oils and the dichloromethane: methanol 
extracts of A. afra (discussed in Chapter 3), A. betulina and the combination of the two, 
revealed the presence of fluorescent compounds, which were visible under UV light of 254 
nm as well as 365 nm. The aqueous extracts did not show good separation of the compounds 
and thus were not included. Figure 5.1 shows the chromatograms derived for the essential 
oils. A black fluorescent compound in A. betulina, at Rf = 0.5 was seen at 254 nm as well as 
at 365 nm (lighter in colour). Another major compound was detected in A. betulina at 365 nm 
at Rf = 0.6. When derivatized these compounds and various others were noted. 
  
 
 
 
 
 
 
 
 
 
Figure 5.1 TLC fingerprints of the essential oils of A. afra and A. betulina alone and in 
combination at 254 nm, 365 nm and visualized with vanillin-sulphuric acid reagent. Aa – A. 
afra; Ab – A. betulina; Aa + Ab – A. afra with A. betulina. 
 
The dichloromethane: methanol extracts (Figure 5.2) showed the presence of many 
compounds in A. betulina and in the combination with A. afra. At 254 nm major compounds 
were seen at Rf = 0.65 and Rf = 0.8. At 365 nm a compound showing up red was detected 
with an Rf = 0.65 as well. Under white light, the same compound is detected with the same Rf 
value. When derivatized the compound is not as visible but is mixed in with other visualized 
compounds.  
254 nm 
 
A 
365nm 
 
B 
Derivatized 
 
C 
   Aa         Ab     Aa +Ab     Aa         Ab        Aa + Ab          Aa         Ab      Aa + Ab 
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Figure 5.2 TLC fingerprints of the dichloromethane: methanol extracts of A. afra and A. 
betulina alone and in combination at 254 nm, 365 nm, visualized under white light and 
visualized with vanillin-sulphuric acid reagent. Aa – A. afra; Ab – A. betulina; Aa + Ab – A. 
afra with A. betulina. 
 
5.2.2 Antimicrobial analysis 
5.2.2.1 MIC assays and FIC determination  
5.2.2.1.1 Essential oils 
The MIC values and of the essential oil of A. betulina individually and in combination with 
A. afra are given in Table 5.2. The MIC values of A. betulina essential oils ranged between 
1.0-16.0 mg/ml depending on the pathogen tested. The lowest MIC value was noted against 
S. pyogenes with noteworthy activity (MIC value of 1.0 mg/ml). Other noteworthy activity 
obtained was against S. pneumoniae and M. smegmatis (MIC values of 2.0 mg/ml). Some 
antimicrobial activity was obtained against C. neoformans, giving a MIC value of 6.0 mg/ml. 
Very low antibacterial activity was obtained against K. pneumoniae, M. catarrhalis, E. 
faecalis and S. agalactiae (MIC values ≥8.0 mg/ml). 
 
The antimicrobial activity of the essential oil of buchu was previously studied using the agar 
diffusion method (Lis-Balchin et al., 2001). The pathogens tested included E. coli, 
Enterococcus hirae, P. aeruginosa, Saccharamyces cerevisiae and S. aureus. Very poor to no 
antimicrobial activity was obtained against the pathogens. 
 
In another study, the antimicrobial activity of the essential oil of A. betulina was tested using 
the MIC micro-titre plate method (Moolla, 2006; Viljoen et al., 2006a). Essential oils tested 
were from Landmeterskop, Middelberg by Moolla, (2006) and a commercial product was 
254 nm 
 
A 
365 nm 
 
B 
White light 
 
C 
Derivatized 
 
D 
Aa     Ab   Aa +Ab    Aa      Ab    Aa + Ab    Aa      Ab    Aa +Ab   Aa      Ab    Aa+ Ab 
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tested by Viljoen et al., (2006a). Some activity was noted against the pathogens tested i.e. B. 
cereus, C. albicans, K. pneumoniae and S. aureus with MIC values from 4.0-32.0 mg/ml. 
Results obtained against K. pneumoniae (MIC value = 8.0 mg/ml) in the current study were 
congruent with those mentioned in the review by Moolla and Viljoen, (2008). 
 
Table 5.2 MIC and ∑FIC values of essential oils of A. afra and A. betulina, alone and in 
combination. 
*Values in bold indicate noteworthy activity. 
Shaded area: results previously discussed in Chapter 3 but included here for reference 
purposes. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail 
regarding control values. 
 
For the combination of A. afra with A. betulina, the lowest MIC value with noteworthy 
activity (2.0 mg/ml) obtained against the pathogens S. pneumoniae, S. pyogenes and M. 
smegmatis. Against C. neoformans and S. agalactiae some antimicrobial activity was noted 
(MIC values of 4.0 mg/ml). Very low activity was seen against K. pneumoniae, M. 
catarrhalis and E. faecalis with MIC values of 8.0 mg/ml. 
 
Micro-organism 
MIC (mg/ml) ∑FIC 
A. afra A. betulina 
A. afra with  
A. betulina 
A. afra with 
A. betulina 
(1:1) 
Interpretation 
K. pneumoniae 
NCTC 9633 
8.0 8.0 8.0 1.0 Additive 
M. catarrhalis 
ATCC 23246 
8.7 16.0 8.0 0.7 Additive 
E. faecalis  
ATCC 29212 
8.7 8.0 8.0 1.0 Additive 
C. neoformans 
ATCC 90112 
3.8 6.0 4.0 0.9 Additive 
S. pneumoniae 
ATCC 49619 
3.3 2.0 2.0 0.8 Additive 
S. pyogenes 
ATCC 8668 
1.7 1.0 2.0 1.6 Indifferent 
S. agalactiae 
ATCC 55618 
4.8 8.0 4.0 0.7 Additive 
M. smegmatis 
(clinical) 
1.5 2.0 2.0 1.2 Indifferent 
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∑FIC values obtained against K. pneumoniae, M. catarrhalis, E. faecalis, C. neoformans S. 
pneumoniae and S. agalactiae displayed additive pharmacological interactions. Indifferent 
interactions were noted against S. pyogenes and M. smegmatis. Importantly, however, the 
combination of A. afra with A. betulina essential oil did not illustrate any antagonism.  
 
5.2.2.1.2 Dichloromethane: methanol extracts 
The dichloromethane: methanol extracts of A. betulina showed some antimicrobial activity 
(Table 5.3) against C. neoformans, S. pneumoniae, S. pyogenes, S. agalactiae and M. 
smegmatis with MIC values ranging  from 1.4-4.0 mg/ml. Moderate inhibition was noted 
against S. pneumoniae (MIC value of 1.4 mg/ml), S. pyogenes (1.5 mg/ml) and M. smegmatis 
(1.5 mg/ml). Very poor activity (MIC value of 16.0 mg/ml) was obtained against M. 
catarrhalis while no activity was seen against K. pneumoniae and E. faecalis at the highest 
concentration tested. A. afra independently showed some antimicrobial activity as noted in 
Chapter 3. 
 
Moolla et al. (2007) explored the biological activity of the non-volatile fraction of Agathosma 
species. The dichloromethane: methanol extracts of A. betulina from Landmeterskop, 
Middelberg, were tested using the MIC micro-titre plate method against B. cereus, S. aureus, 
K. pneumoniae and C. albicans. The MIC values obtained (2.0-4.0 mg/ml) showed the 
presence of some activity. The MIC value obtained against K. pneumoniae was 4.0 mg/ml.  
 
Sandasi (2008) investigated the antimicrobial activity of the essential oils, dichloromethane: 
methanol and the methanol extracts of A. betulina. MIC micro-titre plate assays were 
conducted on seven micro-organisms i.e. L. monocytogenes, P. aeruginosa, C. albicans, E. 
coli, P. vulgaris S. aureus and E. faecalis. The greatest activity was seen with the 
dichloromethane: methanol extracts with MIC values from 3.0-6.0 mg/ml. these results 
correlate with the findings reported here. In the current study, the best result was obtained in 
the combination of A. afra with A. betulina against S. pneumoniae with a MIC value of 0.6 
mg/ml. This demonstrates that the combination of A. afra with A. betulina is far superior to 
when used independently for the treatment of microbial infections.  
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Table 5.3 MIC and ∑FIC values of dichloromethane: methanol extracts of A. afra and A. 
betulina, alone and in combination. 
*Values in bold indicate noteworthy activity. 
ND
1
 No ∑FIC value could be calculated as no MIC end point for A. betulina was obtained at 
the highest concentration tested. 
2
 Tentative interpretation according to MIC data. 
Shaded area: results previously discussed in Chapter 3 but included here for reference 
purposes. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail 
regarding control values. 
 
The combination of A. afra with A. betulina showed noteworthy antimicrobial activity against 
S. pneumoniae with an MIC value of 0.6 mg/ml. Some antimicrobial activity was seen 
against M. catarrhalis, C. neoformans, S. pyogenes, S. agalactiae and M. smegmatis with 
moderate inhibition against C. neoformans, S. pyogenes and M. smegmatis (MIC values of 
1.3-2.0 mg/ml). Poor activity was observed for K. pneumoniae and E. faecalis. A very 
interesting synergistic reaction to the combination against M. catarrhalis occurred wherein a 
∑FIC value of 0.3 was noted.  
 
∑FIC values could not be calculated for the interactions against K. pneumoniae and E. 
faecalis as no end point for A. betulina was obtained. However, a tentative interpretation of 
Micro-organism 
MIC (mg/ml) ∑FIC 
A. afra 
A. 
betulina 
A. afra with  
A. betulina 
A. afra with 
A. betulina 
(1:1) 
Interpretation 
K. pneumoniae 
NCTC 9633 
6.3 ≥16.0 10.3 ND1 Additive/indifferent2 
M. catarrhalis 
ATCC 23246 
4.7 16.0 2.0 0.3 Synergy 
E. faecalis  
ATCC 29212 
6.3 ≥16.0 8.0 ND1 Additive/indifferent2 
C. neoformans 
ATCC 90112 
1.2 4.0 1.3 0.7 Additive 
S. pneumoniae 
ATCC 49619 
0.5 1.4 0.6 0.8 Additive 
S. pyogenes 
ATCC 8668 
1.1 1.5 1.3 1.0 Additive 
S. agalactiae 
ATCC 55618 
3.0 2.5 2.0 0.7 Additive 
M. smegmatis 
(clinical) 
1.7 1.5 1.3 0.8 Additive 
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the interaction is given. The MIC results of the combination compared to the individual plant 
extracts against K. pneumoniae and E. faecalis showed that the interaction is probably 
additive or indifferent. ∑FIC values calculated against C. neoformans, S. pneumoniae, S. 
pyogenes, S. agalactiae and M. smegmatis gave additive interactions for the combination. 
The antimicrobial activity of the combination was mostly additive indicating a positive 
rationale for the use with A. afra for the treatment of respiratory related diseases. 
 
5.2.2.1.3 Aqueous extracts 
The aqueous extracts (Table 5.4) of A. betulina were not active against any the pathogens at 
the highest concentration tested.  
 
Table 5.4 MIC and ∑FIC values of aqueous extracts of A. afra and A. betulina, alone and in 
combination. 
*Values in bold indicate noteworthy activity. 
ND
1 
No ∑FIC value could be calculated as no MIC end point for A. betulina was obtained at 
the highest concentration tested. 
2
 Tentative interpretation according to MIC data. 
Shaded area: results previously discussed in Chapter 3 but included here for reference 
purposes. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail 
regarding control values. 
Micro-organism 
MIC (mg/ml) ∑FIC 
A. afra A. betulina 
A. afra with  
A. betulina 
A. afra with  
A. betulina 
(1:1) 
Interpretation 
K. pneumoniae 
NCTC 9633 
12.0 ≥16.0 8.0 ND1 Additive/indifferent2 
M. catarrhalis 
ATCC 23246 
8.0 ≥16.0 ≥16.0 ND1 Indifferent/antagonistic2 
E. faecalis  
ATCC 29212 
8.0 ≥16.0 8.0 ND1 Additive/indifferent2 
C. neoformans 
ATCC 90112 
4.0 ≥16.0 5.0 ND1 Additive/indifferent2 
S. pneumoniae 
ATCC 49619 
8.0 ≥16.0 ≥16.0 ND1 Indifferent/antagonistic2 
S. pyogenes 
ATCC 8668 
5.3 ≥16.0 ≥16.0 ND1 Indifferent/antagonistic2 
S. agalactiae 
ATCC 55618 
1.7 ≥16.0 ≥16.0 ND1 Indifferent/antagonistic2 
M. smegmatis 
(clinical) 
8.0 ≥16.0 ≥16.0 ND1 Indifferent/antagonistic2 
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Some poor activity was noted for the combination of A. afra with A. betulina aqueous 
extracts against K. pneumoniae, E. faecalis and C. neoformans (MIC values between 5.0-8.0 
mg/ml). Due to the lack of susceptibility of any of the selected pathogens to the extracts of A. 
betulina, ∑FIC values could not be calculated. Tentative interpretations of the interactions 
based on the comparison of the MIC values were made. Additive/indifferent interactions 
were assumed for the combination against K. pneumoniae, E. faecalis and C. neoformans. 
Against M. catarrhalis, S. pneumoniae S. pyogenes, S. agalactiae and M. smegmatis, the 
interaction was interpreted as indifferent/antagonistic. 
 
5.2.2.2 Isobologram interpretation 
The isobolograms of the interactions of A. afra with A. betulina essential oils against M. 
catarrhalis (Figure 5.3) showed additive interactions for most of the ratios tested. Two ratios 
showed indifference i.e. 8:2 and 7:3 (Figure 5.3, a) where A. afra is in the majority. The 
dichloromethane: methanol extracts showed activity wherein three ratios were synergistic, 
four were additive and two of them indifferent. The ratios showing indifference are 2:8 and 
1:9, wherein A. betulina is in the majority. The synergistic interactions occur at the ratios 3:7, 
4:6 and 1:1 (Figure 5.3, b). The ∑FIC interpretation data correlates with the 1:1 interaction 
where a FIC value of 0.3 was noted (Table 5.3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3 Isobologram of the combination of A. afra and A. betulina essential oils (   ) and 
the dichloromethane: methanol extracts (   ) against M. catarrhalis (a – ratios 8:2 and 7:3; b – 
ratios 3:7, 4:6 and 1:1);       1:1 combination. 
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The isobologram of the combination of A. afra with A. betulina against the pathogen K. 
pneumoniae showed additive interactions with all the ratios of the essential oil combination 
tested (Figure 5.4).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 Isobologram of the combination of A. afra and A. betulina essential oils (   ) 
against K. pneumoniae;        1:1 combination. 
 
Figure 5.5 depicts the interactions of A. afra with A. betulina against E. faecalis. The 
essential oils show additive interactions for all the ratios tested with one point (9:1) showing 
indifference (Figure 5.5, c).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5 Isobologram of the combination of A. afra and A. betulina essential oils (   ) 
against E. faecalis (c – ratio 9:1);        1:1 combination. 
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The pathogen C. neoformans, tested for antimicrobial susceptibility to various combinations 
of A. afra and A. betulina essential oils are illustrated in Figure 5.6.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6 Isobologram of the combination of A. afra and A. betulina essential oils (   ) and 
dichloromethane: methanol extracts (   ) against C. neoformans (d – ratio 7:3, e – ratio 1:9);  
      1:1 combination. 
 
The combination proved to give additive interactions for all ratios tested. The 
dichloromethane: methanol extracts were additive in this combination for most of the ratios 
tested with the exception of two (7:3 and 1:9). These two points (Figure 5.6, d and e) proved 
to be indifferent in their interactions against C. neoformans. 
 
The interpretation of the interactions of the 1:1 combination of A. afra with A. betulina 
essential oils against M. catarrhalis, K. pneumoniae, E. faecalis and C. neoformans showed 
congruency between the ∑FIC determination and the isobologram method. The combination 
was also congruent for the dichloromethane: methanol extracts against M. catarrhalis and C. 
neoformans.  
 
The dichloromethane: methanol extracts against K. pneumoniae and E. faecalis did not yield 
an end point MIC value for A. betulina, thus isobolograms could not be drawn. The MIC 
values of the combination of different ratios of the dichloromethane: methanol extracts of A. 
afra with A. betulina are shown in Figure 5.7.  
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Figure 5.7 MIC values of the different ratios of the combination of A. afra with A. betulina 
dichloromethane: methanol extracts against K. pneumoniae and E. faecalis. 
 
The graph depicts lower MIC values for ratios 9:1, 8:2 and 7:3 against K. pneumoniae. These 
MIC values (3.0 mg/ml) occur when A. afra is the dominant extract in the combination. 
These ratios can therefore be interpreted as being synergistic or additive. As the ratio of A. 
betulina increases, so does the MIC value. The MIC values drop again at ratios 2:8 and 1:9 
when the ratio of A. betulina is higher. Thus at different ratios, the interaction between the 
combination varies. This can be interpreted as synergy or additivity at very specific and 
narrow ratios. 
 
The MIC values obtained for the nine ratios of the dichloromethane: methanol extracts of A. 
afra with A. betulina tested against E. faecalis, showed an increase in MIC value as the ratio 
of A. betulina increases. The graph serves to demonstrate the change in MIC value as the 
ratio of plant extracts change.  
 
The aqueous extracts of the combination of A. afra with A. betulina against M. catarrhalis, E. 
faecalis, K. pneumoniae and C. neoformans could not be plotted onto the isobologram, as A. 
betulina had no end point MIC value. The graph constructed using the MIC data for all the 
>16 
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ratios tested are shown (Figure 5.8). The MIC values generally increases as the percentage of 
A. betulina increases in the ratio combination with A. afra.  
Figure 5.8 The MIC values of the different ratios of the combination of A. afra with A. 
betulina aqueous extracts against K. pneumoniae, M. catarrhalis, E. faecalis and C. 
neoformans. 
 
The results from this study have demonstrated that A. afra and A. betulina may have a better 
inhibitory effect depending on the dosage forms in which they are tested. This may have 
selective effects on the interactions of the combination and thus confirms that method of 
administration is an essential area for future studies in order to better understand the use of 
combinations in traditional medicine. 
 
Here, the essential oils showed the most additivity in the combination and therefore may 
validate the use of these plants in an inhaled form. The solvent extracts of the combination 
showed the only evidence of synergy against M. catarrhalis. This is an interesting aspect as 
the most common use of this combination is an herbal wine. 
  
>16 
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5.3 Conclusions 
 The main constituents found in the essential oil (97.5% of the total composition) of A. 
betulina were limonene (18.9%), menthone (10.0%), isomenthone (31.4%), 
pseudodiosphenol (7.5%), and diosphenol (8.1%). 
 TLC showed the presence of many compounds visible at 254 nm and 365 nm. After 
derivatization with vanillin-sulphuric acid reagent, many more compounds were made 
visible. 
 The MIC studies revealed the best antimicrobial activity for the essential oil of A. 
betulina was against S. pyogenes with a MIC value of 1.0 mg/ml. The best and most 
noteworthy activity of the combination of the essential oil was against S. pneumoniae, 
S. pyogenes and M. smegmatis (MIC values of 2.0 mg/ml). 
 The dichloromethane: methanol extracts of the combination of A. afra with A. 
betulina gave the best activity against S. pneumoniae with a MIC value of 0.6 mg/ml. 
 A. betulina aqueous extracts were inactive at the concentration tested against all eight 
pathogens. The combination with A. afra showed some activity against K. 
pneumoniae, E. faecalis and C. neoformans. 
 Synergy was noted for the combination of the dichloromethane: methanol extracts 
against M. catarrhalis with ∑FIC value of 0.3. 
 Synergy was noted for three ratios in the isobologram of the dichloromethane: 
methanol extracts against M. catarrhalis.  
 The predominantly additive interactions of the essential oils and the synergy of the 
dichloromethane: methanol extracts against M. catarrhalis observed in the 
combination of A. afra with A. betulina give credibility and provides preliminary 
evidence to support the traditional uses in the treatment of respiratory tract infections. 
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Chapter 6 
The antimicrobial efficacy of Artemisia afra Jacq. Ex Willd and 
Eucalyptus globulus Labill. In combination 
 
6.1 Introduction 
Although E. globulus is not indigenous to South Africa, this medicinal plant is used 
extensively in African traditional herbal medicine. The combination of A. afra with E. 
globulus is one that is used frequently in the treatment of flu-like symptoms and chest-related 
complaints. The combination of the leaf of A. afra and the leaf of E. globulus has been said to 
be used either externally or internally as an influenza remedy (Smith, 1895; Watt and Breyer-
Brandwijk, 1962). Additionally a decoction of the combination is used for the common cold 
or catarrh (Smith, 1895). The steam from a strong decoction of the leaves of the combination 
of these two plants is said to relieve immediate symptoms (Smith, 1895). 
 
Thus, it is important to include in the evaluation of A. afra plant combinations. It is not only 
commonly used by traditional healers but it also demonstrates the versatility of the traditional 
healers and their practices to incorporate a variety of medicinal plants into their treatment 
regimen. 
 
6.2 Results and discussion 
6.2.1 Chromatographic techniques 
6.2.1.1 Essential oil composition of E. globulus 
Analysis of the essential oils constituents of E. globulus revealed 22 compounds (Table 6.1) 
by comparison of mass spectral data and retention times of authentic compounds. The main 
compound found was 1,8-cineole making up 63% of the total composition of the essential oil 
(96.4%). Other major compounds identified were α-pinene (16.7%), limonene (3.6%) and ρ-
cymene (2.7%). 
 
The essential oil of E. globulus has been well characterized (Batista-Pereira et al., 2006; 
Mayaud et al., 2008; George et al., 2009; Tohidpour et al., 2010). Mayaud et al. (2008) 
performed GC-MS analysis on the essential oil of E. globulus supplied by Pranarôm 
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(International S.A., Ghislenghein, Belgium) and found the main constituents to be 1,8-cineole 
(80.4%), limonene (7.47%), α, β and γ-terpinene (3.7%) and ρ-cymene (2.5%). 
 
Table 6.1 Essential oil constituents of E. globulus. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*RRI:  Relative retention indices calculated against n-alkanes. 
% calculated from TIC data. 
 
George et al. (2009) studied the chemical variation of E. globulus from China. The main 
constituents found were 1,8-cineole (81.9%), D-limonene (7.6%), α-pinene (3.3%) and 
benzene (3.4%). Previously Cimanga et al. (2002) studied the essential oil composition of E. 
globulus and found less of the 1,8-cineole (44.3%) than George et al. (2009). It is very 
common to find variation in the chemical composition of an essential oil between different 
varieties or within a plant (Moreno et al., 2007; George et al., 2009). Tohidpour et al. (2010) 
found the major constituents of the essential oil of E. globulus from Iran to be eucalyptol 
(47.2%), as the major constituent and most characteristic component of E. globulus, (+) 
spathulenol (18.1%) and α-pinene (9.6%). The percentage of 1,8-cineole found in this study 
(Table 6.1) was not as much as that of Mayaud et al. (2008) and George et al. (2009), but 
neither was it as low as that found by Tohidpour et al. (2010). The results of the chemical 
RRI* Compounds Area (%) 
1016 α-Pinene 16.7 
1104 β-Pinene 0.3 
1193 Limonene 3.6 
1202 1,8-Cineole 63.0 
1270 p-Cymene 2.7 
1436 p-Cymenene 0.1 
1441 trans-Linalool oxide 0.1 
1471 cis-Linalool oxide 0.1 
1521 Camphor 0.1 
1546 Linalool 0.3 
1573 Pinocarvone 0.6 
1583 Fenchol 0.1 
1590 Calarene 0.1 
1602 Terpinen-4-ol 0.6 
1604 Aromadendrene 1.2 
1647 allo Aromadendrene 0.2 
1662 trans Pinocarveol 1.1 
1701 α-Terpineol 1.6 
1709 Borneol 0.2 
1876 cis Carveol 0.2 
2031 epi-Globulol 0.7 
2094 Globulol + cubenol 2.8 
Total 96.4 
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composition of E. globulus essential oil found in the current study are consistent with the 
percentage of 1,8-cineole found by George et al. (2009) where the main compound found was 
1,8-cineole at 63.0% of the total composition of the essential oil. 
 
6.2.1.2 Thin layer chromatography 
The presence of major compounds is detected using TLC (Ahmad and Beg, 2001). 
Compounds in E. globulus that are responsible for activity are alkaloids, phenols and tannins, 
as described by Ahmad and Beg (2001). 
 
The essential oil (Figure 6.1) of E. globulus showed two compounds at 254 nm. These were 
at Rf values of 0.45 and 0.5. No fluorescent compounds were visible under 365 nm. After 
derivatization, many compounds became visible. Compound at Rf values of 0.9, 0.25, 0.35 
and 0.4 were some that were seen. Once again, the TLC chromatograms showed the 
complexity of the essential oils alone and the increased complexity in combination. 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1 TLC of the essential oils of A. afra and E. globulus individually and in 
combination at 254 nm, 365 nm and visualized with vanillin-sulphuric acid reagent. Aa – A. 
afra; Eg – E. globulus; Aa + Eg – A. afra with E. globulus. 
 
The TLC chromatograms of the dichloromethane: methanol extracts are depicted in Figure 
6.2 Good separation is seen for E. globulus individually and in combination with A. afra. At 
254 nm, many compounds between Rf value 0.35 and 0.55 as well as between Rf 0.8 and 0.9 
were seen. Two highly fluorescent red compounds are seen in E. globulus at 365 nm at Rf = 
0.65 and 0.9 respectively. 
 
254 nm 
 
A 
365 nm 
 
B 
Derivatized 
 
C 
 Aa         Eg      Aa + Eg     Aa         Eg      Aa + Eg     Aa        Eg       Aa + Eg 
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Figure 6.2 TLC of the dichloromethane: methanol extracts of A. afra and E. globulus 
individually and in combination at 254 nm, 365 nm, visualized under white light and 
visualized with vanillin-sulphuric acid reagent. Aa – A. afra; Eg – E.globulus; Aa + Eg – A. 
afra with E. globulus. 
 
The aqueous extracts of E. globulus and its combination with A. afra are shown in Figure 6.3. 
At 254 nm, few compounds are visible. Two compounds in E. globulus at Rf values of 0.55 
and 0.6 are seen at 365 nm, compounds were not visible. Under white light, the separation of 
compounds showed up mostly yellow. 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3 TLC of the aqueous extracts of A. afra and E. globulus individually and in 
combination at 254 nm, 365 nm, visualized under white light and visualized with vanillin-
sulphuric acid reagent. Aa – A. afra; Eg – E. globulus; Aa + Eg – A. afra with E. globulus. 
 
254 nm 
 
A 
365 nm 
 
B 
Derivatized 
 
C 
     Aa     Eg   Aa + Eg  Aa     Eg   Aa + Eg  Aa     Eg    Aa + Eg   Aa     Eg      Aa + Eg 
White light 
 
C 
254 nm 
 
A 
365 nm 
 
B 
White light 
 
C 
Derivatized 
 
D 
Aa    Eg   Aa + Eg  Aa    Eg    Aa + Eg  Aa     Eg   Aa + Eg   Aa     Eg   Aa + Eg  
119 
 
Compounds were much more visible after derivatization for E. globulus and the combination 
(Figure 6.3). Blue compounds were seen for E. globulus and in the combination at Rf values 
of 0.39, 0.41 and 0.76. 
 
6.2.2 Antimicrobial analysis 
6.2.2.1 MIC assays and FIC determination 
6.2.2.1.1 Essential oils 
Antimicrobial studies of E. globulus essential oils (Table 6.2) showed diverse results. E. 
globulus against K. pneumoniae, M. catarrhalis and E. faecalis showed very poor 
antimicrobial activity with MIC values of 8.0 mg/ml. Some antimicrobial activity was 
obtained against S. pneumoniae (MIC value = 2.7 mg/ml) and S. agalactiae (5.3 mg/ml). 
Noteworthy activity for the essential oil E. globulus was obtained against S. pyogenes (MIC 
value = 2.0 mg/ml) and M. smegmatis (MIC value = 2.0 mg/ml). The best activity was noted 
against C. neoformans yielding an MIC value of 0.6 mg/ml, 
 
Cimanga et al. (2002) tested the antimicrobial activity of E. globulus essential oil using the 
disc diffusion method. The pathogens included E. coli, B. subtilis, K. pneumoniae, P. 
aeruginosa, S. aureus and S. flexneri. The activity against two K. pneumoniae strains were 
interpreted as very active and against P. aeruginosa the oil was moderately active. 
 
The antimicrobial properties of the essential oil of E. globulus against S. aureus and E. coli 
were confirmed using the aromatogramme, microastmosphere and germs in suspension 
methods (Ghalem and Mohamed, 2008a). In another study on the antimicrobial activity of the 
essential oil of E. globulus, the agar dilution method was used to calculate mean MIC 
percentages (Mayaud et al., 2008). Activity was assessed on a number of micro-organisms 
including K. pneumoniae (mean MIC = 10.0%) and E. faecalis (mean MIC = 5.83 ±SD of 
1.86%). Twelve Streptococci spp were also evaluated for their potential susceptibility (mean 
MIC = 2.78±SD of 2.08%). Good reproducibility and results were found in terms of MIC's. 
 
The antimicrobial activity of an essential oil is linked to the chemical composition of the oil 
i.e. the presence of alcohols, phenols, terpenes and ketones (Iserin, 1997; Inouye et al., 2001; 
Cimanga et al., 2002; Ghalem and Mohamed, 2008a, b). 
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Table 6.2 MIC and ∑FIC values the essential oils of A. afra and E. globulus alone and in 
combination. 
Micro-organism 
MIC (mg/ml) ∑FIC 
A. afra E. globulus 
A. afra with 
E. globulus 
A. afra with E. 
globulus (1:1) 
Interpretation 
K. pneumoniae 
NCTC 9633 
8.0 8.0 8.0 1.0 Additive 
M. catarrhalis 
ATCC 23246 
8.7 8.0 8.0 1.0 Additive 
E. faecalis 
ATCC 29212 
8.7 8.0 8.0 1.0 Additive 
C. neoformans 
ATCC 90112 
3.8 0.6 0.8 0.8 Additive 
S. pneumoniae 
ATCC 49619 
3.3 2.7 3.0 1.0 Additive 
S. pyogenes 
ATCC 8668 
1.7 2.0 1.5 0.8 Additive 
S. agalactiae 
ATCC 55618 
4.8 5.3 4.0 0.8 Additive 
M. smegmatis 
(clinical) 
1.5 2.0 1.3 0.7 Additive 
*Values in bold indicate noteworthy activity. 
Shaded area: results previously discussed in Chapter 3 but included here for reference 
purposes. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail 
regarding control values. 
 
Recently Tohidpour et al. (2010) tested the essential oil of E. globulus using the disk 
diffusion and the agar diffusion methods. Zones of inhibition and MIC values were calculated 
for B. cereus, E. coli, K. pneumoniae, Methicillin resistant S. aureus (MRSA) and S. aureus. 
E. coli was the most sensitive pathogen tested with an inhibition zone of 8 mm and a MIC 
value of 51.36 μg/ml. K. pneumoniae yielded an inhibition zone of 8 mm and the MIC value 
obtained was 68.48 μg/ml. Some variation against K. pneumoniae is evident between this 
current study and that undertaken by Tohidpour et al. (2010). This is possibly due to the 
different methods of evaluation of antimicrobial activity that were used. 
 
In the combination of A. afra and E. globulus essential oils, the same trend of antimicrobial 
activity as that of E. globulus alone was noticed. Very poor activity was seen against K. 
pneumoniae, M. catarrhalis and E. faecalis (MIC values of 8.0 mg/ml). Some antimicrobial 
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activity was seen against S. pneumoniae (MIC value = 3.0 mg/ml) and S. agalactiae (4.0 
mg/ml). Noteworthy activity was obtained against C. neoformans yielding the best MIC value 
of the combination of 0.8 mg/ml, S. pyogenes (MIC value = 1.5 mg/ml) and M. smegmatis 
(MIC value = 1.3 mg/ml). 
 
The ∑FIC values calculated (Table 6.2) for the combination of A. afra with E. globulus 
essential oil against all the pathogens tested, yielded additive pharmacological interactions. 
 
6.2.2.1.2 Dichloromethane: methanol extracts 
The dichloromethane: methanol extract of E. globulus against all the pathogens tested, 
showed antimicrobial activity with MIC values between 0.01 - 3.0 mg/ml (Table 6.3). Some 
activity was noted against K. pneumoniae (MIC value = 3.0 mg/ml). Moderate inhibitory 
antimicrobial activity was noted against S. agalactiae and M. smegmatis with MIC values of 
1.0 and 1.5 mg/ml respectively. Against M. catarrhalis and E. faecalis, C. neoformans, S. 
pneumoniae and S. pyogenes noteworthy activity was obtained for E. globulus. M. catarrhalis 
and E. faecalis exhibited very strong inhibitory activity with MIC values of 0.01 mg/ml and 
0.02 mg/ml respectively. Moderate inhibition was noted with C. neoformans (MIC value of 
0.5 mg/ml) and S. pyogenes (MIC value of 0.6 mg/ml). Strong inhibition was noted against S. 
pneumoniae where a MIC value of 0.2 mg/ml was obtained.  
 
The antimicrobial activity of E. globulus ethanol extracts against S. pyogenes is supported by 
a study by Caceres et al. (1991). The study found that E. globulus clearly inhibited the in 
vitro growth of S. aureus as well as S. pyogenes. Takahashi et al. (2004) tested the 
antimicrobial activity of E. globulus dichloromethane: methanol extracts on nine micro-
organisms. The MIC value obtained against E. faecalis was 31 mg/l (0.031 mg/ml) which 
was consistent with that found in this study where a MIC value of 0.02 mg/ml was obtained. 
Khan et al. (2009a) recently studied the ethanol extracts of E. globulus against a number of 
pathogens including E. faecalis and two strains of K. pneumoniae. The extract was found to 
be inactive at the concentration tested against both strains of K. pneumoniae. However, 
against E. faecalis an MIC value of 3130 μg/ml (3.13 mg/ml) was found. This activity noted 
was not as good as that reported in this study. This variation could be due to the type of 
extract tested was different or the strain of the organism was not the same. 
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Table 6.3 MIC and ∑FIC values of the dichloromethane: methanol extracts of A. afra and E. 
globulus alone and in combination. 
Micro-organism 
MIC (mg/ml) ∑FIC 
A. afra E. globulus 
A. afra with 
E. globulus 
A. afra with 
E. globulus 
(1:1) 
Interpretation 
K. pneumoniae 
NCTC 9633 
6.3 3.0 2.0 0.5 Synergy 
M. catarrhalis 
ATCC 23246 
4.7 0.01 1.1 5.8 Antagonism 
E. faecalis  
ATCC 29212 
6.3 0.02 2.1 7.6 Antagonism 
C. neoformans 
ATCC 90112 
1.2 0.5 0.8 1.1 Indifferent 
S. pneumoniae 
ATCC 49619 
0.5 0.2 0.3 0.9 Additive 
S. pyogenes 
ATCC 8668 
1.1 0.6 0.3 0.3 Synergy 
S. agalactiae 
ATCC 55618 
3.0 1.0 1.0 0.7 Additive 
M. smegmatis 
(clinical) 
1.7 1.5 0.5 0.3 Synergy 
*Values in bold indicate noteworthy activity. 
Shaded area: results previously discussed in Chapter 3 but included here for reference 
purposes. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail 
regarding control values. 
 
In the combination of A. afra with E. globulus dichloromethane: methanol extracts, MIC 
values were all below 3.0 mg/ml. Some antimicrobial activity was seen against K. 
pneumoniae and E. faecalis while moderate inhibition was noted against M. catarrhalis and 
S. agalactiae. Of particular interest are the MIC values against C. neoformans, S. 
pneumoniae, S. pyogenes and M. smegmatis with MIC‟s of 0.8, 0.3, 0.3 and 0.5 mg/ml 
respectively. These values were interpreted as strong inhibitory activity for the combination 
of A. afra with E. globulus dichloromethane: methanol extract. 
 
∑FIC values were calculated and only one of the combinations showed indifferent 
interactions i.e. against C. neoformans. Additive interactions were noted for the pathogens S. 
pneumoniae and S. agalactiae. Synergistic interactions were found against K. pneumoniae 
(∑FIC value = 0.5), S. pyogenes and M. smegmatis with ∑FIC values of 0.3. For the first time 
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in the study, antagonism was noted and seen against M. catarrhalis and E. faecalis with very 
high ∑FIC values (5.8 and 7.6). If one examines the very low MIC values of E. globulus 
independently against M. catarrhalis and E. faecalis and then examines the combined 
efficacy, it is clear that when treating infections from these two pathogens it is not advisable 
to combine with A. afra. 
 
Looking at the traditional method of administration of the combination when it is 
administered through inhalation of the steam from the infusions or decoctions are 
administered (Hutchings et al., 1996). The alcohol extracts are not cited as being used 
traditionally this shows that care should be taken when using the combinations as the type of 
infection is not known to a traditional healer. Proper diagnostic tests should be considered to 
isolate the pathogen responsible for the infection prior to treatment. This antagonism seen 
could cause unwanted side effects and toxicity, or the plant extracts could be potentially 
harmful. Further investigations in this regard are recommended. 
 
6.2.2.1.3 Aqueous extracts 
The aqueous extracts of E. globulus, as shown in Table 6.4, gave MIC values between 0.8 - 
14.0 mg/ml against all the pathogens tested. Very poor activity was noted against S. 
pneumoniae with a MIC value of 14.0 mg/ml. Some antimicrobial activity was seen against 
K. pneumoniae, M. catarrhalis, E. faecalis and M. smegmatis. Moderate inhibition was 
obtained against S. pyogenes and S. agalactiae and noteworthy antimicrobial activity was 
seen against C. neoformans with a MIC value of 0.8 mg/ml. 
 
In the combination with A. afra, antimicrobial activities ranged between 0.4-8.0 mg/ml 
against the pathogens tested. Moderate inhibition was seen, with an MIC value of 1.0 mg/ml, 
against S. agalactiae. Some activity was observed in combination against pathogens C. 
neoformans, S. pneumoniae and S. agalactiae. Noteworthy strong inhibition was obtained 
against C. neoformans with a MIC value of 0.4 mg/ml. 
 
∑FIC values determined revealed no antagonism in the combination against any of the 
pathogens tested. Synergy was obtained against C. neoformans and S. pneumoniae (∑FIC 
values of 0.3 and 0.2). Additive interactions were noted against K. pneumoniae, M. 
catarrhalis, S. pyogenes, S. agalactiae and M. smegmatis. Against E. faecalis, an indifferent 
pharmacological interaction was noted. 
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Table 6.4 MIC and ∑FIC values of the aqueous extracts of A. afra and E. globulus alone and 
in combination. 
Micro-organism 
MIC (mg/ml) ∑FIC 
A. afra E. globulus 
A. afra with 
E. globulus 
A. afra with 
E. globulus 
(1:1) 
Interpretation 
K. pneumoniae 
NCTC 9633 
12.0 6.0 8.0 1.0 Additive 
M. catarrhalis 
ATCC 23246 
8.0 3.5 4.0 0.8 Additive 
E. faecalis  
ATCC 29212 
7.0 2.5 4.0 1.1 Indifferent 
C. neoformans 
ATCC 90112 
4.0 0.8 0.4 0.3 Synergy 
S. pneumoniae 
ATCC 49619 
8.0 14.0 2.0 0.2 Synergy 
S. pyogenes 
ATCC 8668 
5.3 1.3 2.0 0.9 Additive 
S. agalactiae 
ATCC 55618 
1.7 1.5 1.0 0.6 Additive 
M. smegmatis 
(clinical) 
8.0 4.0 4.0 0.8 Additive 
*Values in bold indicate noteworthy activity. 
Shaded area: results previously discussed in Chapter 3 but included here for reference 
purposes. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail 
regarding control values. 
 
6.2.2.2 Isobologram interpretation 
The essential oils (Figure 6.4 and inset) of the combination of A. afra with E. globulus 
against M. catarrhalis showed additive interactions for all the ratios tested. The 
dichloromethane: methanol extracts were indifferent at four ratios tested and completely 
antagonistic for five of them (Figure 6.4). The ratios in which antagonism were noted are at 
8:2, 7:3, 6:4, 5:5 and 4:6. A. afra and E. globulus vary in concentration at these ratios, but the 
general trend suggests that when the two extracts come closer in concentration to each other 
(1:1), antagonism is the result. In contrast, the aqueous extracts (Figure 6.4 and inset) were 
synergistic at all ratios tested except one. The one exception was the 1:1 ratio and it showed 
an additive interaction. This is interesting to note as the traditional use is the inhalation of the 
steam of an infusion or a decoction of the combination is taken (Hutchings et al., 1996). 
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Furthermore, results of aqueous extracts against M. catarrhalis demonstrate that 1:1 
combinations may not always be the best selection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4 Isobologram of the combination of A. afra and E. globulus essential oils (   ), 
dichloromethane: methanol extracts (   ) and aqueous extracts (   ) against M. catarrhalis; 
       1:1 combination. 
 
For K. pneumoniae (Figure 6.5), the essential oils of the combination showed additive 
interactions for all the ratios tested. The dichloromethane: methanol extracts showed additive 
interactions for most of the ratios. However, two exceptions at ratios 4:6 and 5:1 (Figure 6.5, 
a) were synergistic. This synergy occurred when A. afra and E. globulus were at the same 
ratio and when E. globulus was slightly more than A. afra (ratio 4:6). The aqueous extracts of 
the combination of A. afra with E. globulus showed a mixture of indifferent and additive 
interactions. Additivity was noted at ratios 6:4, 4:6, 3:7, 2:8 and 1:9 and the 1:1 combination. 
Indifferent interactions were seen at ratios 9:1, 8:2 and 7:3. A higher concentration of E. 
globulus is better to obtain more synergy in the combination of the aqueous extracts against 
K. pneumoniae. 
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Figure 6.5 Isobologram of the combination of A. afra and E. globulus essential oils (   ), 
dichloromethane: methanol extracts (   ) and aqueous extracts (   ) against K. pneumoniae (a - 
ratios 4:6 and 5:1);       1:1 combination. 
 
In Figure 6.6, the interactions of the combination of A. afra with E. globulus against E. 
faecalis is shown. The essential oil (Figure 6.6, inset) results show additive interactions for 
all the ratios tested.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.6 Isobologram of the combination of A. afra and E. globulus essential oils (   ), 
dichloromethane: methanol extracts (   ) and aqueous extracts (  ) against E. faecalis (b – 
ratios 6:4 and 1:1);        1:1 combination. 
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The dichloromethane: methanol extracts (Figure 6.6) showed additive interactions for three 
ratios (3:7, 2:8 and 1:9), where E. globulus is the dominant essential oil in the combination. 
Four of the ratios were indifferent and two ratios were antagonistic Figure 6.6 shows the 
antagonistic ratios at (b), which are the 6:4 and the 5:5 combinations of the essential oils. The 
aqueous extracts showed indifferent interactions for all the ratios tested, except one, which 
was additive (ratio 4:6). 
 
The isobolographic interactions of the combination against C. neoformans (Figure 6.7) show 
additive interaction for the essential oils at all the ratios tested. The dichloromethane: 
methanol extracts showed mixed interactions. Ratios 9:1, 8:2, 4:6, 1:9 and 3:7 show additive 
interactions while ratios 7:3, 6:4, 2:8, and the 1:1 combinations were indifferent. The aqueous 
extracts displayed very interesting activity with all the ratios to be synergistic. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.7 Isobologram of the combination of A. afra and E. globulus essential oils (   ), 
dichloromethane: methanol extracts (   ) and aqueous extracts (   ) against C. neoformans; 
       1:1 combination. 
 
The interactions of the 1:1 combination evaluated using the ∑FIC method and the 
isobologram interaction method were in congruence with each other against M. catarrhalis 
and E. faecalis. Variation was noted against K. pneumoniae with the dichloromethane: 
methanol extracts where the ∑FIC value indicated additivity and the isobologram was 
synergistic. The aqueous extracts against K. pneumoniae also expressed some variation where 
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the ∑FIC interpretation was indifferent and the isobologram interpretation was additive. The 
essential oil results of the interactions were congruent. 
 
Against C. neoformans, the variations occurred in the essential oil 1:1 combination wherein 
the ∑FIC interpretation was synergistic and the isobologram interpretation was additive. The 
dichloromethane: methanol extract combination showed additivity when the ∑FIC was 
calculated and indifference with the isobologram. 
 
The interactions observed for the 1:1 combination against M. catarrhalis, E. faecalis, K. 
pneumoniae and C. neoformans using the ∑FIC determination method were in congruence 
with those observed when using the isobologram method. 
 
The combination of E. globulus essential oil with chlorhexidine dicgluconate has been 
studied by Karpanen et al. (2008). The MIC chequerboard method was used to evaluate the 
antimicrobial activity against two strains of S. epidermidis of the combination, in suspension 
and in biofilms. Using the ∑FIC determination method, the interactions of the combination in 
suspension was indifferent. However, when E. globulus was combined with chlorhexidine 
dicgluconate against both strains of S. epidermidis growing in biofilms, synergistic activity 
was obtained. 
 
It is fascinating to note that the interactions of the combination, whether evaluated by MIC, 
∑FIC or the isobolograms, showed that the essential oil were mostly additive. In Low et al. 
(1974) (Hasegawa et al., 2008), the essential oils of Eucalyptus spp is used for the treatment 
of pulmonary infections by inhalation. This is also the case in the combination of A. afra with 
E. globulus. The traditional use is cited in Hutchings et al. (1996) wherein it states that the 
combination is administered by the inhalation of the steam of the infusion. The results 
obtained in the study show the essential oils exhibit the most consistent activity with 
predominantly additive interactions against the four pathogens tested. Thus, correlates with 
the traditional use of the combination by traditional healers. 
 
The dichloromethane: methanol extracts in combination however, were the most antagonistic 
in their interactions against M. catarrhalis. Additivity or indifference was predominant 
against E. faecalis, K. pneumoniae and C. neoformans. 
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The aqueous extracts showed very good activity and if not synergistic interactions the ratios 
were additive against M. catarrhalis, K. pneumoniae and C. neoformans. Indifference was 
noted from three ratios against K. pneumoniae and against E. faecalis. These results are 
interesting as none of the combinations exhibited antagonism against the pathogens tested. In 
addition, the literature cites the combination to be taken as decoction (Hutchings et al., 1996). 
Thus, the traditional method of administration ties in with the results obtained. This serves to 
validate the use of A. afra in combination with E. globulus essential oils and aqueous extract 
to treat respiratory infections. 
 
6.3 Conclusions 
 The major compounds present in E. globulus were 1,8-cineole (63%) and α-pinene 
(16.7%), limonene (3.6%) and ρ-cymene (2.7%). 
 The essential oil of E. globulus showed some antimicrobial activity with the best and 
noteworthy activity against C. neoformans (MIC value of 0.6 mg/ml). 
 The dichloromethane: methanol extract of E. globulus showed very good 
antimicrobial activity against, C. neoformans (MIC value = 0.5 mg/ml), S. 
pneumoniae (MIC value = 0.19 mg/ml) and S. pyogenes (MIC value = 0.56 mg/ml) 
with the best activity against E. faecalis with a MIC value of 0.02 mg/ml and  M. 
catarrhalis (MIC value = 0.014 mg/ml). 
 In the combination of the dichloromethane: methanol extracts of A. afra with E. 
globulus, the best antimicrobial activity was obtained against S. pneumoniae (MIC 
value = 0.25 mg/ml), S. pyogenes (MIC value = 0.25 mg/ml) and M. smegmatis (MIC 
value = 0.5 mg/ml). 
 The ∑FIC determination method of the dichloromethane: methanol extract 
combination gave antagonistic interactions against M. catarrhalis and E. faecalis. 
Synergy was noted against K. pneumoniae, S. pyogenes and M. smegmatis. 
 The best MIC value obtained with the aqueous extract of E. globulus was 0.8 mg/ml 
against C. neoformans. The combination with A. afra also gave the best MIC value 
against C. neoformans (MIC value of 0.4 mg/ml). 
 The combination of the aqueous extracts showed synergistic ∑FIC interactions 
against C. neoformans (0.3) and S. pneumoniae (0.2) 
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 The essential oils of the combination of A. afra with E. globulus showed additive 
interactions against M. catarrhalis, K. pneumoniae, E. faecalis and C. neoformans 
when assessing the isobolograms. 
 The isobolograms showed antagonistic interactions (five ratios) for the 
dichloromethane: methanol extract of the combination against M. catarrhalis. The 
aqueous extracts of the combination showed very promising results with most or all 
ratios showing synergy against M. catarrhalis and C. neoformans. 
 Overall, C. neoformans was the most sensitive pathogen to the combination of A. afra 
with E. globulus essential oils and aqueous extracts. 
 
  
131 
 
Chapter 7 
The antimicrobial efficacy of Artemisia afra Jacq. ex Willd and 
Zanthoxylum capense (Thunb.) Harv. in combination 
 
7.1 Introduction 
The combination of A. afra with Z. capense has been used by traditional healers for the 
treatment of head colds and influenza (Watt and Breyer-Brandwijk, 1962; Hutchings et al., 
1996). It was a popular remedy in the influenza epidemic in 1918. A decoction and an 
infusion of the leaves of Z. capense is made with A. afra and cited as been used in febrile 
conditions. If it was used as a remedy for influenza since 1918, it follows that the 
combination be analyzed for its validity in treatment of respiratory illnesses. Even though Z. 
capense is aromatic in nature, no essential oil was obtained through hydro-distillation. The 
dichloromethane: methanol extracts and the aqueous extracts were thus only studied.  
 
7.2 Results and discussion 
7.2.1 Chromatographic techniques 
7.2.1.1 Thin layer chromatography  
Thin layer chromatography analysis of the dichloromethane: methanol extracts of Z. capense 
revealed at 254 nm (Figure 7.1), that many of the compounds did not migrate up the plate. It 
is also evident at 365 nm that a blue fluorescent band was visible at the bottom. Many 
fluorescent red compounds are also visible at 365 nm. In Z. capense alone and in the 
combination with A. afra, a dark green band is visible at Rf = 0.9. A bright yellow compound 
at Rf = 0.8 is also seen under white light (Figure 7.1). After derivatization, the compounds 
mentioned are seen as bluish-purple. 
 
Three fluorescent compounds seen at 365 nm are dominant in the combination of A. afra with 
Z. capense dichloromethane: methanol extracts. These are shown in Figure 7.1. two 
compounds are from A. afra and extract 1 compound is from Z. capense extract. 
 
The aqueous extracts as seen in Figure 7.2, showed a limited number of compounds at 254 
nm.  
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Figure 7.1 A. afra dichloromethane: methanol extracts alone and in combination with Z. 
capense visualizing at 254 nm, 365 nm, white light and after derivatization with vanillin-
sulphuric acid. Aa - A. afra; Zc - Z.capense; Aa + Zc - A. afra with Z. capense. 
 
 
 
 
Figure 7.2 A. afra aqueous extracts alone and in combination with Z. capense visualizing at 
254 nm, 365 nm, white light and after derivatization with vanillin-sulphuric acid. Aa - A. 
afra; Zc - Z.capense; Aa + Zc - A. afra with Z. capense. 
 
7.2.2 Antimicrobial analysis 
7.2.2.1 MIC assays and FIC determination  
7.2.2.1.1 Dichloromethane: methanol extracts  
For the dichloromethane: methanol extracts (Table 7.1), moderate inhibitory antimicrobial 
activity was noted against E. faecalis and S. pneumoniae. Some antimicrobial activity was 
noted against M. catarrhalis, K. pneumoniae, S. pyogenes and S. agalactiae. Noteworthy 
254 nm 365 nm White light Derivatized 
Aa       Zc    Aa + Zc   Aa      Zc     Aa + Zc     Aa       Zc    Aa + Zc      Aa       Zc     Aa + Zc 
254 nm Derivatized 365 nm White light 
  Aa       Zc     Aa + Zc    Aa        Zc      Aa + Zc    Aa       Zc       Aa + Zc     Aa         Zc       Aa + Zc 
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activity with strong inhibition was obtained against C. neoformans (MIC value = 0.4 mg/ml) 
and moderate inhibition against M. smegmatis with MIC values of 0.8 mg/ml. 
 
Table 7.1 MIC and ∑FIC values of A. afra and Z. capense dichloromethane: methanol 
extracts independently and in combination.  
*Values in bold indicate noteworthy activity. 
Shaded area: results previously discussed in Chapter 3 but included here for reference 
purposes. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail 
regarding control values. 
 
Antimicrobial activity (moderate inhibition) was noted for the combination of A. afra with Z. 
capense dichloromethane: methanol extracts, against S. pyogenes with an MIC value of 1.0 
mg/ml. Some antimicrobial activity was seen against K. pneumoniae, M. catarrhalis, E. 
faecalis, S. agalactiae and M. smegmatis. The lowest MIC values and noteworthy inhibition 
were obtained against pathogens C. neoformans (0.4 mg/ml) and S. pneumoniae (0.3 mg/ml) 
 
∑FIC values of the combination of the dichloromethane: methanol extracts of A. afra with Z. 
capense demonstrated synergy against S. pneumoniae (∑FIC value = 0.4). Additive ∑FIC 
values were obtained for the combination against K. pneumoniae, M. catarrhalis, E. faecalis, 
Micro-organism 
MIC (mg/ml) ∑FIC 
A. afra Z. capense 
A. afra with Z. 
capense 
A. afra with 
Z. capense 
(1:1) 
Interpretation 
K. pneumoniae 
NCTC 9633 
6.3 1.7 2.0 0.8 Additive 
M. catarrhalis 
ATCC 23246 
4.7 2.0 2.0 0.7 Additive 
E. faecalis  
ATCC 29212 
6.3 1.3 2.0 0.9 Additive 
C. neoformans 
ATCC 90112 
1.2 0.4 0.4 0.7 Additive 
S. pneumoniae 
ATCC 49619 
0.5 1.5 0.3 0.4 Synergy 
S. pyogenes 
ATCC 8668 
1.1 2.0 1.0 0.7 Additive 
S. agalactiae 
ATCC 55618 
3.0 4.0 4.0 1.2 Indifference 
M. smegmatis 
(clinical) 
1.7 0.8 2.0 1.9 Indifference 
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C. neoformans and S. pyogenes. Indifferent interactions were noted for the combination 
against S. agalactiae and M. smegmatis. 
 
7.2.2.1.2 Aqueous extracts 
The aqueous extracts of Z. capense (Table 7.2), showed the lowest MIC value with strong 
and noteworthy activity against S. agalactiae at 0.4 mg/ml. Some antimicrobial activity was 
seen against C. neoformans with a MIC value of 2.0 mg/ml.  
 
Table 7.2 MIC and ∑FIC of A. afra and Z. capense aqueous extracts independently and in 
combination. 
*Values in bold indicate noteworthy activity. 
ND
1 
No ∑FIC value could be calculated as no MIC end point for Z. capense/A. afra with Z. 
capense was obtained at the highest concentration tested. 
2
 Tentative interpretation according to MIC data. 
Shaded area: results previously discussed in Chapter 3 but included here for reference 
purposes. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail 
regarding control values. 
 
 
Micro-organism 
MIC (mg/ml) ∑FIC 
A. afra Z. capense 
A. afra 
with Z. 
capense 
A. afra 
with Z. 
capense 
(1:1) 
Interpretation 
K. pneumoniae 
NCTC 9633 
12.0 13.3 12.0 1.0 Additive 
M. catarrhalis 
ATCC 23246 
8.0 16.0 8.0 0.8 Additive 
E. faecalis 
ATCC 29212 
7.0 16.0 ≥16.0 ND1 Additive/Antagonistic2 
C. neoformans 
ATCC 90112 
4.0 2.0 4.0 1.5 Indifferent 
S. pneumoniae 
ATCC 49619 
8.0 ≥16.0 ≥16.0 ND1 Additive/Antagonistic2 
S. pyogenes 
ATCC 8668 
5.3 ≥16.0 ≥16.0 ND1 Additive/Antagonistic2 
S. agalactiae 
ATCC 55618 
1.7 0.4 1.3 2.0 Indifferent 
M. smegmatis 
(clinical) 
8.0 ≥16.0 3.0 ND1 Synergy2 
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In 2003, Motsei et al. tested the aqueous and the solvent extracts (ethanol, ethyl acetate, and 
hexane extracts) of Z. capense against C. albicans clinical isolates from a 5-month-old baby, 
an adult, and a standard strain. Results showed that the aqueous extract and the solvent 
extracts of the bark of Z. capense to be inactive against all the isolates at the highest 
concentration (100 mg/ml) tested.  
 
In a study by Buwa and van Staden, (2006) that investigated the antimicrobial activity of 
South African traditional medicinal plants to treat venereal diseases, Z. capense leaf was one 
of the plants tested against B. subtilis, E. coli, K. pneumoniae, S. aureus as well as Candida 
albicans. The ethanol extract of Z. capense against K. pneumoniae yielded an MIC value of 
3.125 mg/ml and the aqueous extract gave an MIC value of 12.5 mg/ml against the same 
pathogen (Buwa and van Staden, 2006). In the current study, results showed that against K. 
pneumoniae, Z. capense aqueous extract gave an MIC value of 13.3 mg/ml. This is consistent 
and comparable with the study conducted by Buwa and van Staden (2006). 
 
The combination of Z. capense with A. afra against S. agalactiae yielded the highest 
antimicrobial activity (1.3 mg/ml). Some activity was noted against C. neoformans and M. 
smegmatis and very poor activity was obtained against K. pneumoniae and M. catarrhalis. No 
inhibition was noted against E. faecalis, S. pneumoniae and S. pyogenes. 
 
∑FIC values calculated denoted indifferent interactions against S. agalactiae and C. 
neoformans and additivity against K. pneumoniae and M. catarrhalis. No end point MIC 
value was obtained for Z. capense against S. pneumoniae, S. pyogenes and M. smegmatis and 
in the combination against E. faecalis, S. pneumoniae and S. pyogenes. Thus, ∑FIC values 
could not be calculated. However, tentative interpretations based on the MIC values obtained 
were considered. (Table 7.2) 
 
7.2.2.2 Isobologram interactions 
For the combination of A. afra and Z. capense against M. catarrhalis (Figure 7.3), the 
dichloromethane: methanol extracts showed mainly additive interactions with the exception 
of two points at the ratio 2:8 and 1:9 (Figure 7.3, a), which proved indifferent. These points 
are ratios in which Z. capense is in the majority. For the aqueous extracts no end point MIC 
value was determined at the highest concentration tested thus no isobologram could be 
constructed. However, Figure 7.7 shows a graph depicting the MIC values of the combination 
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at different ratios. The results show that the MIC value increases as the ratio of Z. capense 
aqueous extract increases. The MIC value remains the same as A. afra alone for ratios, 9:1, 
8:2, and 7:3, and then it increases from the ratio 6:4 where no MIC value was obtained at the 
highest concentration tested. Thus, no increase in activity is seen when the aqueous extracts 
of A. afra was combined with Z. capense at different ratios. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.3 Isobologram of the combination of A. afra and Z. capense dichloromethane: 
methanol extracts (   ) against M. catarrhalis (a – ratio 2:8 and 1:9);        1:1 combination. 
 
The combination against K. pneumoniae as shown in Figure 7.4 yielded additive interactions 
for all the ratios tested for the dichloromethane: methanol extracts. Interactions of the 
aqueous extracts are given in Figure 7.7 where the MIC values of the different ratios are 
given against K. pneumoniae. The MIC values of the ratios 9:1, 8:2, 7:3, 6:4 and 5:5 are 
lower than the MIC values of A. afra and Z. capense individually. Thus, a tentative 
interpretation of synergy is made for the interaction of these ratios of the combination. The 
MIC values show additive interactions at ratios 4:6, 3:7 and 2:8. It is evident that an 
increasing ratio of Z capense leads to an increase in MIC value against K. pneumoniae. 
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Figure 7.4 Isobologram of the combination of A. afra and Z. capense dichloromethane: 
methanol extracts (   ) against K. pneumoniae;       1:1 combination. 
 
Isobologram interactions of the combination of A. afra and Z. capense against E. faecalis 
(Figure 7.5) showed mainly additive interactions for the dichloromethane: methanol extracts. 
One ratio was synergistic (Figure 7.5, b), i.e. 6:4, where A. afra was in the majority in the 
combination.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.5 Isobologram of the combination of A. afra and Z. capense dichloromethane: 
methanol extracts (   ) against E. faecalis (b – ratio 6:4);        1:1 combination. 
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The graph depicted in Figure 7.7 shows the MIC values of the combination at different ratios, 
against E. faecalis, increasing as the ratio of Z. capense increases. Additivity of the 
combination is seen at ratios 9:1, 8:2 and 7:3, when A. afra is the dominant extract present. 
From the 1:1 ratio, the MIC value is not determinable at the highest concentration tested.  
 
The dichloromethane: methanol extracts of the combination of A. afra with Z. capense 
against C. neoformans (Figure 7.6) showed additivity for most of the ratios tested. Synergistic 
activity was obtained for one ratio i.e. 7:3 (Figure 7.6, c), where A. afra was dominant. The 
aqueous extracts showed interactions including additivity and indifference. Two points, at 
ratios 4:6 and 1:9, where Z. capense was dominant, was additive. The remaining ratios tested 
gave indifferent pharmacological profiles. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.6 Isobologram of the combination of A. afra and Z. capense dichloromethane: 
methanol extracts (   ) and aqueous extracts (   ) against C. neoformans (c – ratio 7:3);       
1:1 combination. 
 
Against S. pneumoniae, S. pyogenes and M. smegmatis the aqueous extract of Z. capense was 
not active (Table 7.2). For the aqueous extracts of the combination of A. afra with Z. capense, 
MIC values (Table 7.2) were not determined at the highest concentration tested against E. 
faecalis, S. pneumoniae and S. pyogenes. Tentative interpretations were carried out to 
determine the ∑FIC interpretations of the interactions. For the isobologram construction, the 
MIC values of Z. capense could not be calculated against M. catarrhalis, K. pneumoniae and 
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E. faecalis. Comparisons of the interpretations are made against the pathogens M. catarrhalis, 
K. pneumoniae and E. faecalis.  
 
Against M. catarrhalis, the ∑FIC calculated (Table 7.2) was interpreted as additive and the 
tentative interpretation of the combination in ratios (Figure 7.7) was interpreted as being 
additive or indifferent. Against K. pneumoniae, ∑FIC interpretation was additive and the 
tentative interpretation of the ratios (Figure 7.7) was synergistic or additive. The ∑FIC value 
and the interpretation of the ratios (Figure 7.7) against E. faecalis could not be determined, 
thus tentative interpretations were carried out and both were consistent and interpreted as 
either additive or antagonistic.  
Figure 7.7 The MIC values of the different ratios of the combination of A. afra with Z. 
capense aqueous extracts against K. pneumoniae, M. catarrhalis and E. faecalis. 
 
No other comparable studies are available to compare interactions noted between A. afra with 
Z. capense. The aqueous extracts of A. afra and Z. capense would represent an infusion or 
decoction. Z. capense proved inactive at the concentrations tested. However, other ways to 
determine if the combination is synergistic for the above-mentioned diseases or illness are 
available e.g. time-kill assays. Nevertheless, the isobologram results obtained give an 
indication that the dichloromethane: methanol extracts of Z. capense in combination with A. 
0 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
10:0 9:1 8:2 7:3 6:4 5:5 4:6 3:7 2:8 1:9 0:10 
M
IC
 v
a
lu
e 
(m
g
/m
l)
 
Ratio (A. afra: Z. capense) 
K. pneumoniae 
M. catarrhalis 
E. faecalis 
>16 
140 
 
afra, give synergistic and additive results depending on the ratios in which they are 
combined.  
 
7.3 Conclusions 
 TLC of Z. capense dichloromethane: methanol extracts revealed many different 
compounds present. Thus in the combination of A. afra and Z. capense the number of 
compounds present increased.  
 The best antimicrobial activities noted for Z. capense dichloromethane: methanol 
extracts individually was against C. neoformans (MIC value = 0.4 mg/ml) and M. 
smegmatis (MIC value = 0.8 mg/ml). 
 Noteworthy synergistic activity was noted in the combination of A. afra with Z. 
capense dichloromethane: methanol extract against S. pneumoniae (MIC value of 0.3 
mg/ml and ∑FIC value of 0.4). 
 The highest antimicrobial activity (MIC value of 0.4 mg/ml) obtained for the aqueous 
extracts of Z. capense was against S. agalactiae. 
 The combination of A. afra with Z. capense aqueous extracts also yielded the best 
MIC value against S. agalactiae (MIC value = 1.3 mg/ml). 
 Isobologram interactions revealed mainly additivity for the dichloromethane: 
methanol extracts against the four pathogens tested. Synergy was noted in the ratio 
6:4 against K. pneumoniae and 7:3 against C. neoformans. 
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Chapter 8 
Artemisia afra in triple plant combinations 
 
8.1 Introduction 
Western (conventional) medicine has increasingly begun using three or more agents as viable 
antimicrobial treatment options (Lange, 1995). This has been achieved by combining drugs 
like anti-retrovirals (Stavudine
®
-Lamivudine
®
-Efavirenz
®
), analgesics (Synap Forte
®
, 
Lentogesic
®
), as well as chemotherapeutic drugs (Irinotecan-fluorouracil-folinic acid) 
(Rossiter et al., 2010; Turner et al., 2010). A study by Ocio et al. (2010), has confirmed the 
efficacy of a triple combination in contrast to a double combination for the treatment of 
multiple myeloma. Examples of studies incorporating triple combinations include those 
discussed by Rochon-Edouard et al. (2000) which investigated the efficacy of β-lactams, 
vancomycin and netilmicin against methicillan-resistant S. aureus strains using time-kill 
studies. Results showed that the combination could, at sub-inhibitory concentrations be 
bactericidal after 24 hrs. These are at higher rates than a double combination of vancomycin-
netilmicin. Another study of note is by O‟Shaughnessy et al. (2006), where the antifungal 
interaction of amphotericin B, caspofungin and voriconazole was tested in combination at 
different drug concentrations, against Aspergillus species. Antifungal interactions, namely 
synergy, was found at low concentrations of amphotericin B (<0.2 mg/l) and voriconazole 
(<0.5 mg/l). Antagonism was found when the concentrations of amphotericin B and 
voriconazole was increased i.e. between 0.3-0.5 mg/l and >0.25 mg/l respectively. Another 
study pertaining to triple combinations and their uses for the treatment of Plasmodium 
falciparum infections, demonstrated no decrease in activity when folinic acid was added to a 
double combination (Yeo and Rieckmann, 1997). The third compound could possibly 
alleviate toxic effects of the other two compounds and thus prevent adverse effects normally 
seen in the double combination.  
 
In order to fully explore the use of combinations in traditional medicine, it is important to 
recognise that plants are not only used in a two-plant combination. There are instances where 
three or more plants are used. Double combinations have been discussed in detail in Chapters 
3-7. Typically, one would assume that the addition of a third substance to a combination 
would increase or improve the efficacy of a combination. However, the combinations of 
substances in triple or more cannot be assumed to result in synergistic or even additive 
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interaction. The combinations must be verified and the interaction must be established 
(O‟Shaughnessy et al., 2006). Natural drugs or compounds are known to exhibit complex 
pharmacological action (Biavatti, 2009), therefore, the outcome of combining more than one 
or more plants is difficult to predict. Thus, it is important to test the activity in combination 
and thereafter have a basis upon which we may be able to scientifically validate the 
combinations in which they are prescribed. 
 
Triple combinations of ethnobotanical origin are used substantially all over the world for the 
treatment of various conditions. Figure 8.1 shows the results obtained from an internet search 
on the use of triple plant combinations in general and then on triple combinations of plants in 
South Africa. The findings show that there is little scientific evidence on the validation of the 
use of triple combinations, particularly for Southern African plants. Only one validation 
based on southern African plants could be  found, Sibandze et al., (2010), combined three 
Swazi traditional medicinal plants i.e. Breonadia salicina, Syzgium cordatum with Ozoroa 
sphaerocarpa to treat diarrhoea. Results of this study showed predominantly synergism when 
the three plants were combined and thus support the traditional use of the combination in 
Swazi traditional medicine. Other triple plant combination studies elsewhere in the world 
include the investigation of corni fructus, cinnamon and Chinese chive to determine the 
antimicrobial efficacy of the three plant extracts in combination against common food borne 
pathogens (Hsieh et al., 2001). Results showed that the combination 8:1:1 of the extracts 
produced an entire spectrum of antimicrobial activity as well as being very stable to heat and 
pH changes.  
 
In South African traditional medicine, combinations of plants, either in triple or more are 
used frequently by traditional healers (Watt and Breyer-Brandewijk, 1962; Hutchings et al., 
1996; Felhaber, 1997). Some such examples are seen in Table 1.3 and include the boiling and 
drinking of the combination of the powdered leaves of Eucalyptus globulus with powdered 
root of Corbichonia decumbens and powdered rhizome of A. calamus to relieve a stuffy or 
blocked nose. Phoenix reclinata, Euclea natalensis, Capparis tomentosa and Maytennus 
heterophylla are combined to treat pleurodynia and pleurisy wherein the steam from the 
decoction is blown into the wound (Bryant, 1970; Hutchings et al., 1996).  
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Figure 8.1 Summary of the reports available on triple combinations of medicinal plants.  
  
General search on conventional antimicrobial and ethnobotanical combinations 
"Triple combinations" 
 
Search for triple combinations within ethnobotanicals 
"Triple combinations AND plants" 
 
About 5,580,000 results using 
“Google” 
 
13,813 results using 
“ScienceDirect” 
 
417 results on “Scopus” 
50 hits on “PubMed” 
Ethnobotanically in SA 
"Triple combinations AND plants AND 
South Africa" 
 
1356 hits on 
“ScienceDirect” 
 
15 results on “Scopus” 
 
1 result on “Pubmed” 
About 1,100,000 
results using “Google” 
 
95,280 results using “ScienceDirect” 
8722 results using “Scopus” 
1517 using “PubMed” 
About 2,520,000 results using “Google” 
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A boiled infusion of the combination of Eucalyptus globulus, Corbichonia decumbens and A. 
calamus is also used for a blocked nose (Felhaber, 1997). 
 
Combinations where A. afra is a component are in the treatment of asthma, wherein the root 
of A. amatymbica with the leaves of A. afra and the leaves of L. leonurus are boiled together, 
and taken (Felhaber, 1997). For the treatment of chronic bronchitis and emphysema, the 
leaves of A. afra are mixed with the bark of W. salutaris and the rhizome of Acoras calamus, 
which are then boiled and drank (Felhaber, 1997). The leaves of A. afra, O. asteriscoides 
with E. globulus were reported to be used extensively by the Europeans in South Africa for 
the treatment of influenza. An infusion of the leaves of A. afra, Leonotis microphylla and E. 
globulus is used by the Sotho and European people in South Africa for the relief of digestive 
disturbances accompanied by fever as well as for chest infections. The decoction of the 
combination of A. afra, Allium sativum with Zanthoxylum capense is used as a febrifuge 
(Watt and Breyer-Brandewijk, 1962).   
 
From the literature searched, none of the afore-mentioned combinations have been 
scientifically validated. Moreover, evidence for synergy or antagonism between three or more 
plant combinations is sparse. It is important that these combinations are properly validated in 
order to reduce complications and adverse effects that might result if the plants used together 
are incompatible. Four of the triple combinations mentioned in Table 1.3 that included A. 
afra in the treatment of respiratory diseases have been selected for this study. The selection 
was based on the availability of the plant species, keeping in mind sustainable harvesting 
practices. The triple combinations evaluated are A. afra, O. asteriscoides with E. globulus; A. 
afra, L. randii with E. globulus and the combination of A. afra, Allium sativum with Z. 
capense. 
 
8.2 Results and discussion 
8.2.1 A. afra, O. asteriscoides and E. globulus in combination 
The botanical description, locality, medicinal uses and phytochemistry of A. afra is discussed 
in Chapter 1 and similarly for  E. globulus  and O. asteriscoides are discussed in Appendix 
A4 and A7, respectively. The dichloromethane: methanol extracts of A. afra, O. asteriscoides 
and E. globulus were evaluated using thin layer chromatography. MIC determination and FIC 
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interpretation was carried out on the essential oils, dichloromethane: methanol and the 
aqueous extracts according to the methods described in Chapter 2.  
 
8.2.1.1 Chromatographic techniques 
8.2.1.1.1 Thin layer chromatography  
The compounds present in the plant extracts at 256 nm, individually and in combination 
fluoresce somewhat blackish under this wavelength due to the presence of conjugated double 
bonds (Figure 8.2).  
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Figure 8.2 TLC plates of the dichloromethane: methanol extracts of A. afra, O. asteriscoides 
and E. globulus alone and in combination at 254 nm, 365 nm, white light and visualized with 
vanillin-sulphuric acid reagent.   
 
At 365 nm (Figure 8.2), some fluorescent compounds, bright blue and red compounds, are 
visible. For the TLC plate viewed under white light, only the coloured compounds are 
detected i.e. a green compound at Rf = 0.9 in A. afra. When the TLC plate was derivatized 
with vanillin-sulphuric acid reagent, organic compounds in the test sample are coloured 
yellow, brown, or black (Houghton and Raman, 1998). The combination of the 
dichloromethane: methanol extracts of A. afra, O. asteriscoides and E. globulus 
independently and in combination thus yield compounds that are visible under UV light at 
254 nm and 365 nm.  
 
8.2.1.2 Antimicrobial analysis 
8.2.1.2.1 MIC assays and FIC determination 
MIC values of A. afra, O. asteriscoides and E. globulus individually and in combination are 
included in Table 8.1, 8.2 and 8.3 for the sake of completeness, (shaded areas) but have been 
discussed in Chapters 3, 4 and 6. The combination of O. asteriscoides with E. globulus has 
been studied here to give a detailed overview of each 1:1 plant combination within the triple 
combination. MIC values for the controls i.e. ciprofloxacin and amphotericin B are shown in 
Table 3.3. 
 
8.2.1.2.1.1 Essential oils 
Table 8.1 shows the MIC values of O. asteriscoides in combination with E. globulus essential 
oils against eight pathogens. The highest antimicrobial activity with noteworthy inhibition 
Derivatized 
1             2           3           4             5           6           7 
 
1  2    3     4      5       6       7 
1            2            3           4            5            6           7 
 
1  2    3    4      5       6       7 
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was obtained for the combination of O. asteriscoides with E. globulus against E. faecalis, 
(0.5 mg/ml). Other noteworthy activity was noted for the combination against C. neoformans 
(MIC value = 0.75 mg/ml), S. pneumoniae (MIC value = 1.0 mg/ml), S. pyogenes (MIC value 
= 2.0 mg/ml) and M. smegmatis (MIC value = 1.5 mg/ml). Some antimicrobial activity was 
obtained in the combination against S. agalactiae and very low activity against K. 
pneumoniae and M. catarrhalis.  
 
∑FIC values calculated for the combination of O. asteriscoides with E. globulus showed 
additive interactions against K. pneumoniae, M. catarrhalis, C. neoformans S. pneumoniae, S. 
agalactiae and M. smegmatis. The most significant synergistic activity in this triple 
combination study was noted against E. faecalis with a ∑FIC value = 0.1.  
 
In the combination of the three essential oils i.e. A. afra, O. asteriscoides and E. globulus, 
noteworthy activity was obtained against S. pneumoniae, S. pyogenes and M. smegmatis 
(MIC value = 2.0 mg/ml). Some activity was noted against S. agalactiae and very poor 
activity was seen against K. pneumoniae, M. catarrhalis, E. faecalis and C. neoformans. 
∑FIC‟s that were then calculated and demonstrated antagonistic activity against C. 
neoformans (∑FIC value = 6.5). Additive interactions were noted against K. pneumoniae, M. 
catarrhalis, E. faecalis and S. agalactiae. Against S. pneumoniae, S. pyogenes and M. 
smegmatis ∑FIC values showed indifferent/non-interactive interactions (∑FIC values 1.1-
1.3) (Table 8.1). 
 
In the combination of A. afra with O. asteriscoides essential oils, six of the pathogens showed 
additive interactions and two pathogens showed indifference. The combination of A. afra 
with E. globulus, all eight pathogens tested showed additive pharmacological interactions. 
When O. asteriscoides was combined with E. globulus, six pathogens were additive, one was 
indifferent and the interaction against E. faecalis was synergistic. When A. afra, O. 
asteriscoides and E. globulus essential oils were combined in a 1:1:1 ratio, four pathogens 
showed additive interactions, three were indifferent and one pathogen showed antagonism (C. 
neoformans). 
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Table 8.1 MIC and ∑FIC values of the essential oils of A. afra, O. asteriscoides and E. globulus alone and in combination. 
*Values in bold indicate noteworthy activity. 
Shaded area: results previously discussed in Chapter 3, 4 and 5 but included here for reference purposes. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail regarding control values. 
 
 
Micro-organism 
MIC (mg/ml)/ ∑FIC value indicated in brackets where applicable ∑FIC 
A. afra 
O. 
asteriscoides 
A. afra with  
O. 
asteriscoides 
E. 
globulus 
A. afra 
with E. 
globulus 
O. 
asteriscoides 
with  
E. globulus 
A. afra, O. 
asteriscoide
s with  
E. globulus 
A. afra, O. 
asteriscoides 
with  
E. globulus 
Interpretation 
K. pneumoniae 
NCTC 9633 
8.0 8.0 8.0 (1.0) 8.0 8.0 (1.0) 8.0 (1.0) 8.0 1.0 Additive 
M. catarrhalis 
ATCC 23246 
8.7 8.0 8.0 (1.0) 8.0 8.0 (1.0) 8.0 (1.0) 8.0 1.0 Additive 
E. faecalis  
ATCC 29212 
8.7 8.0 8.0 (1.0) 8.0 8.0 (1.0) 0.5 (0.1) 8.0 1.0 Additive 
C. neoformans 
ATCC 90112 
3.8 2.0 2.0 (0.8) 0.6 0.8 (0.8) 0.8 ( 0.8) 8.0 6.5 Antagonism 
S. pneumoniae 
ATCC 49619 
3.3 1.0 1.0 (0.7) 2.7 3.0 (1.0) 1.0 (0.7) 2.0 1.1 Indifferent 
S. pyogenes 
ATCC 8668 
1.7 1.7 1.5 (0.9) 2.0 1.5 (0.8) 2.0 (1.1) 2.0 1.1 Indifferent 
S. agalactiae 
ATCC 55618 
4.8 4.7 7.0 (1.5) 5.3 4.0 (0.8) 4.0 (0.8) 4.0 0.8 Additive 
M. smegmatis 
(clinical) 
1.5 1.3 1.5 (1.1) 2.0 1.3 (0.7) 1.5 (1.0) 2.0 1.3 Indifferent 
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The triple combination did not show any marked increase in activity or synergy when 
compared to the double combinations. In fact, against C. neoformans, it is imperative that the 
three oils are not combined as detrimental effects could result due to the antagonism they 
present. Inhalation is not used when administering this combination thus it was not surprising 
that the combination did not show any marked improvement in interaction. One combination 
that stands out in the combinations involving the essential oils is O. asteriscoides with E. 
globulus against E. faecalis where the most significant synergistic interaction was observed 
for the entire study.  
 
8.2.1.2.1.2 Dichloromethane: methanol extracts 
For the dichloromethane: methanol extracts, MIC values of the combination of O. 
asteriscoides with E. globulus are shown in Table 8.2. Noteworthy inhibitory activity was 
seen against C. neoformans (MIC value = 0.3 mg/ml), S. pneumoniae (MIC value = 0.5 
mg/ml) and S. agalactiae (MIC value = 0.5 mg/ml). Moderate inhibition was noted against S. 
pyogenes with a MIC value of 1.0 mg/ml.  
 
Some antimicrobial activity was seen against K. pneumoniae, M. catarrhalis, E. faecalis and 
M. smegmatis. The ∑FIC values calculated for the combination of O. asteriscoides with E. 
globulus gave additive interactions against K. pneumoniae and C. neoformans with ∑FIC 
values of 0.7 and 0.8 respectively. Synergy was obtained against S. agalactiae where the 
∑FIC calculated was 0.4. Antagonism was observed for studies against M. catarrhalis and E. 
faecalis.   
 
For the triple combination of the plants extracts, MIC values (0.5 mg/ml) demonstrated 
noteworthy strong inhibition against C. neoformans and S. agalactiae. Noteworthy moderate 
inhibition was observed for S. pneumoniae (MIC value = 0.6 mg/ml). Moderate inhibitory 
antimicrobial activity was obtained against S. pyogenes with a MIC value of 1.0 mg/ml.  
 
Some activity was noted against K. pneumoniae, M. catarrhalis, E. faecalis and M. 
smegmatis. ∑FIC values of the triple combination yielded synergistic interactions against two 
pathogens i.e. against K. pneumoniae (∑FIC value = 0.5) and S. agalactiae (∑FIC value = 
0.4). Two pathogens revealed complete antagonism when the ∑FIC values were calculated. 
These were M. catarrhalis and E. faecalis. One combination was additive against C. 
neoformans (∑FIC value = 0.9).  
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Table 8.2 MIC and ∑FIC values of the dichloromethane: methanol extracts of A. afra, O. asteriscoides and E. globulus alone and in 
combination. 
*Values in bold indicate noteworthy activity. 
Shaded area: results previously discussed in Chapter 3, 4 and 5 but included here for reference purposes. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail regarding control values. 
  
Micro-organism 
MIC (mg/ml)/∑FIC value indicated in brackets where applicable ∑FIC 
A. afra 
O. 
asteriscoid
es 
A. afra with 
O. 
asteriscoides 
E. 
globulus 
A. afra with 
E. globulus 
O. 
asteriscoid
es with E. 
globulus 
A. afra, O. 
asteriscoides 
with E. 
globulus 
A. afra, O. 
asteriscoides 
with E. 
globulus 
Interpretation 
K. pneumoniae 
NCTC 9633 
6.3 4.0 6.0 (1.2) 3.0 2.0 (0.5) 2.0 (0.7) 2.0 0.5 Synergism 
M. catarrhalis 
ATCC 23246 
4.7 4.0 4.0 (0.9) 0.01 1.1 (5.8) 2.2 (77.3) 4.0 57.6 Antagonism 
E. faecalis  
ATCC 29212 
6.3 2.0 4.0 ( 1.3) 0.02 2.1 (7.6) 1.1 ( 34.0) 2.0 42.9 Antagonism 
C. neoformans 
ATCC 90112 
1.2 0.3 0.3 ( 0.7) 0.5 0.8 ( 1.1) 0.3 ( 0.8) 0.5 0.9 Additive 
S. pneumoniae 
ATCC 49619 
0.5 0.4 0.1 (0.3) 0.19 0.3 (0.9) 0.5 (1.9) 0.6 1.9 Indifferent 
S. pyogenes 
ATCC 8668 
1.1 0.4 0.1 (0.2) 0.6 0.3 (0.3) 1.0 (2.1) 1.0 1.7 Indifferent 
S. agalactiae 
ATCC 55618 
3.0 1.3 1.0 (0.6) 1.0 1.0 (0.7) 0.5 (0.4) 0.5 0.4 Synergism 
M. smegmatis 
(clinical) 
1.7 1.4 0.5 (0.3) 1.5 0.5 (0.3) 2.0 (1.4) 2.0 1.3 Indifference 
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The combination of the dichloromethane: methanol extracts of A. afra with O. asteriscoides 
showed varied  interactions .The combination of A. afra with E. globulus demonstrated three 
synergistic interactions (against K. pneumoniae, S. pyogenes and M. smegmatis) and two 
antagonistic (M. catarrhalis and E. faecalis) interactions.. For the combination of O. 
asteriscoides with E. globulus, only one interaction was evident and this was against S. 
agalactiae. The triple combination of A. afra with O. asteriscoides and E. globulus 
demonstrated varied interactions with two synergistic interactions against K. pneumoniae and 
S. agalactiae. The triple combination is thus better than the double combinations when 
treating K. pneumoniae and S. agalactiae relating infections. However, care should be taken 
when treating M. catarrhalis and E. faecalis infections due to the antagonism encountered 
with these two pathogens. Thus, the causative micro-organism should be identified before 
treatment is administered to avoid any unwanted side effects. 
 
8.2.1.2.1.3 Aqueous extracts 
The MIC values of the aqueous extracts (Table 8.3) of the combination of O. asteriscoides 
with E. globulus demonstrated moderate inhibition against S. agalactiae (MIC value = 1.0 
mg/ml). Some antimicrobial activity was obtained against M. catarrhalis, E. faecalis, C. 
neoformans, S. pneumoniae, S. pyogenes and M. smegmatis. The aqueous extracts showed 
additive ∑FIC values of 0.8, 1.0, 0.7 and 1.0 against M. catarrhalis, E. faecalis, S. agalactiae 
and M. smegmatis respectively. Against K. pneumoniae, C. neoformans, S. pneumoniae and 
S. pyogenes indifferent interactions were noted. 
 
The MIC values of the triple combination ranged from 2.0 - 6.0 mg/ml with K. pneumoniae 
having the least sensitivity to the combination (MIC value of 6.0 mg/ml). In contrast, the 
triple combination was most active against S. pyogenes and S. agalactiae with MIC values of 
2.0 mg/ml. The ∑FIC values of the triple combination against K. pneumoniae, M. catarrhalis, 
E. faecalis, S. pyogenes and M. smegmatis all demonstrate  additive interactions i.e. ∑FIC 
values of 0.8, 0.7, 0.9, 1.0 and 0.8 respectively. ∑FIC values calculated against C. 
neoformans, S. pneumoniae and S. agalactiae showed indifferent interactions when the 
aqueous extracts of all three plants were combined. 
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Table 8.3 MIC and ∑FIC values of the aqueous extracts of A. afra, O. asteriscoides and E. globulus alone and in combination. 
 
Micro-organism 
MIC (mg/ml)/∑FIC value indicated in brackets where applicable ∑FIC 
A. afra 
O. 
asteriscoides 
A. afra 
with O. 
asteriscoide
s 
E. globulus 
A. afra 
with E. 
globulus 
O. 
asteriscoides 
with E. 
globulus 
A. afra, O. 
asteriscoides 
with E. 
globulus 
A. afra, O. 
asteriscoides 
with E. 
globulus 
Interpretation 
K. pneumoniae 
NCTC 9633 
12.0 8.0 8.0 (0.8) 6.0 8.0 (1.0) 8.0 (1.2) 6.0 0.8 Additive 
M. catarrhalis 
ATCC 23246 
8.0 8.0 8.0 ( 1.0) 3.5 4.0 (0.8) 4.0 (0.8) 4.0 0.7 Additive 
E. faecalis  
ATCC 29212 
7.0 9.0 8.0 ( 1.0) 2.5 4.0 (1.1) 4.0 (1.0) 4.0 0.9 Additive 
C. neoformans 
ATCC 90112 
4.0 0.5 0.5 ( 0.6) 0.8 0.4 (0.3) 2.0 (3.3) 3.0 2.3 Indifferent 
S. pneumoniae 
ATCC 49619 
8.0 1.5 2.0 (0.8) 14.0 2.0 (0.2) 4.0 (1.5) 4.0 1.2 Indifferent 
S. pyogenes 
ATCC 8668 
5.3 1.8 1.5 (0.6) 1.3 2.0 (0.9) 2.0 (1.3) 2.0 1.0 Additive 
S. agalactiae 
ATCC 55618 
1.7 1.5 2.0 (1.3) 1.5 1.0 (0.6) 1.0 (0.7) 2.0 1.3 Indifferent 
M. smegmatis 
(clinical) 
8.0 4.0 4.0 (0.8) 4.0 4.0 (0.8) 4.0 (1.0) 4.0 0.8 Additive 
*Values in bold indicate noteworthy activity. 
Shaded area: results previously discussed in Chapter 3, 4 and 5 but included here for reference purposes. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail regarding control values. 
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The aqueous extracts of the combination of A. afra with O. asteriscoides yielded interactions 
against seven pathogens to be additive and one indifferent. The combination of the extracts of 
A. afra with E. globulus showed varied interactions with, two noteworthy synergistic (against 
C. neoformans and S. pneumoniae) profiles. For the combination of O. asteriscoides with E. 
globulus, indifferent number of varied interactions were also noted, none of which were 
antagonistic. The triple combination is administered as an infusion (van Wyk and Wink, 
2004). The results obtained correlate with the traditional use and the advantage of the 
administration of the triple combination can be seen, as none of the interactions obtained 
against the pathogens demonstrated any adverse effects. 
 
8.2.2 A. afra, E. globulus and L. randii in combination 
The botanical description, locality, medicinal uses and phytochemistry of A. afra is discussed 
in Chapter 3 and similarly of E. globulus and L. randii are discussed in Appendix A4 and A5. 
The dichloromethane: methanol extracts of A. afra, E. globulus with L. randii were evaluated 
using thin layer chromatography. MIC determination and ∑FIC interpretation was carried out 
on the dichloromethane: methanol and the aqueous extracts according to the methods 
described in Chapter 2. Although L. randii is an aromatic plant, the essential oils were not 
studied as no oil was obtained during the hydrodistillation process, and thus have been 
excluded in the triple combination study. 
  
8.2.2.1 Chromatographic techniques 
8.2.2.1.1 Thin layer chromatography  
Thin layer chromatography analysis of the dichloromethane: methanol extracts of A. afra, E. 
globulus, and L. randii shows conjugated double bonded compounds, which are highly 
fluorescent at 254 nm (Figure 8.3).  
 
 
 
 
 
 
 
 
1           2            3          4            5          6          7 
 
1  2    3     4      5       6       7 
   1            2           3          4           5           6         7 
 
1  2    3     4      5       6       7 
254 nm 
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Figure 8.3 TLC plates of the dichloromethane: methanol extracts of A. afra, L. randii and E. 
globulus alone and in combination at 254 nm, 365 nm, white light and visualized with 
vanillin-sulphuric acid reagent. 
 
At 365 nm, L. randii displayed many compounds, which showed up red and blue in colour. 
Under white light (Figure 8.3), L. randii showed the most coloured compound of yellow. This 
compound was found between Rf values 0.8 and 0.9. 
  
1 A. afra 
2 L. randii 
3 E. globulus 
4 A. afra with  L. randii 
5 
A. afra with E. 
globulus 
6 
L. randii with E. 
globulus 
7 
A. afra,  L. randii with 
E. globulus 
365 nm 
White light 
Derivatized 
  1          2            3           4          5           6           7 
 
1  2    3     4      5       6       7 
  1           2          3           4           5           6          7 
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8.2.2.2 Antimicrobial analysis 
8.2.2.2.1 MIC assays and FIC determination 
8.2.2.2.1.1 Dichloromethane: methanol extracts 
The MIC values of A. afra, L. randii and E. globulus dichloromethane: methanol extracts 
against the various pathogens tested are shown in Table 8.4. MIC values individually of L. 
randii showed noteworthy activity against M. smegmatis with a MIC value of 0.5 mg/ml. 
when tested against K. pneumoniae and S. pyogenes, weak inhibition was noted with mean 
MIC values of 2.0 mg/ml and 1.0 mg/ml respectively. Moderate inhibitory antimicrobial 
activity was noted against M. catarrhalis (MIC value = 1.3 mg/ml), E. faecalis (MIC value = 
1.5 mg/ml) and S. pneumoniae (MIC value = 1.5 mg/ml).Very poor activity was seen against 
C. neoformans and S. agalactiae with MIC values of 8.0 mg/ml and 12.0 mg/ml.  
 
In the combination of the dichloromethane: methanol extracts of A. afra and L. randii mean  
MIC values ranged from 0.3-8.0 mg/ml. C. neoformans and M. smegmatis gave the best MIC 
values, with noteworthy strong inhibition, of 0.3 mg/ml and 0.5 mg/ml respectively. Against 
S. pyogenes, the poorest activity of the combination was noted at 8.0 mg/ml. Moderate 
inhibitory activity was noted against S. pneumoniae with a mean MIC value of 1.0 mg/ml. 
Some activity was seen against K. pneumoniae, M. catarrhalis, E. faecalis and S. agalactiae. 
The ∑FIC values, in brackets (Table 8.4) showed synergy for C. neoformans with a ∑FIC 
value of 0.14. Additive interactions were noted against M. catarrhalis, E. faecalis, S. 
agalactiae and M. smegmatis. 
 
A study was recently conducted (Eloff, 2010) testing the antimicrobial activity of the acetone 
extract of L. randii against four pathogens i.e. S. aureus, P. aeruginosa, E. coli and E. 
faecalis. Results showed good antimicrobial activities with MIC values below 0.1 mg/ml 
against S. aureus (0.058 mg/ml), P. aeruginosa (0.033 mg/ml) and E. faecalis (0.015 mg/ml). 
The MIC value against E. coli was 0.113 mg/ml. The study concluded that after toxicity and 
stability studies are carried out, L. randii could be promising as a commercial antibacterial 
agent. 
 
The combination of E. globulus and L. randii showed noteworthy inhibitory antimicrobial 
activity against K. pneumoniae (MIC value = 0.5 mg/ml), C. neoformans (MIC value = 0.5 
mg/ml), S. pneumoniae (MIC value = 0.3 mg/ml) and M. smegmatis (MIC value = 0.5 
mg/ml).   
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Table 8.4 MIC and ∑FIC values of the dichloromethane: methanol extracts of A. afra, L. randii, and E. globulus alone and in combination. 
*Values in bold indicate noteworthy activity 
Shaded area: results previously discussed in Chapter 3 and 6 but included here for reference purposes. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail regarding control values. 
 
 
 
Micro-organism 
MIC (mg/ml)/ ∑FIC value indicated in brackets where applicable ∑FIC 
A. afra L. randii 
A. afra 
with L. 
randii 
E. 
globulus 
A. afra 
with E. 
globulus 
L. randii 
with E. 
globulus 
A. afra, L. 
randii 
with E. 
globulus 
A. afra, L. 
randii and E. 
globulus 
Interpretation 
K. pneumoniae 
NCTC 9633 
6.3 2.0 4.0 (1.3) 3.0 2.0 (0.5) 0.5 (0.23) 0.8 0.3 Synergy 
M. catarrhalis 
ATCC 23246 
4.7 1.3 2.0 (1.0) 0.01 1.1 ( 5.8) 1.4 (36.55) 0.04 1.0 Additive 
E. faecalis 
ATCC 29212 
6.3 1.5 2.0 (0.8) 0.02 2.1 ( 7.6) 1.0 (25.1) 0.04 0.8 Additive 
C. neoformans 
ATCC 90112 
1.2 8.0 0.3 (0.1) 0.5 0.8 (1.1) 0.5 (0.5) 0.3 0.3 Synergy 
S. pneumoniae 
ATCC 49619 
0.5 1.5 1.0 (1.3) 0.2 0.3 (0.9) 0.3 (0.9) 0.3 0.8 Additive 
S. pyogenes 
ATCC 8668 
1.1 1.7 8.0 (3.0) 0.6 0.3 (0.3) 1.0 (1.1) 0.8 0.8 Additive 
S. agalactiae 
ATCC 55618 
3.0 12.0 4.0 (0.8) 1.0 1.0 (0.7) 2.0 (1.1) 8.0 3.8 Indifference 
M. smegmatis 
(clinical) 
1.7 0.5 0.5 (0.7) 1.5 0.5 (0.3) 0.5 (0. 7) 0.5 0.5 Synergy 
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Noteworthy moderate inhibition was obtained against E. faecalis with a MIC value of 0.99 
mg/ml. Some inhibition was seen against M. catarrhalis, S. pyogenes and S. agalactiae. 
∑FIC values for this combination gave synergistic activity against K. pneumoniae (∑FIC 
value = 0.23) and additive interactions against C. neoformans, S. pneumoniae and M. 
smegmatis. Antagonism was noted against M. catarrhalis and E. faecalis. 
 
The triple combination, A. afra with E. globulus and L. randii, yielded noteworthy activity 
against all pathogens tested except against S. agalactiae, which gave very poor activity with 
an MIC value of 8.0 mg/ml. The best antimicrobial activity, and very strong inhibition, of the 
triple combination was against M. catarrhalis and E. faecalis with mean MIC values of 0.04 
mg/ml. Against K. pneumoniae and S. pyogenes moderate inhibitory activity was noted, while 
against C. neoformans, S. pneumoniae and M. smegmatis, strong inhibition was evident. 
∑FIC values of the triple combination thus gave additive interactions against M. catarrhalis, 
E. faecalis, S. pneumoniae and S. pyogenes. Synergistic inhibition was obtained against K. 
pneumoniae, C. neoformans and M. smegmatis. 
 
Comparisons of this study with that of L. randii acetone extracts (Eloff, 2010) showed some 
variation. This variation could be due to the difference in extract prepared or due to different 
plant collection sites. 
 
For the combination of A. afra with L. randii (dichloromethane: methanol extracts) against 
the eight pathogens tested, four of them demonstrated additive interactions with one 
antagonistic (S. pyogenes) and one synergistic (C. neoformans). The interactions for the 
combination of A. afra with E. globulus gave three synergistic interactions against K. 
pneumoniae, S. pyogenes and M. smegmatis. Two pathogens displayed antagonism (M. 
catarrhalis and E. faecalis). The combination of L. randii with E. globulus gave one 
synergistic interaction against K. pneumoniae, three additive interactions and two 
antagonistic interactions (M. catarrhalis and E. faecalis). The combination of A. afra with L. 
randii and E. globulus displayed varied interactions, depending on the pathogen studied. The 
triple combination is better than the double combinations as no antagonism was noted and 
positive results (synergistic and additive interactions) were obtained. The traditional use of 
the triple combination is cited as being administered as an infusion. However, due to the 
results obtained, the use of a tincture might be a more viable option.  
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8.2.2.2.1.2 Aqueous extracts 
The aqueous extracts of L. randii independently, as shown in Table 8.5, proved ineffective in 
inhibiting E. faecalis, S. pneumoniae, and S. pyogenes at the highest concentration tested. 
Some activity was noted against K. pneumoniae, C. neoformans, S. agalactiae and M. 
smegmatis and very poor activity was obtained against M. catarrhalis. 
 
For the combination of A. afra with L. randii, no activity at the highest concentration tested 
was noted against S. pneumoniae and S. pyogenes. Some activity was noted against K. 
pneumoniae, E. faecalis, C. neoformans, S. agalactiae and M. smegmatis. Very poor activity 
was seen against M. catarrhalis, with a MIC value of 12.0 mg/ml. ∑FIC values calculated for 
the combination gave additive interactions against K. pneumoniae, C. neoformans and M. 
smegmatis. Tentative interpretations against S. pneumoniae and S. pyogenes showed additive 
or antagonistic interactions present.  
 
In the combination of E. globulus with L. randii aqueous extract moderate inhibitory activity 
with MIC values of 1.0 mg/ml was obtained against C. neoformans and S. pneumoniae. 
Noteworthy strong inhibition was obtained against M. smegmatis (MIC value = 0.5 mg/ml). 
∑FIC values calculated showed additive interactions of E. globulus with L. randii aqueous 
extract against K. pneumoniae and C. neoformans. A synergistic interaction against M. 
smegmatis was shown with a ∑FIC value = 0.2. The combination against S. agalactiae was 
interpreted as being antagonistic.  
 
In the combination of the three plants together i.e. A. afra, E. globulus with L. randii, very 
poor activity with a  MIC value of 16.0 mg/ml and 8.0 mg/ml was noted against S. 
pneumoniae and M. catarrhalis  respectively. Some activity was seen against K. pneumoniae, 
E. faecalis, C. neoformans, S. agalactiae and M. smegmatis. The ∑FIC values calculated, 
showed an additive interaction against K. pneumoniae. Tentative interpretations of the 
interactions of the triple combination showed synergistic or additive activity against E. 
faecalis and additive or indifferent activity against S. pneumoniae.
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Table 8.5 MIC and ∑FIC values of the aqueous extracts of A. afra, L. randii, and E. globulus alone and in combination. 
 
Micro-organism 
MIC (mg/ml)/ ∑FIC value indicated in brackets where applicable ∑FIC 
A. afra L. randii 
A. afra 
with L. 
randii 
E. 
globulus 
A. afra 
with E. 
globulus 
L. randii 
with E. 
globulus 
A. afra, L. 
randii with 
E. globulus 
A. afra, L. 
randii with 
E. globulus 
Interpretation 
K. pneumoniae 
NCTC 9633 
12.0 6.0 6.0 (0.8) 6.0 8.0 (1.0) 6.0 (1.0) 4.0 0.7 Additive 
M. catarrhalis 
ATCC 23246 
8.0 8.0 12.0 (1.5) 3.5 4.0 (0.8) 8.0 (1.6) 8.0 1.3 Indifferent 
E. faecalis  
ATCC 29212 
7.0 ≥16.0 2.0 (ND1) 2.5 4.0 (1.1) 2.0 (ND1) 2.0 ND1 Synergistic/Additive2 
C. neoformans 
ATCC 90112 
4.0 6.0 4.0 (0.8) 0.8 0.4 (0.3) 1.0 (0.7) 2.0 1.1 Indifferent 
S. pneumoniae 
ATCC 49619 
8.0 ≥16.0 
≥16.0 
(ND
1
) 
14.0 2.0 (0.2) 1.0  (ND
1
) 16.0 ND
1 
Additive/Indifferent
2
 
S. pyogenes 
ATCC 8668 
5.3 ≥16.0 
≥16.0 
(ND
1
) 
1.3 2.0 (0.9) 6.0 (ND
1
) ≥16.0 ND1 Antagonism/Indifferent2 
S. agalactiae 
ATCC 55618 
1.7 4.0 4.0 (1.7) 1.5 1.0 (0.6) 
≥16.0 
(ND
1
) 
4.0 1.6
 
Indifferent 
M. smegmatis 
(clinical) 
8.0 2.0 3.0 (0.9) 4.0 4.0 (0.8) 0.5 (0.2) 4.0 1.4 Indifferent 
*Values in bold indicate noteworthy activity. 
ND
1 
No ∑FIC value could be calculated as no MIC end point for L. randii/combination was obtained at the highest concentration tested. 
2
 Tentative interpretation according to MIC data. 
Shaded area: results previously discussed in Chapter 3 and 6 but included here for reference purposes. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail regarding control values. 
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The combination of A. afra with L. randii aqueous extract displayed three additive 
interactions against the pathogens tested. Tentative interpretations showed additive or 
antagonistic interactions against S. pneumoniae and S. pyogenes respectively. Synergy was 
also noted against the pathogen E. faecalis. For the combination of A. afra with E. globulus, 
the interactions against five pathogens showed additivity and against two pathogens 
synergism was noted (C. neoformans and S. pneumoniae). The interactions observed for the 
combination of E. globulus with L. randii against one pathogen was synergistic (M. 
smegmatis). Tentatively interpretations against E. faecalis were synergistic or additive. 
Against S. pneumoniae synergy was noted and against S. pyogenes additivity or indifference 
was observed. The interaction against S. agalactiae tentatively displayed antagonism. The 
triple combination, A. afra with L. randii and E. globulus displayed an interaction against one 
pathogen which was additive. Tentatively, synergy or additivity was noted against E. faecalis. 
 
Traditionally infusions of the triple combination of A. afra with L. randii and E. globulus are 
used to treat chest infections (Watt and Breyer-Brandwijk, 1962). The results obtained 
correlate somewhat with the traditional use. The combination against S. pyogenes related 
infections warrants caution as the possibility of antagonism is evident. In comparison with the 
dichloromethane: methanol extracts, the results obtained in the study for the triple 
combination shows that although the traditional use is through an infusion, tinctures may be  
a better option to treat respiratory infections. 
 
8.2.3 A. afra, Z. capense and Allium sativum in combination 
Garlic (Allium sativum) has been described and proven as a “cure all” (Harris et al., 2001). 
The Xhosa of South Africa drink a decoction of the leaf and the bulb of garlic as a febrifuge. 
This is prepared with the addition of Z. capense and A. afra (Watt and Breyer-Brandwijk, 
1962). Hence, as the focus of the study was combinations with A. afra, this combination was 
studied. Garlic has been used for centuries in different cultures and societies (Rivlin, 2001). 
The antimicrobial activity has been extensively investigated (Sivam et al., 1997; Phay et al., 
1999; Hsieh et al., 2001; Ward et al., 2002; Benkeblia, 2004). In Nigeria, it is used to treat 
abdominal discomfort, diarrhoea, otitis media and respiratory tract infections (Ankri and 
Mirelman, 1999; Jaber and Al-Mossawi, 2007; Abubakar, 2009). 
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The botanical description, locality, medicinal uses and phytochemistry of A. sativum, A. afra 
(Chapter 3) and Z. capense (Chapter 7) are discussed in Appendix A2, A3 and A9 
respectively. The dichloromethane: methanol extracts of A. afra, Z. capense and A. sativum 
were evaluated using thin layer chromatography. MIC determination and ∑FIC interpretation 
was carried out on the, dichloromethane: methanol and the aqueous extracts according to the 
methods described in Chapter 2.  
 
8.2.3.1 Chromatographic techniques 
8.2.3.1.1 Thin layer chromatography  
A large number of compounds were seen under the different wavelengths for each individual 
plant sample and majority of these were seen in the combination samples. In the combination 
of all three it is evident that majority of the same bands that appear in the individual TLC‟s 
are present in the combination. At Rf = 0.6, a major compound in A. sativum was found. At 
365 nm, A. sativum shows pooling of the compounds at the bottom of the plate. The major 
green coloured compound found in Z. capense is seen in the combination with A. afra (Figure 
8.4, lane 5), A. sativum (Figure 8.4, lane 6) and in the triple combination (Figure 8.4, lane 7) 
at Rf = 0.85.  
 
 
 
                                                                                                           
 
 
 
 
                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                
 
 
 
 
                                                                 
 
 
1 A. afra 
2 A. sativum 
3 Z. capense 
4 A. afra with  A. 
sativum 
5 A. afra with  Z. 
capense 
6 A. sativum with  Z. 
capense 
7 A. afra,  A. sativum 
with  Z. capense 
254 nm 
365 nm 
  1            2           3           4           5           6          7    
  1            2           3           4           5           6          7    
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Figure 8.4 TLC plates of the dichloromethane: methanol extracts of A. afra, Z. capense with 
A. sativum alone and in combination at 254 nm, 365 nm, white light and visualized with 
vanillin-sulphuric acid reagent.  
 
The combination of A. afra, Z. capense and A. sativum shows at 254 nm, 365 nm, under 
white light and after derivatization, the complexity of the mixture and the presence of 
compounds from each individual plant in the combination. 
 
8.2.3.2 Antimicrobial analysis 
8.2.3.2.1 MIC assays and FIC determination 
8.2.3.2.1.1 Dichloromethane: methanol extracts 
As shown in Table 8.6, A. sativum dichloromethane: methanol extracts generally showed 
poor to no activity at the highest concentration tested. The highest antimicrobial activity for 
A. sativum was against C. neoformans, which gave an MIC value of 2.0 mg/ml.  
 
The combination of A. afra with A. sativum showed moderate activity against M. catarrhalis 
(MIC value = 1.0 mg/ml) and S. pyogenes (MIC value = 1.5 mg/ml). Some antimicrobial 
activity was noted against C. neoformans, S. pneumoniae and M. smegmatis.  
Derivatized 
White light 
  1            2           3           4           5           6          7    
  1            2           3           4           5           6          7    
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Table 8.6 MIC and ∑FIC values of the dichloromethane: methanol extracts of A. afra, Z. capense, and A. sativum alone and in combination. 
*Values in bold indicate noteworthy activity. 
ND
1 
No ∑FIC value could be calculated as no MIC end point for A. sativum/combination was obtained at the highest concentration tested. 
2
 Tentative interpretation according to MIC data. 
Shaded area: results previously discussed in Chapter 3 and 7 but included here for reference purposes. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail regarding control values. 
 
Micro-organism 
MIC (mg/ml)/ ∑FIC value indicated in brackets where applicable ∑FIC 
A. 
afra 
Z. 
capense 
A. afra 
with Z. 
capense 
A. sativum 
A. afra 
with A. 
sativum 
Z. capense 
with A. 
sativum 
A. afra, Z. 
capense 
with A. 
sativum 
A. afra, Z. 
capense 
with A. 
sativum 
Interpretation 
K. pneumoniae 
NCTC 9633 
6.3 1.7 2.0 (0.8) ≥16.0 8.0 (ND1) 4.0 (ND1) 6.0 ND 1 Indifferent2 
M. catarrhalis 
ATCC 23246 
4.7 2.0 2.0 (0.7) ≥16.0 1.0 (ND1) 8.0 (ND1) 1.8 ND1 Indifferent2 
E. faecalis  
ATCC 29212 
6.3 1.3 2.0 (0.9) ≥16.0 6.0 (ND1) 12.0 (ND1) 3.0 ND1 Indifferent2 
C. neoformans 
ATCC 90112 
1.2 0.4 0.4 (0.7) 2.0 2.0 (1.3) 0.8 (1.2) 1.2 1.5 Indifferent 
S. pneumoniae 
ATCC 49619 
0.5 1.5 0.3 (0.4) 8.0 2.0 (2.1) 4.0 (1.6) 1.5 1.4 Indifferent 
S. pyogenes 
ATCC 8668 
1.1 2.0 1.0 (0.7) 16.0 1.5 (0.7) 4.0 (1.1) 2.0 1.0 Additive 
S. agalactiae 
ATCC 55618 
3.0 4.0 4.0 (1.2) 16.0 ≥16.0 (ND1) 16.0 (2.5) 10.7 2.3 Indifferent 
M. smegmatis 
(clinical) 
1.7 0.8 2.0 (1.9) ≥16.0 4.0 (ND1) 1.5 (ND1) 0.5 ND1 Additive/Synergy2 
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Poor to no activity was noted against K. pneumoniae, E. faecalis and S. agalactiae. ∑FIC 
values calculated showed additive interactions against S. pyogenes and indifference against 
C. neoformans and S. pneumoniae.  
 
In the combination of the dichloromethane: methanol extracts of Z. capense with A. sativum, 
the best antimicrobial activity showing noteworthy moderate inhibition, was noted against C. 
neoformans with an MIC value of 0.8 mg/ml. Moderate inhibitory activity was seen against 
M. smegmatis with a MIC value of 1.5 mg/ml. Very poor activity was noted against K. 
pneumoniae, M. catarrhalis, S. pneumoniae, S. pyogenes, E. faecalis and S. agalactiae. 
 
Indifferent interactions were calculated against C. neoformans, S. pneumoniae, S. pyogenes 
and S. agalactiae while tentative interpretations of indifference were made against K. 
pneumoniae, M. catarrhalis, E. faecalis and M. smegmatis. 
 
For the triple combination i.e. A. afra, Z. capense with A. sativum dichloromethane: methanol 
extracts (Table 8.6), noteworthy strong inhibition was noted against M. smegmatis with a 
MIC value of 0.5 mg/ml. Moderate inhibition was noted against C. neoformans and S. 
pneumoniae. Some activity was obtained against K. pneumoniae, M. catarrhalis, E. faecalis 
and S. pyogenes. Very poor activity was seen against S. agalactiae. ∑FIC values calculated 
for the triple combination gave an additive interaction against S. pyogenes. 
 
Tentative ∑FIC interpretations showed indifferent interactions against K. pneumoniae, M. 
catarrhalis and E. faecalis and synergistic or additive interactions against M. smegmatis. 
 
The combination of A. afra with Z. capense dichloromethane: methanol extracts shows the 
interactions to be mostly additive, with one interaction displaying synergism (S. 
pneumoniae). For the combination of A. afra with A. sativum, only three interactions could be 
calculated, wherein two pathogens showed indifference (C. neoformans and S. pneumoniae) 
and one was additive (S. pyogenes). Tentative interpretations were made for the rest of the 
five pathogens. Two pathogens showed additive or indifferent interactions (E. faecalis and M. 
smegmatis), one pathogen was either indifferent or antagonistic (S. agalactiae), one was 
additive (K. pneumoniae) and one pathogen displayed synergy (M. catarrhalis). In the 
combination of Z. capense with A. sativum, mostly indifference was observed. The triple 
combination displayed varied interactions but mostly indifference. The results indicate that 
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the administration of a triple combination instead of any of the double combinations would 
have no benefit with respect to increased antimicrobial activity. 
 
8.2.3.2.1.2 Aqueous extracts 
Table 8.7 shows the antimicrobial activity of the aqueous extracts of A. afra, Z. capense, and 
A. sativum independently and in various combinations with each other. A. sativum aqueous 
extract showed no activity at the highest concentration tested against K. pneumoniae, M. 
catarrhalis, E. faecalis, S. pneumoniae, S. agalactiae and M. smegmatis. However, against S. 
pyogenes, very poor activity with a MIC value of 12.0 mg/ml was obtained. Moderate 
inhibition was found against C. neoformans and the MIC value obtained was 1.0 mg/ml.  
 
The aqueous garlic extract was tested by Farbman et al. (1993) using the macro-dilution MIC 
assay. Results showed that S. pneumoniae was sensitive to a 1:2 dilution. It was ascertained 
that garlic had a broad spectrum of activity. 
 
Jaber and Al-Mossawi (2007) tested the water, ethanol, dichloromethane, n-hexane extracts 
and the raw juice of garlic against different strains of S. aureus and E. coli, Salmonella 
goldcoast and Klebsiella aerogenes. Disc diffusion and chequerboard assays we performed 
on the water extract and the raw juice only as they produced the best results in the 
preliminary screening. However, poor activities were noted with the MIC values when they 
were tested in water and when they were subjected to different pH conditions (acid or alkali).  
 
The water extracts did however, perform better that the solvent extracts even though poor 
activities were noted. 
 
Abubakar (2009) tested the ethanol, chloroform and the aqueous extracts of A. sativum using 
the well diffusion method against S. aureus, E. coli, S. pneumoniae and P. aeruginosa. 
Results obtained against S. pneumoniae were 21 mm for the ethanol extracts, 19 mm for the 
chloroform extracts and 23 mm for the aqueous extracts. The aqueous extract was more 
active than the solvent or organic extracts, which is congruent with Roy et al. (2006), Jaber, 
and Al-Mossawi (2007). 
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Table 8.7 MIC and ∑FIC values of the aqueous extracts of A. afra, Z. capense, and A. sativum alone and in combination. 
Values in bold indicate noteworthy activity. 
ND
1 
No ∑FIC value could be calculated as no MIC end point for A. sativum/combination was obtained at the highest concentration tested. 
2
 Tentative interpretation according to MIC data. 
Shaded area: results previously discussed in Chapter 3 and 7 but included here for reference purposes. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail regarding control values. 
Micro-organism 
MIC (mg/ml)/ ∑FIC value indicated in brackets where applicable ∑FIC 
A. afra Z. capense 
A. afra 
with Z. 
capense 
A. 
sativum 
A. afra 
with A. 
sativum 
Z. capense 
with A. 
sativum 
A. afra, Z. 
capense 
with A. 
sativum 
A. afra, Z. 
capense 
with A. 
sativum 
Interpretation 
K. pneumoniae 
NCTC 9633 
12.0 13.3 12.0 (1.0) ≥16.0 16.0 (ND1) 8.0 (ND1) 16.0 ND1 Additive/Indifference2 
M. catarrhalis 
ATCC 23246 
8.0 16.0 8.0 (0.8) ≥16.0 16.0 (ND1) 12.0 (ND1) 12.0 ND1 Indifference2 
E. faecalis  
ATCC 29212 
7.0 16.0 ≥16.0 (ND1) ≥16.0 ≥16.0 (ND1) 12.0 (ND1) 4.0 ND1 Synergy2 
C. neoformans 
ATCC 90112 
4.0 2.0 4.0 (1.5) 1.0 1.5 (0.9) 4.0 (3.0) 1.0 0.6 Additive 
S. pneumoniae 
ATCC 49619 
8.0 ≥16.0 ≥16.0 (ND1) ≥16.0 ≥16.0 (ND1) 2.0 (ND1) ≥16.0 ND1 Indifference/Antagonism2 
S. pyogenes 
ATCC 8668 
5.3 ≥16.0 ≥16.0 (ND1) 12.0 16.0 (2.2) 4.0 (ND1) ≥16.0 ND1 Indifference/Antagonism2 
S. agalactiae 
ATCC 55618 
1.7 0.4 1.3 (2.0) ≥16.0 3.0 (ND1) ≥16.0 (ND1) 1.0 ND1 Additive/Indifference2 
M. smegmatis 
(clinical) 
8.0 
 
≥16.0 
 
3.0 (ND
1
) ≥16.0 8.0 (ND1) 1.0 (ND1) 1.0 ND1 Synergy/Additive2 
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When A. afra was combined with A. sativum aqueous extracts, MIC values were not obtained 
against E. faecalis and S. pneumoniae at the highest concentration tested. Very poor 
antimicrobial activity was seen against K. pneumoniae, M. catarrhalis, S. pyogenes and M. 
smegmatis. Some activity was noted against S. agalactiae with a MIC value of 3.0 mg/ml. 
Moderate inhibitory activity (MIC value of 1.5 mg/ml) was obtained against C. neoformans. 
When the ∑FIC values were calculated, additive interactions were noted against C. 
neoformans and indifferent activity was seen against S. pyogenes.  
 
When Z. capense was combined with A. sativum, MIC values were varied from 1.0-12.0 
mg/ml. Very poor activity was noted against K. pneumoniae, M. catarrhalis, and E. faecalis. 
Some activity was seen against C. neoformans, S. pneumoniae and S. pyogenes. The best 
activity (MIC value = 1.0 mg/ml) found for the combination was moderate inhibitory activity 
and it was obtained against M. smegmatis. ∑FIC values for the combination of A. sativum 
with Z. capense showed an indifferent interaction against C. neoformans.  
 
For the combination of the three plants i.e. A. afra, A. sativum and Z. capense, no activity was 
seen against S. pneumoniae and S. pyogenes while very poor activity was noted against K. 
pneumoniae and M. catarrhalis. Some antimicrobial activity was noted against E. faecalis 
with a MIC value of 4.0 mg/ml. The best activity of the triple combination was found against 
C. neoformans as well as against S. agalactiae and M. smegmatis with moderate inhibitory 
activity (MIC values of 1.0 mg/ml). A ∑FIC value of 0.6 and denoting an additive interaction 
were obtained for the combination of the three plants against C. neoformans. Tentative 
interpretations of the MIC data on the interactions of the combination showed additive or 
indifferent interactions against K. pneumoniae and S. agalactiae. An indifferent interaction 
was noted against M. catarrhalis and indifference or antagonistic interactions against S. 
pneumoniae and S. pyogenes was seen. Synergy was evident against E. faecalis and additivity 
or synergy was noted against M. smegmatis. 
 
The combination of A. afra with Z. capense (aqueous extracts) showed the interactions to be 
varied depending on the pathogen studied. The combination of A. afra with A. sativum 
showed additivity against one pathogen (C. neoformans) and an indifferent interaction against 
another (S. pyogenes). The combination of A. sativum with Z. capense resulted in interactions 
against three pathogens (S. pneumoniae, S. pyogenes and M. smegmatis) as synergy. The 
triple combination showed only one definite additive interaction against C. neoformans 
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therefore the triple combination could be advantages in E. faecalis related infections. 
However, care should be taken against S. pneumoniae and S. pyogenes as the possibility of 
antagonism exists.  
 
In light of these interactions, the results do not show any significant enhancement of 
antimicrobial activity with the triple combination. Thus, the addition of the third plant by 
traditional healers could possibly due to the presence of other pharmacological properties that 
may assist in holistic healing. These properties could contribute to the treatment of the 
respiratory diseases by producing anti-inflammatory, anti-histamine, decongestant, anti-
pyretic or analgesic effects. 
 
8.3 Conclusions 
 The TLC results of the combination of A. afra with O. asteriscoides and E. globulus; 
the combination of A. afra, E. globulus and L. randii; and the combination of A. afra 
with Z. capense and A. sativum highlighted the complexity of the plants being tested 
individually and in combination. 
 The MIC values of the combination of A. afra with O. asteriscoides and E. globulus 
essential oils showed noteworthy antimicrobial activity against S. pneumoniae, S. 
pyogenes and M. smegmatis. Antagonism was seen when the ∑FIC values were 
determined against C. neoformans. Additivity was also evident against K. 
pneumoniae, M. catarrhalis, E. faecalis and S. agalactiae. 
 The MIC values of the dichloromethane: methanol extracts of the combination of A. 
afra with O. asteriscoides and E. globulus showed noteworthy activity against C. 
neoformans, S. pneumoniae and S. agalactiae. Synergistic activity was noted when 
the ∑FIC values were calculated against K. pneumoniae and S. agalactiae. 
Antagonism was noted against M. catarrhalis and E. faecalis. 
 Very good antimicrobial activity was noted for the combination of A. afra with E. 
globulus and L. randii dichloromethane: methanol extracts with noteworthy MIC 
values against all the pathogens tested with the exception of S. agalactiae. The ∑FIC 
values of the triple combination showed predominantly additive and synergistic 
activity against all the pathogens tested, except for the indifference noted against S. 
agalactiae. 
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 The aqueous extracts of the combination of A. afra with E. globulus and L. randii 
showed some antimicrobial activity against K. pneumoniae, E. faecalis, C. 
neoformans, S. agalactiae and M. smegmatis. Additive interactions were calculated 
against K. pneumoniae.  
 The dichloromethane: methanol extracts of the combination of A. afra with A. sativum 
and Z. capense showed noteworthy inhibitory activity against M. smegmatis.  
 Moderate inhibition was seen in the MIC values, of the aqueous extracts of the 
combination of A. afra with A. sativum and Z. capense, obtained against C. 
neoformans, S. agalactiae and M. smegmatis. Indifference was predominant in the 
interactions of the combination with synergy noted against E. faecalis. Synergy or 
additive interactions were noted against M. smegmatis. 
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Chapter 9 
Artemisia afra in combination with adjuncts 
 
9.1Introduction 
An adjunct is added as a supplementary agent to an active drug and is not an essential part of 
the formulation (http://www.encyclopedia.com/topic/adjunct.aspx). With respect to 
pharmacological applications, an example would be the use of syrup (sugar) to mask the taste 
of paracetamol in Panado
®
. The addition of the green colour and flavouring is also an 
example of the use of an adjunct. In this case, it is added to provide flavour and is more 
aesthetically pleasing to children.  
 
The use of adjuncts with medicinal plants by traditional healers is a popular, yet unstudied 
area in phytomedicine (Watt and Breyer-Brandwijk, 1962; Hutchings et al., 1996; van Wyk et 
al., 2008). Investigation of traditional medicinal practices have revealed a number of 
instances where plants are  mixed with milk, honey, salt, butter, and yoghurt to improve the 
acceptability of the medicine (Roberts, 1990; Hutchings et al., 1996;  Jäger, 2003; Johnston, 
2009; Thring and Weitz, 2006;  van Wyk et al., 2008; van Wyk, 2008b; Liu, et al., 2009; 
Poonam and Singh, 2009). A combination of plants are frequently used and sometimes mixed 
with adjuncts before administration, the most common being honey, milk, sugar, salt, fat and 
brandy (Figure 9.1). 
 
Traditional preparations often require sugar or honey to make syrups (van Wyk et al., 2008). 
The use of these provides a sweet vehicle for the medicament, allowing palatability of the 
plant and thus making the patient more comfortable with swallowing it. Fat or oil are also 
used as vehicles, perhaps to increase viscosity for topical applications or to provide an oily 
vehicle for eardrops (Thring and Weitz, 2006; van Wyk, 2008b). They are readily available 
and the familiarity of these vehicles provides a level of comfort when being used by the 
patients. Sometimes milk is used instead of water when making decoctions or teas perhaps 
because of the availability or even because a particular plant may sometimes be more soluble 
in milk than water (Bhattarai et al., 2006). Brandy and vinegar are used to make tinctures 
(Watt and Breyer-Brandwijk, 1962). They are also commonly used when preparing poultices 
for wounds.  
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Figure 9.1 The various adjuncts used in traditional medicinal practices. (Roberts, 1990; 
Hutchings et al., 1996; Jäger, 2003; Johnston, 2009; Thring and Weitz, 2006; van Wyk et al., 
2008; van Wyk, 2008b; Liu, et al., 2009). 
 
One example where the practical use of adjuncts is applied is the use of the leaf and stem of 
Lippia javanica as a weak tea made with either water or milk for coughs, colds and bronchial 
complaints (van Wyk et al., 2009; Watt and Breyer-Brandwijk, 1962). Another example is 
the use of A. afra with honey or sugar for coughs and colds (Roberts, 1990; Liu et al., 2009). 
It is also commonly used with brandy for infantile colic (Watt and Breyer-Brandwijk, 1962). 
These and other examples are elaborated on in Table 9.1. 
 
Aside from the practical applications of these adjuncts i.e. to aid in medicinal plant delivery, 
it is possible that each adjunct could have a therapeutic effect. There are many instances 
where these adjuncts are used independently as remedies. There are documented incidents 
where vinegar and honey have been used for wound care from the time of Hippocrates 
(Johnston, 2009). In fact, evidence suggests that vinegar on its own has therapeutic value, in 
the management of blood glucose, as suggested by Johnston (2009). In order to accurately 
assess the activity and effectiveness of the plants, it is important to take into account the 
Plant 
Honey 
Milk 
Sugar 
Salt Vinegar 
Brandy 
Oil/fat 
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traditional preparation of the medicine (Jäger, 2003). The addition of honey or sugar could 
prove to have an effect on the extent to which that plant works.  
 
Table 9.1 Various plants used in combination with adjuncts. 
Plant/s Adjunct Use Complaint Reference 
A. afra with 
Tetradenia riparia 
Salt Decoction Coughs 
Hutchings et al. 
(1996). 
A. afra with 
Warburgia 
salutaris 
Honey, 
brown 
sugar 
Infusion Cough Felhaber, (1997). 
Agathosma 
betulina 
Vinegar, 
brandy 
Soaked leaves, 
poultice, 
sprayed 
Wounds, sprains, 
contusions 
Thring and Weitz, 
(2006); van Wyk, 
(2008b). 
A. afra 
Honey, 
sugar 
Infusion, 
decoction 
Bronchial troubles, coughs 
and colds, chills, 
dyspepsia, loss of appetite, 
stomach ache, colic, croup, 
whooping cough, gout and 
as a purgative. 
Roberts, (1990);   
Liu et al. (2009). 
A. afra 
Brandy, 
vinegar 
Moistened leaf Infantile colic 
Watt and Breyer-
Brandwijk, (1962). 
A. afra Brandy 
Tincture taken 
by mouth 
Colic 
Watt and Breyer-
Brandwijk, (1962). 
A. afra Milk 
Suspension of 
ground up plant 
as enema 
Constipation and intestinal 
worms 
Watt and Breyer-
Brandwijk, (1962). 
Ballota africana Sugar Syrup Colds 
Thring and Weitz, 
(2006). 
Carbobrotus 
edulis or C. 
acinaciformis or C. 
murii 
Milk 
Added to the 
squeezed juice 
of leaves 
Stomach troubles 
Thring and Weitz, 
(2006). 
Cissampelos 
capensis 
Vinegar, 
sugar 
Root infusion Fever 
van Wyk et al. 
(2008b). 
Clematis brachiata Honey Decoction Sinusitis Felhaber, (1997). 
Crassula ovata Milk Boil leaves Diarrhoea van Wyk, (2008b). 
Crassula tetragona Milk Boiled leaves Diarrhoea van Wyk, (2008b). 
Cynodon dactylon Fat Rubbed in skin Gout van Wyk, (2008b). 
Datura spp. 
Potassiu
m nitrate 
Powdered Asthma van Wyk, (2008b). 
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Plant/s Adjunct Use Complaint Reference 
Eberlanzia spinosa Sugar 
Decoction of 
leaves 
Angina 
van Wyk et al. 
(2008). 
Elytropappus 
rhinocerotis 
Brandy, 
vinegar 
Leaves are 
soaked and 
taken, 
Soaked leaves 
on a cloth, 
wrapped around 
sore area 
Bladder, kidney, 
convulsions, diabetes, 
fever, headache, cough, 
cold, flu, stomach-ache 
Thring and Weitz, 
(2006). 
Euryops multifidus Fat 
Resins mixed 
with fats, 
applied 
Sores van Wyk, (2008b). 
Exomis 
microphylla/ 
Exomis axyroides 
Milk Leaf decoction 
Khoi remedy for epilepsy; 
winds, cramps and 
convulsions in infants 
van Wyk, (2008b). 
Galenia africana Salt 
Boil in water 
and wash 
wounds 
Wounds 
van Wyk et al. 
(2008). 
Galium 
tomentosum 
Sugar 
Infusion of the 
roots 
Remove acid in babies 
 
van Wyk et al. 
(2008). 
Gnidia 
polycephala 
Milk 
Drink a root 
infusion mixed 
with milk, 
purgative 
Constipation 
van Wyk et al. 
(2008). 
Heamanthus 
coccineus 
Vinegar Sliced bulbs Expectorant, diuretic van Wyk, (2008b). 
Heeria argentea Sweet oil 
Gum and oil 
mixed to make a 
plaster 
Burns. Wounds and tender 
nipples 
van Wyk, (2008b). 
Helichrysum 
litorale  
Fat 
Powdered herb, 
applied 
Ulcers van Wyk, (2008b). 
Lippia javanica Milk 
Infusion of leaf 
and stem 
Coughs, colds, bronchial 
troubles 
 
Watt and Breyer-
Brandwijk, (1962). 
Melianthus 
comosus 
Vinegar 
Apply fresh 
leaves as a 
poultice 
Knee pain 
van Wyk et al. 
(2008). 
Pelargonium 
antidysenterium 
Milk Decoction Dysentery van Wyk, (2008b). 
Peliostomum 
origanoides 
Sweet 
oil/linsee
d oil or 
cod liver 
oil 
Tea made from 
the twigs + oil 
Acid in babies 
van Wyk et al. 
(2008). 
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Some of these adjuncts e.g. honey and vinegar has shown independent antimicrobial activity 
(Wahdan, 1998; Johnston, 2009). In fact, as alternate medicine increases in popularity, many 
studies are aiming to verify and support the use of these traditional remedies. For a number of 
years the interest in the benefits of honey has increased. The antimicrobial activity of honey 
alone, at various concentrations, has been established. These are for bacteria commonly 
found to infect wounds, as well as a number of fungi (Efem et al., 1992; Molan, 1996; Malika 
et al., 2005; Alandejani et al., 2009). These studies further provide an interest in the possible 
contribution of honey and other adjuncts to the efficacy of traditional plant medicines. 
 
This study was undertaken with the aim of finding a scientific rationale for the use of 
adjuncts in combination with medicinal plants that are commonly used in South African 
traditional medicine. As the primary focus of this study, A. afra was chosen as the main plant 
around which adjunct studies has focussed. This plant was chosen due to its prominence as 
Plant/s Adjunct Use Complaint Reference 
Pteronia 
onobromoides 
Fat 
Mixed with 
powdered leaf 
Burns, sunburn, earache van Wyk, (2008b). 
Schinus molle Vinegar 
Place fresh 
leaves in a cloth, 
with vinegar and 
apply to the 
head 
Headache 
van Wyk et al. 
(2008). 
Sutherlandia 
microphylla 
Honey Drink General medicine 
van Wyk et al. 
(2008). 
Trichilia emetica 
Milk, 
honey 
Mixed with 
powdered roots 
Asthma, cough, bronchial 
trouble, fever, vomiting 
Sutovska et al. 
(2009). 
Tulbaghia alliacea milk Infusion 
Intestinal worms, fever, 
influenza high blood 
pressure tuberculosis 
van Wyk, (2008b). 
Tulbaghia violecea Milk Infusion 
Intestinal worms, fever, 
influenza, high blood 
pressure, TB 
van Wyk, (2008b). 
Tulbaghia violecea 
Castor 
oil 
Ear drops Earache 
Thring and Weitz, 
(2006). 
Tulbaghia violecea Brandy 
Seed-pods 
soaked and 
taken 
Sleeplessness, heart 
condition, relieves 
stomach pain, convulsions 
Thring and Weitz, 
(2006). 
Viscum capense Brandy 
Whole pieces 
soaked and 
taken 
Fever, cold symptoms 
Thring and Weitz, 
(2006). 
 175 
one of the foremost plants used frequently in combinations with other plants as well as with 
adjuncts. This is shown Table 1, where A. afra was commonly found to be combined with 
honey, salt, brandy, and milk (Watt and Breyer-Brandwijk, 1962).  
 
9.2 Results and discussion 
9.2.1 Individual MIC values 
Individual MIC values of adjuncts show no antimicrobial activity against M. catarrhalis, E. 
faecalis, K. pneumoniae and C. neoformans. Exceptions were noted with honey where very 
low activity was seen against K. pneumoniae. Vinegar was also poorly active against K. 
pneumoniae and C. neoformans with MIC values of 16.0 mg/ml. Table 9.2 documents the 
individual MIC values for all adjuncts.  
 
Table 9.2 Individual mean MIC values of all adjunct samples tested. 
 
9.2.2 Honey in combination with A. afra 
The different types of honey used in this study were commercially purchased orange blossom 
honey, wild blossom honey and blue gum honey.  
 
Sample 
MIC values (mg/ml) 
M. catarrhalis 
ATCC 23246 
E. faecalis 
ATCC 29212 
K. pneumoniae 
NCTC 9633 
C. neoformans 
ATCC 90112 
Honey ≥16.0 ≥16.0 8.0 ≥16.0 
Orange Blossom 
Honey (100%) 
≥25.0 ≥25.0 ≥25.0 ≥25.0 
Wild Blossom 
Honey (100%) 
≥25.0 ≥25.0 ≥25.0 ≥25.0 
Blue Gum Honey 
(100%) 
≥25.0 ≥25.0 ≥25.0 ≥25.0 
Salt (4%) ≥10.0 ≥10.0 ≥10.0 ≥10.0 
Skim milk ≥25.0 ≥25.0 ≥25.0 ≥25.0 
Full cream milk ≥25.0 ≥25.0 ≥25.0 ≥25.0 
Brandy ≥16.0 ≥16.0 ≥16.0 ≥16.0 
Vinegar ≥16.0 ≥16.0 16.0 16.0 
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The testing of different honey samples was carried out to determine if there is any differing 
microbial activity among differing types of honey. Studies conducted on honey samples in 
the past have shown that honey from different sources may display different activities (Lee et 
al., 2008). Honey (100%) was used as it displayed good antimicrobial activity in a previous 
study (Efem et al., 1992).  
 
The MIC values represented in Table 9.3 are those of the different types of honey in 
combination with the essential oil and extracts of A. afra. Significant values to note are those 
of honey at 64.0 mg/ml with the A. afra aqueous extract, which shows considerably better 
MIC values than that of honey alone. Against M. catarrhalis and E. faecalis, some activity 
was obtained with a MIC of 3.0 mg/ml. Similarly, moderate inhibition was obtained against 
K. pneumoniae with a MIC of 1.5 mg/ml. For the 100% blue gum honey in combination with 
the dichloromethane: methanol extracts of A. afra, some activity was noted against K. 
pneumoniae and C. neoformans. A. afra aqueous extract in combination with 100% orange 
blossom or wild blossom showed some activity against E. faecalis and K. pneumoniae. 
Moderate inhibitory antimicrobial activity (1.3 mg/ml) was noted against C. neoformans in 
the combination of A. afra dichloromethane: methanol extract and 100% orange blossom 
honey. 
 
Although MIC values can be interpreted as being favorable in the combinations tested, a 
better understanding of the interactions of the combinations can be sought by calculating of 
∑FIC values. In the testing of the use of adjuncts in combination with A. afra most of the 
results of the MIC values showed no end point at the concentrations tested. Thus, bar graphs 
have been constructed to make comparisons of the ∑FIC interactions. Figure 9.2 shows the 
∑FIC values of the combinations against the four different micro-organisms tested. 
 
In the combination of A. afra and honey at a concentration of 64.0 mg/ml, the majority of 
combinations showed indifference. The combination of orange blossom honey at 64.0 mg/ml 
in combination with A. afra aqueous extracts against C. neoformans showed an additive 
interaction. 
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Table 9.3 MIC values for different types of honey in combination with A. afra samples. 
Sample 
MIC values (mg/ml) 
M. catarrhalis 
ATCC 23246 
E. faecalis 
ATCC 29212 
K. pneumoniae 
NCTC 9633 
C. neoformans 
ATCC 90112 
A. afra essential oil 8.0 8.0 8.0 13.0 
A. afra 
dichloromethane: 
methanol extracts 
4.0 4.0 2.0 4.3 
A. afra aqueous 
extract 
4.0 8.0 8.0 13.0 
A. afra essential 
oil: honey (64.0 
mg/ml) 
16.0 16.0 16.0 48.0 
A. afra essential 
oil: orange blossom 
honey (100%) 
57.0 57.0 57.0 28.5 
A. afra essential 
oil: wild blossom 
honey (100%) 
57.0 57.0 57.0 14.3 
A. afra essential 
oil: blue gum 
honey (100%) 
57.0 57.0 57.0 14.3 
A. afra 
dichloromethane: 
methanol extracts: 
honey (64.0 
mg/ml) 
8.0 8.0 8.0 22.0 
A. afra 
dichloromethane: 
methanol extracts 
orange blossom 
honey (100%) 
10.3 10.3 5.1 1.3 
A. afra 
dichloromethane: 
methanol extracts 
wild blossom 
honey (100%) 
10.3 10.3 5.1 2.6 
A. afra 
dichloromethane: 
methanol extracts 
blue gum honey 
(100%) 
10.3 5.1 2.6 2.5 
A. afra aqueous 
extract: honey 
(64.0 mg/ml) 
3.0 3.0 1.5 8.0 
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Sample 
MIC values (mg/ml) 
M. catarrhalis 
ATCC 23246 
E. faecalis 
ATCC 29212 
K. pneumoniae 
NCTC 9633 
C. neoformans 
ATCC 90112 
A. afra aqueous 
extract: orange 
blossom honey 
(100%) 
26.0 5.1 2.6 41.0 
A. afra aqueous 
extract: wild 
blossom honey 
(100%) 
26.0 5.1 2.6 41.0 
A. afra aqueous 
extract: blue gum 
honey (100%) 
26.0 10.3 10.3 41.0 
 
In the combination of A. afra essential oil and orange blossom honey at 100%, antagonism 
was observed. The dichloromethane: methanol extract showed synergistic activity against C. 
neoformans. The aqueous extracts showed additivity against K. pneumoniae, and antagonism 
against E. faecalis and C. neoformans.  
 
These results show a high incidence of antagonism with essential oil and aqueous extract 
combinations of A. afra with honey. In traditional healing practices, essential oils are seldom 
combined with honey. Synergism seems to be restricted to the combinations where 
dichloromethane: methanol extracts are combined with all three 100% honey products against 
C. neoformans. Results obtained support the assumption that the addition of honey is mainly 
for sweetening the plant decoctions thereby disguising any unpleasant taste that may be 
encountered by the patient. 
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Figure 9.2 The ∑FIC interactions of the different types of honey in combination with A. afra. 
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9.2.3 Skim milk and full cream milk in combination with A. afra 
The MIC values obtained for the combination of A. afra together with skim milk and full 
cream milk are shown in Table 9.4. Both these were tested as the traditional healer uses either 
one depending on circumstances.  
 
MIC values in combination show poor activity. However, against M. catarrhalis, in the 
combination of A. afra aqueous extract and skim milk display some antimicrobial activity 
(MIC value of 5.1 mg/ml). 
 
Table 9.4 MIC values of A. afra in combination with milk. 
 
Figure 9.3 shows the ∑FIC interaction of the combination of skim or full cream milk with A. 
afra essential oils, dichloromethane: methanol and aqueous extracts. The interactions with 
skim milk show mainly indifference. Exceptions were seen in the combination of A. afra 
Sample 
MIC values (mg/ml) 
M. catarrhalis 
ATCC 23246 
E. faecalis 
ATCC 29212 
K. pneumoniae 
NCTC 9633 
C. neoformans 
ATCC 90112 
A. afra essential 
oil 
8.0 8.0 8.0 13.0 
A. afra 
dichloromethane: 
methanol extracts 
4.0 4.0 2.0 4.3 
A. afra aqueous 
extract 
4.0 8.0 8.0 13.0 
A. afra essential 
oil: skim milk 
28.5 57.0 28.5 14.3 
A. afra essential 
oil: full cream 
57.0 28.5 28.5 41.5 
A. afra 
dichloromethane: 
methanol extracts: 
skim milk 
20.5 20.5 20.5 20.5 
A. afra 
dichloromethane: 
methanol extracts: 
full cream milk 
20.5 20.5 10.3 20.5 
A. afra aqueous 
extract: skim milk 
5.1 20.5 41.0 30.7 
A. afra aqueous 
extract: full cream 
milk 
20.5 ≥41.0 41.0 41.0 
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aqueous extract with skim milk where an additive interaction was noted against M. 
catarrhalis. 
 
Figure 9.3 A. afra in combination with milk. 
 
An additive interaction was also noted for the essential oil and skim milk combination against 
C. neoformans. Antagonism was seen against E. faecalis for the essential oil combination in 
both skim milk and full cream milk. Antagonism was also evident against K. pneumoniae and 
E. faecalis for the aqueous extract combination with skim milk and full cream milk 
respectively. 
 
Essential oils are not known to be administered with milk and hence the antagonism noted 
with the essential oils may not be significant when observing traditional practises. Milk may 
possibly help alter the taste of the medicine and therefore make it more acceptable to the 
patient to consume. For further consideration, there is the possibility that the role of milk may 
be more beneficial as an excipient in the formulation to improve the absorption of the plant 
mixture. In addition, as milk has a soothing and calming connotation for many people it may 
also be employed as a means to increase comfort to the gastrointestinal tract of the patient. 
≥ 
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With the exception of one or two instances, it is also noted that the addition of milk has no 
negative impact on the antimicrobial activity of A. afra. 
 
9.2.4 Vinegar and/brandy in combination with A. afra 
The concentration of the vinegar sample tested was 64.0 mg/ml. The MIC values obtained 
when vinegar was combined with A. afra essential oil showed very poor activities (Table 
9.5).  
 
Table 9.5 A. afra in combination with vinegar and brandy. 
 
In combination with the dichloromethane: methanol extract, some activity was noted against 
M. catarrhalis with a MIC value of 4.0 mg/ml. Essential oil and aqueous extract 
combinations with vinegar have antagonistic interactions against the pathogens tested in this 
study. The ∑FIC values for all pathogens and in combination with essential oil and water 
Sample 
MIC values (mg/ml) 
M. catarrhalis 
ATCC 23246 
E. faecalis 
ATCC 29212 
K. pneumoniae 
NCTC 9633 
C. neoformans 
ATCC 90112 
A. afra essential oil 8.0 8.0 8.0 13.0 
A. afra 
dichloromethane: 
methanol extract 
4.0 4.0 2.0 4.3 
A. afra aqueous 
Extract 
4.0 8.0 8.0 13.0 
A. afra essential 
oil: brandy 
48.0 48.0 48.0 24.0 
A. afra essential 
oil: vinegar 
48.0 48.0 48.0 24.0 
A. afra 
dichloromethane: 
methanol extract : 
brandy 
4.0 16.0 16.0 32.0 
A. afra 
dichloromethane: 
methanol extract : 
vinegar 
16.0 8.0 8.0 16.0 
A. afra aqueous 
extract: brandy 
32.0 32.0 32.0 4.0 
A. afra aqueous 
extract: vinegar 
32.0 32.0 16.0 8.0 
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extracts show values >4.0 (Figure 9.4). The dichloromethane: methanol extract show additive 
interactions against M. catarrhalis and E. faecalis. All the A. afra combinations with vinegar 
showed indifference against C. neoformans. 
 
One of the possible reasons for antagonistic actions could be that the main use of vinegar is in 
softening of the leaves for the treatment of colic. The testing of pathogens known to cause 
gastrointestinal distress may yield better interactive efficacies. 
 
Brandy is one of the most commonly used adjuncts to medicinal plants. It is mainly used to 
soften and soak plant leaves and twigs. The brandy is also commonly used in preparations for 
wounds (Table 9.1).  
 
The MIC values of brandy in combination with A. afra are shown in Table 9.5. Poor 
antimicrobial activities were noted in the essential oil, dichloromethane: methanol extract and 
the aqueous extract combinations against all four pathogens tested. 
Figure 9.4 A. afra in combination with vinegar. 
 
One exception with some activity (MIC value of 4.0 mg/ml) was obtained against C. 
neoformans for the aqueous extract combination of A. afra with brandy. 
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Figure 9.5 Brandy in combination with A. afra. 
 
Brandy, in combination with the essential oil and water extract of A. afra show antagonistic 
interactions against three bacteria tested (Figure 9.5). This supports the common, modern 
medicinal practice of discouraging the imbibing of brandy and other alcoholic drinks with 
medication. The dichloromethane: methanol extract, on the other hand showed additive 
interactions against M. catarrhalis and C. neoformans. Indifference was noted against E. 
faecalis and K. pneumoniae. This provides some credibility to the most common use in the 
preparation of tinctures and poultices. Further studies, using other plants and bacteria 
specifically for wound healing are needed to explore this possibility.  
 
9.2.5 Salt in combination with A. afra 
Salt is considered as an antimicrobial agent as it works by restricting bacterial growth. This is 
done in two ways. Either by lowering the amount of free water molecules around the bacteria 
e.g. in food or body tissues. The salt water creates a hypertonic environment then causing 
water to rush out of the bacteria by osmosis and thus killing or rupturing the cells. Moisture is 
essential to bacterial growth and survival and without enough water, they do not grow well. 
Furthermore, bacteria do not thrive or grow well in salty environments. Salt restricts 
microbial growth by interfering with the microbe‟s enzyme activity and thus weakens its 
Antagonism 
Indifference 
Additive 
Synergy 
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DNA molecular structure (Parish, 2006; Shee et al., 2010). The study by Shee et al. (2010) 
tested the potential of salt and sugar as food preservatives. A 2.5% salt solution was used to 
test the preservative efficacy. Results demonstrated that the solution was able to contain the 
growth of bacteria tested (not specified) until the third day. The study by Milne et al. (2007) 
examined the effects of a 15% salt impregnated dressing for critically colonized wounds. 
Results showed a reduction of bacteria in critically colonized wounds in the majority of the 
patients following the 24 hrs after application.  
 
The MIC values obtained for the combination of salt with A. afra essential oil, 
dichloromethane: methanol and aqueous extract are shown in Table 9.6. The MIC values 
show very poor activity against all the pathogens for the essential oils, dichloromethane: 
methanol and aqueous extracts. 
 
The results of the interactions of A. afra and salt combinations are shown in Figure 9.6. All 
pathogens in combination with essential oil, aqueous extract, and dichloromethane: methanol 
extracts respond with indifference (∑FIC values calculated were between 1.0 and 4.0). 
 
Table 9.6 MIC values of salt in combination with A. afra. 
 
Sample 
MIC values (mg/ml) 
M. catarrhalis 
ATCC 23246 
E. faecalis 
ATCC 29212 
K. pneumoniae 
NCTC 9633 
C. neoformans 
ATCC 90112 
A. afra essential oil 8.0 8.0 8.0 13.0 
A. afra 
dichloromethane: 
methanol extracts 
4.0 4.0 2.0 4.3 
A. afra aqueous 
extract 
4.0 8.0 8.0 13.0 
A. afra essential 
oil: salt 
21.0 21.0 18.5 21.0 
A. afra 
dichloromethane: 
methanol extracts: 
salt 
13.0 13.0 13.0 6.5 
A. afra aqueous 
extract: salt 
13.0 26.0 13.0 26.0 
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Although essential oil salt combination values are slightly lower than the other extracts it is 
not significantly low to be additive. The use of salt as a flavour enhancer does not in any way 
diminish the antimicrobial activity of the plant. 
 
Figure 9.6 The interaction of A. afra with salt. 
 
One can assume that the addition of these said adjuncts are possibly used for other purposes 
by traditional healers. Some of the possible uses include the use of honey to enhance taste, 
especially in children. Milk could be helpful in producing a possible enzymatic reaction. Salt 
could also be primarily added to mask unpleasant bitterness of the medicinal plant. Brandy 
and vinegar may be used in the making of poultices to create a cooling sensation when they 
evaporate or even just as a means to soften the leaf and roots of the plant.  
 
9.2.5.1 The combination of A. afra, Tetradenia riparia and salt 
Salt, together with A. afra and T. riparia is used as a decoction for the treatment of coughs 
(Hutchings et al., 1996). The use of salt in combination with plants is also mentioned in 
Adams et al. (2009) where it states that salt is used in combination with the crushed leaves of 
Plantago lanceolata and are then placed on arthritic limbs (Bock, 1577;  Matthiolus, 1590; 
Lonicerus, 1770). 
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Furthermore, it is also worth considering that as the combination of A. afra with T. riparia 
and salt is typically ingested, the salt content may play a role in the dissolution and/or 
absorption of the active components. It is known that the salt form of drugs e.g. salicylic acid 
shows faster dissolution and absorption rates. Salts increase dissolution rates thus increasing 
absorption rates. When salt encounters aqueous environments, it rapidly dissolves and takes 
the compounds bound to it with it in solution. This enables easier absorption (Kerns and Di, 
2008). When used as an application to the skin, the salt may have a cooling effect or the 
rough texture may be beneficial in helping to stimulate blood flow in these areas. Thus, the 
administration of the combination is essential to ultimately understanding the possible 
benefits of these medicinal plants.  
 
The antimicrobial activity of the combination of T. riparia with A. afra and salt has not been 
tested previously and represents a new area for further in depth analysis into the implications 
of administration methods and additives to the overall activity and effectiveness of medicinal 
plants 
 
9.2.5.1.1 Chromatographic techniques 
9.2.5.1.1.1 Essential oil composition of T. riparia 
Essential oil was distilled from T. riparia, which was collected from the Walter Sisulu 
Botanical gardens in Johannesburg. Forty-two compounds were identified in the essential oil, 
representing 91.2% of the total composition (Table 9.7). The major compounds in the 
essential oil comprised of γ-terpinene (4.1%), β-caryophyllene (32.4%), germacrene D 
(6.3%), bicyclogermacrene (4.8%), and α-cadinol (5.4%).  
 
Table 9.7 Essential oil composition of T. riparia. 
RRI* Compound name Area (%) 
1016 α-Pinene 0.1 
1019 α-Thujene 0.1 
1104 β-Pinene 0.1 
1117 Sabinene 0.3 
1193 α-Terpinene 1.9 
1193 Limonene 0.1 
1203 β –Phellandrene 0.1 
1242 γ-Terpinene 4.1 
1270 p-Cymene 1.0 
1281 Terpinolene 1.1 
1701 Verbenene 0.1 
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RRI*: Relative retention indices calculated against n-alkanes. 
Area (%) calculated from FID data. 
Tr = Trace; *UD: Undetermined. Major peaks: 288, 273, 245, t: tentative identification. 
 
Campbell et al. (1997) have reported on the composition of the essential oil of T. riparia from 
South Africa. Thirty-five compounds were identified and the main constituents found in the 
study were α-terpineol (22.6%), fenchone (13.6%), β-fenchyl alcohol (10.7%), β-
caryophyllene (7.9%) and perillyl alcohol (6.0%). A study by Omolo et al. (2004) revealed 
the major compound present in the essential oil of T. riparia from Kenya to be fenchone 
(±65%), limonene (±2.0%) and 1, 8-cineole (1.5%).  
 
RRI* Compound name Area (%) 
1456 trans Sabinene hydrate 3.4 
1448 α-Copaene 0.3 
1511 β-Bourbonene 1.2 
1528 α-Gurjunene 0.5 
1546 Linalool 0.2 
1562 Terpinen-4-ol acetate 1.0 
1586 β-Elemene 0.2 
1589 β-Copaene 0.1 
1595 β-Caryophyllene 32.4 
1627 cis-Menth-2-en-1-ol 0.7 
1647 allo Aromadendrene 0.3 
1674 α-Humulene 0.9 
1701 α-Terpineol 0.7 
1715 Germacrene D 6.3 
1728 α-Muurolene 0.8 
1741 Bicyclogermacrene 4.8 
1763 δ-Cadinene 2.1 
1768 γ-Cadinene 0.4 
1861 p-Cymen-9-ol 0.2 
1900 Cubebol 0.1 
1948 Palustrol 2.6 
2009 Caryophyllene oxide 0.7 
2067 Germacrene-4-D-ol 0.2 
2084 Cubenol 0.5 
2103 Guaiol 0.1 
2141 Spathulenol 0.5 
2185 T-Cadinol 1.1 
2196 Eusdesmol 2.4 
2201 α-Cadinol 5.4 
2327 Undetermined* 9.8 
 Abiatatriene (t) 2.3 
Total  91.2 
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 A recent study (Gazim et al., 2010) was carried out on the seasonal variation, chemical 
composition and analgesic and antimicrobial properties of the essential oil from the leaves of 
T. riparia in Brazil. The authors reported a total of 36 compounds identified from the 
essential oil, accounting for 95.0-99.6% of the volatile constituents. The major constituents 
found were 14-hydroxy-9-epi-caryophyllene (±20%), cis-muurolol-5-en-4-α-ol (±10%), α-
cardinol (±6%), ledol (±6%), calyculone (±20%), abietadiene (±10%) and fenchone (±10%).  
 
The current study showed the major compound present as β-caryophyllene at 32.4% with an 
unidentified compound at 9.8%. This is different from the composition found by Campbell et 
al. (1997), where β-caryophyllene was only found at 7.9% and Gazim et al. (2010) found β-
caryophyllene in small amounts only. Omolo et al. (2004) did not find any β-caryophyllene in 
the essential oil at all. In fact, fenchone was the main compound in Omolo et al. (2004), but 
no trace was found in the essential oil of T. riparia in this study. The differences in the 
constituents of the essential oils of T. riparia in South Africa and Kenya, and Brazil may be 
due to differences in environmental factors, chemotype, nutrition of the plants and genetics 
(Gazim et al., 2010). 
 
9.2.5.1.1.2 Thin layer chromatography 
In previous TLC assays, two major bands were found for T. riparia (Scott et al., 2004). A 
grey band with an Rf value of 0.36 (in a toluene: diethyl ether: 1.75 M acetic acid solvent) 
and 0.76 and another which was the 1,8-cineole marker at Rf value of 0.79 which was light 
blue in colour (Scott et al., 2004; Scott and Springfield, 2004).  
 
Similar bands were noted in the T. riparia extracts in the current study. The same three major 
bands were visible in Figure 9.7, at 254 nm, 365 nm and after derivatization. These bands 
were also visible in the combination with salt (Figure 9.7, lane 7) and in the triple 
combination.  
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Figure 9.7 TLC plates of the dichloromethane: methanol extracts of A. afra, Tetradenia 
riparia with salt alone and in combination at 254 nm, 365 nm, white light and visualized with 
vanillin-sulphuric acid reagent. 
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9.2.5.1.2 Antimicrobial analysis 
9.2.5.1.2.1 Essential oils 
In Table 9.8, the MIC values of the essential oils of T. riparia alone and in combination with 
either salt or A. afra or all three together. For studies on T. riparia noteworthy activity was 
seen against C. neoformans (MIC value = 2.0 mg/ml), S. agalactiae (MIC value = 1.5 mg/ml) 
and M. smegmatis (MIC value = 2.0 mg/ml).  
 
The combination of the essential oils of A. afra with T. riparia demonstrated noteworthy 
activity against C. neoformans, S. agalactiae and M. smegmatis. Salt showed no 
antimicrobial activity against K. pneumoniae, M. catarrhalis, E. faecalis, C. neoformans, S. 
pneumoniae and S. pyogenes at the highest concentration tested. However, some activity was 
noted against S. agalactiae and noteworthy activity was seen against M. smegmatis (MIC 
value = 0.6 mg/ml).  
 
The combination of A. afra with salt showed noteworthy activity only against M. smegmatis 
(MIC value of 0.6 mg/ml) was obtained. For the combination of T. riparia with salt, some 
antimicrobial activity was noted. Noteworthy activity was seen against M. smegmatis with a 
MIC value of 1.2 mg/ml.  
 
For the combination of A. afra, T. riparia and salt noteworthy antimicrobial activity was 
noted against C. neoformans, S. pneumoniae and M. smegmatis. The most significant activity 
was noted for M. smegmatis (MIC value of 0.2 mg/ml). ∑FIC values calculated revealed and 
synergy against M. smegmatis. Tentative interpretations showed varied interactions ranging 
from synergism to antagonism. 
 
9.2.5.1.2.2 Dichloromethane: methanol extracts 
In table 9.9 the results of the dichloromethane: methanol extracts of A. afra and T. riparia 
alone and in combination with salt are presented. For T. riparia independently noteworthy 
inhibitory activity were noted against C. neoformans, S. pneumoniae and S. pyogenes and S. 
agalactiae (MIC values of 0.5, 0.3, 0.4 and 0.6 mg/ml respectively).  
 
Moderate inhibitory activity was noted for the combination of A. afra with T. riparia against 
K. pneumoniae, M. catarrhalis, E. faecalis and M. smegmatis. Noteworthy strong inhibition 
was obtained against S. pneumoniae with a MIC value of 0.5 mg/ml. 
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The combination of A. afra with salt showed some activity against C. neoformans and S. 
agalactiae and noteworthy moderate inhibition against M. smegmatis (MIC value = 0.7 
mg/ml). For the combination of T. riparia with salt, noteworthy activity for the combination 
was obtained against C. neoformans with a MIC value of 0.3 mg/ml. 
 
MIC values obtained for the triple combination of A. afra with T. riparia and salt showed 
noteworthy activity (values range between 0.1 and 0.5 mg/ml) against all the pathogens tested 
with the exception of E. faecalis and S. agalactiae where poor activity was noted. The ∑FIC 
values calculated showed antagonism against S. agalactiae and additivity against M. 
smegmatis. Tentative interpretations of the interactions of the triple combination showed 
synergistic activity against K. pneumoniae and M. catarrhalis. 
 
9.2.5.1.2.3 Aqueous extracts 
Table 9. 10 shows the MIC values obtained for the aqueous extracts of the combination of A. 
afra with T. riparia and salt against the eight pathogens tested. T. riparia aqueous extract 
showed moderate inhibition against E. faecalis (MIC value = 1.5 mg/ml).  
 
The triple combination of the aqueous extracts showed some activity against K. pneumoniae, 
M. catarrhalis, E. faecalis and C. neoformans. Noteworthy strong inhibition was evident 
against M. smegmatis (MIC value of 0.5 mg/ml). ∑FIC values calculated showed synergy 
against M. smegmatis with a ∑FIC value of 0.3. 
 
A previous antimicrobial study on T. riparia (Boily and van Puyvelde, 1986), an initial 
screening of activity, where the agar dilution method was used. The methanol extracts (80%) 
of the leaves, stems, root fruit, and flowers of T. riparia were tested against Bacillus subtilis, 
Candida albicans, M. smegmatis, P. aeruginosa, S. aureus, and Salmonella gallinarum. The 
leaves inhibited the growth of B. subtilis, C. albicans, M. smegmatis, and P. aeruginosa. The 
stems did not show any inhibitory activity. The roots inhibited only B. subtilis and S. aureus, 
while the fruits only inhibited the growth of C. albicans. The flowers showed good 
antimicrobial action by inhibiting B. subtilis, C. albicans, M. smegmatis, and S. aureus.  
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Table 9.8 MIC and ∑FIC values of the essential oils A. afra, T. riparia, and salt alone and in combination. 
*Values given in bold indicate noteworthy activity. 
ND
1 
No ∑FIC value could be calculated as no MIC end point for salt/combination was obtained at the highest concentration tested. 
2
 Tentative interpretation according to MIC data. 
Shaded area: results previously discussed in Chapter 3 but included here for reference purposes. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail regarding control values. 
 
Micro-organism 
MIC (mg/ml)/)∑FIC value indicated in brackets where applicable ∑FIC 
A. afra T. riparia 
A. afra 
with T. 
riparia 
Salt 
(2%) 
A. afra 
with salt 
T. riparia 
with salt 
A. afra, T. 
riparia with 
salt 
A. afra, T. 
riparia 
with salt 
Interpretation 
K. pneumoniae 
NCTC 9633 
8.0 7.0 8.0 (1.1) ≥5.0 9.3 (ND1) 9.3 (ND1) 12.3 ND1 Indifference/Antagonism2 
M. catarrhalis 
ATCC 23246 
8.7 8.0 8.0 (1.0) ≥5.0 9.3 (ND1) 9.3 (ND1) 12.3 ND1 Indifference/Antagonism2 
E. faecalis  
ATCC 29212 
8.7 32.0 8.0 (0.6) ≥5.0 
18.5 
(ND
1
) 
3.8 (ND
1
) 12.3 ND
1
 Indifferent
2 
C. neoformans 
ATCC 90112 
3.8 2.0 1.0 (0.4) ≥5.0 2.3 (ND
1
) 2.3 (ND
1
) 1.4 ND
1
 Indifferent
2
 
S. pneumoniae 
ATCC 49619 
3.3 8.0 4.0 (0.9) ≥5.0 
18.5 
(ND
1
) 
9.3 (ND
1
) 1.4 ND
1
 Synergistic/Additive
2 
S. pyogenes 
ATCC 8668 
1.7 6.0 6.0 (2.3) ≥5.0 9.3 (ND
1
) 9.3 (ND
1
) 4.3 ND
1
 Indifferent
2
 
S. agalactiae 
ATCC 55618 
4.8 1.5 2.0 (0.9) 3.8 9.3 (2.2) 2.3 (1.1) 5.8 2.2 Indifferent 
M. smegmatis 
(clinical) 
1.5 2.0 1.0 (0.6) 0.6 0.6 (0.7) 1.2 (1.2) 0.2 0.2 Synergy 
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 Table 9.9 MIC and ∑FIC values of the dichloromethane: methanol extracts of A. afra, T. riparia, and salt alone and in combination. 
*Values given in bold indicate noteworthy activity. 
ND
1 
No ∑FIC value could be calculated as no MIC end point for salt/combination was obtained at the highest concentration tested. 
2
 Tentative interpretation according to MIC data. 
Shaded area: results previously discussed in Chapter 3 but included here for reference purposes. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail regarding control values. 
Micro-organism 
MIC (mg/ml))/∑FIC value indicated in brackets where applicable ∑FIC 
A. afra T. riparia 
A. afra 
with T. 
riparia 
Salt 
(2%) 
A. afra 
with salt 
T. riparia 
with salt 
A. afra, T. 
riparia and 
salt 
A. afra, T. 
riparia 
and salt 
Interpretation 
K. pneumoniae 
NCTC 9633 
6.3 1.3 1.0 (0.5) ≥5.0 10.5 (ND1) 
≥10.5 
(ND
1
) 
0.1 ND
1 
Synergy
2 
M. catarrhalis 
ATCC 23246 
4.7 4.0 1.0 (0.2) ≥5.0 10.5 (ND1) 
≥10.5 
(ND
1
) 
0.1 ND
1
 Synergy
2
 
E. faecalis  
ATCC 29212 
6.3 1.3 1.5 (0.7) ≥5.0 ≥10.5 (ND1) 
≥10.5 
(ND
1
) 
6.2 ND
1
 
Indifference/Antagonism
2
 
C. neoformans 
ATCC 90112 
1.2 0.5 2.0 (2.8) ≥5.0 2.6 (ND
1
) 0.3 (ND
1
) 0.4 ND
1
 Indifference/Additive
2 
S. pneumoniae 
ATCC 49619 
0.5 0.3 0.5 (1.3) ≥5.0 ≥10.5 (ND
1
) 
≥10.5 
(ND
1
) 
0.4 ND
1
 Indifferent
2
 
S. pyogenes 
ATCC 8668 
1.1 0.4 8.0 (3.6) ≥5.0 ≥10.5 (ND
1
) 
≥10.5 
(ND
1
) 
0.8 ND
1
 Indifference/Additive
2
 
S. agalactiae 
ATCC 55618 
3.0 0.6 4.0 (4.0) 3.8 4.9 (1.5) 2.6 (2.5) 6.2 4.7 Antagonistic 
M. smegmatis 
(clinical) 
1.7 1.0 1.0 (0.8) 0.6 0.7 (0.7) 1.3 (1.7) 0.5 0.6 Additive 
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Table 9.10 MIC and ∑FIC values of the aqueous extracts A. afra, T. riparia, and salt alone and in combination. 
*Values given in bold indicate noteworthy activity. 
ND
1 
No ∑FIC value could be calculated as no MIC end point for salt/combination was obtained at the highest concentration tested. 
2
 Tentative interpretation according to MIC data. 
Shaded area: results previously discussed in Chapter 3 but included here for reference purposes. 
Controls excluded for the sake of brevity. Please refer to Chapter 3 for further detail regarding control values. 
Micro-organism 
MIC (mg/ml))/∑FIC value indicated in brackets where applicable ∑FIC 
A. afra T. riparia 
A. afra with 
T. riparia 
Salt 
(2%) 
A. afra 
with salt 
T. riparia 
with salt 
A. afra, T. 
riparia and 
salt 
A. afra, T. 
riparia 
and salt 
Interpretation 
K. pneumoniae 
NCTC 9633 
12.0 ≥16.0 2.0 (ND1) ≥5.0 5.3 (ND1) 2.6 (ND1) 3.1 ND1 Synergy2 
M. catarrhalis 
ATCC 23246 
8.0 2.5 ≥16.0 (ND1) ≥5.0 
10.5 
(ND
1
) 
5.3 (ND
1
) 6.2 ND
1
 Indifferent
2
 
E. faecalis  
ATCC 29212 
7.0 1.5 ≥16.0 (ND1) ≥5.0 
10.5 
(ND
1
) 
2.6 (ND
1
) 6.2 ND
1
 Indifferent
2
 
C. neoformans 
ATCC 90112 
4.0 2.0 4.0 (1.5) ≥5.0 2.6 (ND1) 2.6 (ND1) 1.6 ND1 Indifference/Additive2 
S. pneumoniae 
ATCC 49619 
8.0 ≥16.0 ≥16.0 (ND1) ≥5.0 
≥10.5 
(ND
1
) 
≥10.5 (ND1) ≥10.5 ND1 Indifference/Antagonism2 
S. pyogenes 
ATCC 8668 
5.3 ≥16.0 8.0 (ND1) ≥5.0 
≥10.5 
(ND
1
) 
10.5 (ND
1
) ≥10.5 ND1 Indifference/Antagonism2 
S. agalactiae 
ATCC 55618 
1.7 ≥16.0 ≥16.0 (ND1) 3.8 
≥10.5 
(ND
1
) 
≥10.5 (ND1) ≥10.5 ND1 Indifferent2 
M. smegmatis 
(clinical) 
8.0 6.0 2.0 (0.3) 1.3 2.6 (2.4) 9.8 (8.9) 0.5 0.3 Synergy 
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In 1995, Vlietinck et al. tested the antimicrobial activity of the methanol extracts of T. riparia 
where the best activity was obtained against a yeast. This is in partial congruence with the 
current study where good results were obtained against the yeast, C. neoformans. Later, 
McGaw et al. (2000) tested the antimicrobial activity of the methanol, hexane, and aqueous 
extracts, of T. riparia using the disc diffusion method. No activity, against the pathogens was 
noted using the discs thus further microplate MIC determination was not carried out. 
Comparisons with the current study are difficult as the method of antimicrobial testing 
differs.  
 
A recent study (Gazim et al., 2010) tested the antimicrobial activity of the essential oil of T. 
riparia using the disc diffusion method followed by the measurement of the MIC values 
using the microdilution MIC method. The most sensitive micro-organisms were S. aureus, B. 
subtilis, and C. albicans with the largest inhibition zones and the lowest MIC values. These 
antimicrobial activities obtained of T. riparia were highest in the Summer, then Autumn, 
Winter and the lowest in Spring. MIC values obtained against S. aureus ranged from 15.6-
31.2 μg/ml, against B. subtilis MIC values obtained were between 7.8-15.6 μg/ml and against 
C. albicans MIC values were from 31.2-62.4 μg/ml. Good activity was also seen against 
other organisms tested i.e. E. faecalis, P. aeruginosa, E. coli, K. pneumoniae and S. enterica 
with MIC values of 62.5, 125.0 and 250 μg/ml respectively. In the current study the most 
significant activity was noted for the essential oil of T. riparia against S. agalactiae with a 
MIC value of 1.5 mg/ml. 
 
The active principles of T. riparia which display significant antimicrobial properties are the 
8(14), 15-sandaracopimaradiene-7α, 18-diol (De Kimpe et al., 1982; van Puyvelde, 1983; 
Boily and van Puyvelde, 1986; van Puyvelde et al., 1986).  
 
Variation between the results previously obtained could be due to the different localities of 
the T. riparia collected. Boily and van Puyvelde (1986) and Vleitinck et al. (1995) tested T. 
riparia collected from Rwanda and Gazim et al. (2010) tested T. riparia oil from Brazil. 
McGaw et al. (2000) tested the extracts of T. riparia, which was collected from South Africa. 
The T. riparia collected in this study was also from South Africa and the results obtained 
were moderate to poor. Thus this correlates with the findings of the antimicrobial activity that 
was obtained for the South African collections 
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9.3 Conclusions 
 The combination of the dichloromethane; methanol extracts A. afra with orange 
blossom honey (100%), wild blossom honey (100%) and blue gum honey (100%) all 
showed synergy  against C. neoformans.  
 The essential oils in combination with orange blossom, wild blossom and blue gum 
honey are antagonistic against all the pathogens tested with the exception of the 
combination of A. afra with wild blossom honey (100%) and blue gum honey (100%) 
against C. neoformans. 
 Additivity is seen for A. afra essential oil with milk (skim and or full cream) against 
C. neoformans, M. catarrhalis and K. pneumoniae. 
 The dichloromethane: methanol extracts of A. afra are additive in combination with 
vinegar against E. faecalis and K. pneumoniae. 
 The dichloromethane; methanol extracts of A. afra with brandy show additivity 
against M. catarrhalis and C. neoformans. The essential oils and aqueous extracts in 
combination with brandy were antagonistic against M. catarrhalis, E. faecalis and K. 
pneumoniae. 
 Salt in combination with A. afra displays no significant interaction. Salt in the 
combination of A. afra with T. riparia could therefore be incorporated into the 
preparation to augment the taste of these two unpalatable plants in one remedy. 
 The addition of an adjunct to A. afra by traditional healers is most likely due to other 
factors like enhancing taste or preventing bitterness. 
 The results obtained from the triple combination of the essential oils i.e. A. afra, T. 
riparia, and salt, showed the noteworthy and very strong inhibition against M. 
smegmatis with a MIC value of 0.2 mg/ml. ∑FIC values obtained showed synergy 
against M. smegmatis and antagonism against S. agalactiae.  
 The dichloromethane: methanol extracts of the combination of A. afra, Tetradenia 
riparia, and salt showed good activity with noteworthy inhibition against all the 
pathogens tested except against E. faecalis and S. agalactiae. The best activity as 
noted against K. pneumoniae and M. catarrhalis with MIC values of 0.1 mg/ml. ∑FIC 
values showed antagonism against S. agalactiae. 
 The aqueous extracts of the combination of A. afra, Tetradenia riparia and salt 
showed noteworthy activity against M. smegmatis with a MIC value of 0.5 mg/ml.  
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Chapter 10 
Summary and general conclusions 
 
Traditional healers often use combinations of plants or adjuncts with A. afra to treat common 
respiratory complaints. This study was conducted with the aim of validating the traditional 
use of these combinations from an antimicrobial perspective, in order to provide valuable 
insight into the rationale for the use of these herbal combinations.  
 
This research has provided a direction for further studies into the more complex uses of plant 
combinations, particularly with respect to the principle plant A. afra. An in-depth literature 
review was conducted and combinations of plants commonly used by traditional healers to 
treat respiratory infections were identified (Table 1.1). These were elaborated on and 
explored in Chapter 1. Five double combinations and four triple combinations were selected 
for further investigation.  
 
All aromatic plants where essential oil could be obtained were analysed by GC-MS and the 
detailed compositional analysis is provided with the corresponding plants in the thesis and 
monographs. A summary of the main compounds present the six plants essential oils 
evaluated is given in Table 10.1. 
 
Table 10.1 Summary of the major chemical constituents found from all plant essential oils in 
this study. 
Essential oil Major compounds 
% of major 
compound 
A. betulina 
isomenthone 31.4 
limonene 18.9 
menthone 10.0 
diosphenol 8.1 
pseudodiosphenol 7.5 
A. afra 
camphor 41.0 
1,8-cineole 17.0 
borneol 8.6 
β-thujone 6.0 
artemisia ketone 6.4 
camphene 4.0 
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The TLC analysis of the plant essential oils, dichloromethane: methanol and aqueous extracts 
showed good separation of the compounds and the complexity of the plants individually and 
in combination were illustrated.  
 
MIC values for the essential oils and extracts that produced the highest activity are shown in 
Table 10.2. The most significant activity noted for plants studied independently was that from 
E. globulus dichloromethane: methanol extracts against M. catarrhalis with a MIC value of 
0.01 mg/ml.  
 
From the antimicrobial interactions observed in Table 10.3, the most synergistic 
combinations in a 1:1 ratio is observed when A. afra is combined with O. asteriscoides 
(dichloromethane: methanol extracts) against S. pyogenes, when A. afra is combined with E. 
globulus (aqueous extracts) against S. pneumoniae,  when L. randii is combined with E. 
globulus (dichloromethane: methanol extracts) against K. pneumoniae and when the aqueous 
extracts are combined against M. smegmatis in the combination of A. afra with T. riparia 
(dichloromethane: methanol extracts) against M. catarrhalis, all with an ∑FIC value of 0.2.  
 
Essential oil Major compounds 
% of major 
compound 
E. globulus 
1,8-cineole 63.0 
α-pinene 16.7 
limonene 3.6 
ρ-cymene 2.7 
L. javanica 
linalool 70.7 
caryophyllene oxide 6.9 
trans-linalool oxide 4.5 
cis-linalool oxide 4.0 
ρ-cymene 3.4 
1,8-cineole 2.3 
O. asteriscoides 
1,8-cineole 59.0 
camphor 8.2 
α-terpineol 7.2 
T. riparia 
β-caryophyllene 32.4 
germacrene D 6.3 
α-cardinol 5.4 
bicyclogermacrene 4.8 
γ-terpinene 4.1 
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Table 10.2 Summary of the most significant antimicrobial activity of the plant samples tested 
independently.  
Plant Plant preparation Micro-organism 
MIC value 
(mg/ml) 
A. afra 
Essential oil 
M. smegmatis 
(clinical) 
1.5 
Dichloromethane: 
methanol extract 
S. pneumoniae 
(ATCC 49619) 
0.5 
L. javanica 
Essential oil 
S. pyogenes 
(ATCC 8668) 
1.4 
Dichloromethane: 
methanol extract 
S. pneumoniae 
(ATCC 49619) 
0.4 
S. pyogenes 
(ATCC 8668) 
Aqueous extract 
S. agalactiae 
(ATCC 55618) 
0.5 
O. asteriscoides 
Essential oil 
S. pneumoniae 
(ATCC 49619) 
1.0 
Dichloromethane: 
methanol extract 
C. neoformans 
(ATCC 90112) 
0.3 
Aqueous extract 
C. neoformans 
(ATCC 90112) 
0.5 
A. betulina Essential oil 
S. pyogenes 
(ATCC 8668) 
1.0 
E. globulus 
Essential oil 
C. neoformans 
(ATCC 90112) 
0.6 
Dichloromethane: 
methanol extract 
M. catarrhalis 
(ATCC 23246) 
0.01 
Aqueous extract 
C. neoformans 
(ATCC 90112) 
0.8 
L. randii 
Dichloromethane: 
methanol extract 
M. smegmatis 
(clinical) 
0.5 
Z. capense 
Dichloromethane: 
methanol extract 
C. neoformans 
(ATCC 90112) 
0.4 
Aqueous extract 
S. agalactiae 
(ATCC 55618) 
0.4 
T. riparia 
Essential oil 
S. agalactiae 
(ATCC 55618) 
1.5 
Dichloromethane: 
methanol extract 
S. pneumoniae 
(ATCC 49619) 
0.3 
 
The triple combination of A. afra with T. riparia (essential oil) with salt was also synergistic 
(∑FIC value = 0.2) against M. smegmatis. The combination of O. asteriscoides and E. 
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globulus (essential oils) against E. faecalis and the combination of A. afra with L. randii 
(dichloromethane: methanol extracts) against C. neoformans showed synergy with ∑FIC 
values of 0.1. 
 
Various ratios within the isobologram interpretations demonstrated synergy and the most 
significant was that for the combination of A. afra with E. globulus (aqueous extract) against 
C. neoformans wherein all ratios tested were synergistic. 
 
Some antagonism was found and this could be important as these ratios could be highlighted 
as inadvisable for traditional healing practises. The interaction that was most antagonistic in a 
1:1 ratio of the combination of O. asteriscoides with E. globulus (dichloromethane: methanol 
extracts) against M. catarrhalis where a ∑FIC value of 77.3 was obtained. The isobologram 
studies demonstrated the highest incidence of antagonism was the combination of A. afra 
with E. globulus (dichloromethane: methanol extracts) against M. catarrhalis wherein five of 
the nine ratios were antagonistic. 
 
Table 10.3 Summary of the most significant interactions present in the plant combinations 
tested.  
Plant 
combination 
Plant 
part/product 
Micro-organism 
∑FIC 
value/isobologram 
ratios 
Interaction 
A. afra with  
L. javanica 
Dichloromethane: 
methanol extracts 
S. agalactiae 
(ATCC 55618) 
∑FIC value = 0.4 Synergy 
M. catarrhalis 
(ATCC 23246) 
Isobologram  
(ratios 2:8 and 1:9) 
Synergy 
E. faecalis 
(ATCC 29212) 
Isobologram  
(ratio 1:9) 
Synergy 
A. afra with  
O. asteriscoides 
Dichloromethane: 
methanol extracts 
S. pneumoniae 
(ATCC 49619) 
∑FIC value = 0.3 Synergy 
S. pyogenes 
(ATCC 8668) 
∑FIC value = 0.2 Synergy 
M. smegmatis 
(clinical) 
∑FIC value = 0.3 Synergy 
Aqueous extract 
M. catarrhalis 
(ATCC 23246) 
Isobologram  
(ratios 4:6, 3:7, 2:8 
and 1:9) 
Synergy 
K. pneumoniae 
(NCTC 9633) 
Isobologram  
(ratio 8:2) 
Synergy 
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Plant 
combination 
Plant 
part/product 
Micro-organism 
∑FIC 
value/isobologram 
ratios 
Interaction 
E. faecalis 
(ATCC 29212) 
Isobologram  
(ratio 9:1) 
Synergy 
C. neoformans 
(ATCC 90112) 
Isobologram (ratios 
9:1, 8:2, 6:4, 4:6, 
3:7, 2:8 and 1:9) 
Synergy 
Essential oil 
C. neoformans 
(ATCC 90112) 
Isobologram  
(ratio 8:2) 
Synergy 
A. afra with  
A. betulina 
Dichloromethane: 
methanol extracts 
M. catarrhalis 
(ATCC 23246) 
∑FIC value = 0.3 Synergy 
Isobologram (ratios 
3:7, 4:6 and 1:1) 
Synergy 
A. afra with 
E. globulus 
Dichloromethane: 
methanol extracts 
K. pneumoniae 
(NCTC 9633) 
∑FIC value = 0.5 Synergy 
S. pyogenes 
(ATCC 8668) 
∑FIC value = 0.3 
Synergy 
M. smegmatis 
(clinical) 
Synergy 
M. catarrhalis 
(ATCC 23246) 
∑FIC value = 5.8 Antagonism 
E. faecalis 
(ATCC 29212) 
∑FIC value = 7.6 Antagonism 
Aqueous extract 
C. neoformans 
(ATCC 90112) 
∑FIC value = 0.3 Synergy 
S. pneumoniae 
(ATCC 49619) 
FIC value = 0.2 Synergy 
Dichloromethane: 
methanol extracts 
M. catarrhalis 
(ATCC 23246) 
Isobologram  
(ratios 8:2, 7:3, 6:4, 
1:1 and 4:6) 
Antagonism 
K. pneumoniae 
(NCTC 9633) 
Isobologram  
(ratios 4:6 and 1:1) 
Synergy 
E. faecalis 
(ATCC 29212) 
Isobologram  
(ratios 6:4 and 1:1) 
Antagonism 
Aqueous extract 
M. catarrhalis 
(ATCC 23246) 
Isobologram (all 
ratios except 1:1) 
Synergy 
C. neoformans 
(ATCC 90112) 
Isobologram  
(all ratios) 
Synergy 
O. asteriscoides 
with E. globulus 
Essential oil 
E. faecalis 
(ATCC 29212) 
∑FIC value = 0.1 Synergy 
Dichloromethane: 
methanol extracts 
M. catarrhalis 
(ATCC 23246) 
∑FIC value = 77.3 Antagonism 
E. faecalis 
(ATCC 29212) 
∑FIC value = 34.0 Antagonism 
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Plant 
combination 
Plant 
part/product 
Micro-organism 
∑FIC 
value/isobologram 
ratios 
Interaction 
S. agalactiae 
(ATCC 55618) 
∑FIC value = 0.4 Synergy 
A. afra,  
O. asteriscoides 
with E. globulus 
Essential oil 
C. neoformans 
(ATCC 90112) 
∑FIC value = 6.5 Antagonism 
Dichloromethane: 
methanol extracts 
K. pneumoniae 
(NCTC 9633) 
∑FIC value = 0.5 Synergy 
S. agalactiae 
(ATCC 55618) 
∑FIC value = 0.4 Synergy 
M. catarrhalis 
(ATCC 23246) 
∑FIC value = 57.6 Antagonism 
E. faecalis 
(ATCC 29212) 
∑FIC value =42.9 Antagonism 
A. afra with 
L. randii 
Dichloromethane: 
methanol extracts 
C. neoformans 
(ATCC 90112) 
∑FIC value = 0.1 Synergy 
S. pyogenes 
(ATCC 8668) 
∑FIC value = 6.0 Antagonism 
L. randii with  
E. globulus 
Dichloromethane: 
methanol extracts 
K. pneumoniae 
(NCTC 9633) 
∑FIC value = 0.2 Synergy 
M. catarrhalis 
(ATCC 23246) 
∑FIC value =36.6 Antagonism 
E. faecalis 
(ATCC 29212) 
∑FIC value = 25.1 Antagonism 
Aqueous extract 
M. smegmatis 
(clinical) 
∑FIC value = 0.2 Synergy 
A. afra, L. randii 
with E. globulus 
Dichloromethane: 
methanol extracts 
K. pneumoniae 
(NCTC 9633) 
∑FIC value = 0.3 Synergy 
C. neoformans 
(ATCC 90112) 
∑FIC value = 0.3 Synergy 
M. smegmatis 
(clinical) 
∑FIC value = 0.5 Synergy 
A. afra with  
Z. capense 
Dichloromethane: 
methanol extracts 
S. pneumoniae 
(ATCC 49619) 
∑FIC value = 0.4 Synergy 
E. faecalis 
(ATCC 29212) 
Isobologram  
(ratio 6:4) 
Synergy 
C. neoformans 
(ATCC 90112) 
Isobologram  
(ratio 7:3) 
Synergy 
A. afra with  
T. riparia 
Essential oil 
C. neoformans 
(ATCC 90112) 
∑FIC value = 0.4 Synergy 
Dichloromethane: 
methanol extracts 
K. pneumoniae 
(NCTC 9633) 
∑FIC value = 0.5 Synergy 
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Plant 
combination 
Plant 
part/product 
Micro-organism 
∑FIC 
value/isobologram 
ratios 
Interaction 
M. catarrhalis 
(ATCC 23246) 
∑FIC value = 0.2 Synergy 
S. pyogenes 
(ATCC 8668) 
∑FIC value = 13.6 Antagonism 
S. agalactiae 
(ATCC 55618) 
∑FIC value = 4.0 Antagonism 
Aqueous extract 
M. smegmatis 
(clinical) 
∑FIC value = 0.3 Synergy 
T. riparia with 
salt 
Aqueous extract 
M. smegmatis 
(clinical) 
∑FIC value = 8.9 Antagonism 
A. afra, T. riparia 
with salt 
Essential oil 
M. smegmatis 
(clinical) 
∑FIC value = 0.2 Synergy 
Dichloromethane: 
methanol extracts 
S. agalactiae 
(ATCC 55618) 
∑FIC value = 4.7 Antagonism 
Aqueous extract 
M. smegmatis 
(clinical) 
∑FIC value = 0.3 Synergy 
 
Table 10.4 demonstrates a summary of the main results attained when A. afra was combined 
with adjuncts such as honey, milk, vinegar and brandy. The best combinational activity from 
the adjuncts tested in this study was obtained from the combination of A. afra 
(dichloromethane: methanol extracts) with orange blossom honey (100%), with wild blossom 
honey (100%) and blue gum honey (100%) against C. neoformans. All three interactions 
were synergistic. The highest antagonism noted  were in the combinations of A. afra with 
orange blossom honey (100%), A. afra with vinegar and A. afra with brandy against M. 
catarrhalis, E. faecalis, K. pneumoniae and C. neoformans. Thus, care should be taken when 
combining these adjuncts with A. afra. 
 
Table 10.4 Summary of the adjunct interactions with A. afra. 
Adjunct in combination 
with A. afra 
Plant 
part/product 
Micro-organism Interaction * 
A. afra with orange 
blossom honey (64.0 
mg/ml) 
Aqueous extract 
C. neoformans 
(ATCC 90112) 
Additive 
A. afra with orange 
blossom honey (100%) 
Essential oil 
M. catarrhalis 
(ATCC 23246) 
Antagonism 
E. faecalis 
(ATCC 29212) 
Antagonism 
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Adjunct in combination 
with A. afra 
Plant 
part/product 
Micro-organism Interaction * 
K. pneumoniae 
(NCTC 9633) 
Antagonism 
C. neoformans 
(ATCC 90112) 
Antagonism 
Dichloromethane: 
methanol extracts 
C. neoformans 
(ATCC 90112) 
Synergy 
Aqueous extract 
E. faecalis 
(ATCC 29212) 
Antagonism 
C. neoformans 
(ATCC 90112) 
Antagonism 
K. pneumoniae 
(NCTC 9633) 
Additive 
A. afra with wild 
blossom honey (100%) 
Essential oil 
M. catarrhalis 
(ATCC 23246) 
Antagonism 
E. faecalis 
(ATCC 29212) 
Antagonism 
K. pneumoniae 
(NCTC 9633) 
Antagonism 
Dichloromethane: 
methanol extracts 
C. neoformans 
(ATCC 90112) 
Synergy 
Aqueous extract 
E. faecalis 
(ATCC 29212) 
Antagonism 
C. neoformans 
(ATCC 90112) 
Antagonism 
K. pneumoniae 
(NCTC 9633) 
Additive 
A. afra with blue gum 
honey (100%) 
Essential oil 
M. catarrhalis 
(ATCC 23246) 
Antagonism 
E. faecalis 
(ATCC 29212) 
Antagonism 
K. pneumoniae 
(NCTC 9633) 
Antagonism 
Dichloromethane: 
methanol extracts 
 
K. pneumoniae 
(NCTC 9633) 
Additive 
C. neoformans 
(ATCC 90112) 
Synergy 
Aqueous extract 
E. faecalis 
(ATCC 29212) 
Antagonism 
C. neoformans 
(ATCC 90112) 
Antagonism 
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Adjunct in combination 
with A. afra 
Plant 
part/product 
Micro-organism Interaction * 
A. afra with skim milk 
Essential oil 
E. faecalis 
(ATCC 29212) 
Antagonism 
C. neoformans 
(ATCC 90112) 
Additive 
Aqueous extract 
M. catarrhalis 
(ATCC 23246) 
Additive 
K. pneumoniae 
(NCTC 9633) 
Antagonism 
A. afra with full cream 
milk 
Essential oil 
E. faecalis 
(ATCC 29212) 
Antagonism 
Aqueous extract 
E. faecalis 
(ATCC 29212) 
Antagonism 
K. pneumoniae 
(NCTC 9633) 
Additive 
A. afra with vinegar 
Essential oil 
M. catarrhalis 
(ATCC 23246) 
Antagonism 
E. faecalis 
(ATCC 29212) 
Antagonism 
K. pneumoniae 
(NCTC 9633) 
Antagonism 
Dichloromethane: 
methanol extracts 
 
E. faecalis 
(ATCC 29212) 
Additive 
K. pneumoniae 
(NCTC 9633) 
Additive 
Aqueous extract 
M. catarrhalis 
(ATCC 23246) 
Antagonism 
E. faecalis 
(ATCC 29212) 
Antagonism 
K. pneumoniae 
(NCTC 9633) 
Antagonism 
A. afra with brandy 
Essential oil 
M. catarrhalis 
(ATCC 23246) 
Antagonism 
E. faecalis 
(ATCC 29212) 
Antagonism 
K. pneumoniae 
(NCTC 9633) 
Antagonism 
Dichloromethane: 
methanol extracts 
M. catarrhalis 
(ATCC 23246) 
Additive 
C. neoformans 
(ATCC 90112) 
Additive 
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Adjunct in combination 
with A. afra 
Plant 
part/product 
Micro-organism Interaction * 
Aqueous extract 
M. catarrhalis 
(ATCC 23246) 
Antagonism 
E. faecalis 
(ATCC 29212) 
Antagonism 
K. pneumoniae 
(NCTC 9633) 
Antagonism 
*Interactions based on data from bar graphs in Chapter 9. 
 
The purpose of this study was to validate the traditional use of A. afra combinations for the 
treatment of respiratory tract infections. This outcome has been achieved as many of the plant 
combinations have demonstrated that the essential oils have the most additivity in their 
combinations and thus the delivery form of inhalation may ensure that these infections are 
dealt with at the site of the microbial colonisation. Further in vivo studies are needed to 
confirm this. The results obtained from the essential oils mostly support the common use of 
these plants in combination as an inhalant to treat respiratory conditions. This use dates back 
to the origins of time when smoke or steam from a burning or boiling plant was inhaled 
(Mohagheghzadeh et al., 2006). Conventional medicine has also employed this method by 
inhaling drugs into the lungs using a nebulizer or metered dose inhalers for the treatment of 
respiratory illnesses.  
 
The dichloromethane: methanol extracts also showed some outstanding activity. However, 
some antagonism was also noted. Care should be exercised when administering tinctures as 
antagonism is possible. The aqueous extracts, surprisingly, showed good activity in some 
combinations. This corresponds with the traditional use of these combinations in the form of 
decoctions and infusions.  
 
The overall outcome of this study is that a valid and scientific basis for the use of these plants 
in combination has been established and this could prove to pave the way for future studies in 
the fight against bacterial respiratory infections. The study has produced positive and 
encouraging results that largely supports the traditional use of combinations and hopefully set 
the precedent for future research in this area. 
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Recommendations for future studies 
Further testing of the use of adjuncts in combination with A. afra (Table 10.4) could prove 
helpful in the development of cost-effective and efficacious treatments for primary 
healthcare. These adjuncts may prove their value not only as pharmaceutical additives, but 
may prove to have a pharmacological benefit. Some of these benefits may be an enhanced 
activity at receptor sites to achieve an amplified result. They may also serve to improve the 
dissolution of the drug, thereby increasing the absorption of the active component. Studying 
these effects could be beneficial in the future.   
 
Time-kill assays to determine the exact interactive effect of the combinations over time 
should be carried out. Toxicity studies should be undertaken to determine if toxicity is 
reduced or enhanced when plants are combined. The anti-oxidant, anti-inflammatory, 
decongestant, expectorant, antihistamine and antitussive properties should also be 
investigated, as plant combination selection may not only be associated with improved 
antimicrobial activity but also due to other pharmacological properties. There is the 
possibility that two plants are selected with the intention to address infection (one plant) and 
another related symptom for example inflammation. Thus by combining plants, two 
pharmacological effects are achieved within one preparation. Studies conducted should relate 
the synergistic interactions encountered to specific modes of action. 
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Appendix A 
Monographs of plant species investigated 
 
A1Agathosma betulina (P.J. Berguis) Pillans 
Common names of Agathosma betulina (P.J. Berguis) Pillans are: boegoe (Afrikaans); buchu 
(English, Khoi; French, Italy); round leaf buchu; short buchu; ibuchu (Xhosa); Bucco 
(Germany) (van Wyk and Wink, 2004; Moolla, 2006; van Wyk et al., 2009). 
 
A1.1 Botanical description of A. betulina 
Agathosma betulina (Rutaceae) is a round leafed perennial shrub, with woody branches, of up 
to 2 meters in height. The leaves are small, with a rounded apex, which curves backwards, 
and are rich in conspicuous oil glands along the margins and lower surfaces. Thus, they are 
highly aromatic with a rich gold colour oil. The oil has a strong, sweetish peppermint like 
odour (Watt and Breyer-Brandwijk, 1962; Moolla and Viljoen, 2008). Flowers (Figure A1.1) 
are born at the ends, throughout August, September and October (Sigmond, 1838). They are 
small and star shaped in white or purple (Moolla, 2006; van Wyk et al., 2009). 
Figure A1.1 A. betulina flowers (A.M. 
Viljoen). 
Figure A1.2 Botanical distribution of A. 
betulina (SANBI). 
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A1.2 Geographical locality of A. betulina 
A. betulina is found in the sandy mountainous regions of the Cape of South Africa (Figure 
A1.2), specifically the Western Cape Province (Spreeth, 1976; Goldblatt and Manning, 2000; 
van Wyk and Gericke, 2000; Moolla, 2006; Moolla et al., 2007; van Wyk et al., 2009). 
 
A1.3 Medicinal uses of A. betulina 
A. betulina is said to be remedy for “almost every disease which afflicts man” (Watt and 
Breyer-Brandwijk, 1962). Buchu brandy (boegoebrandewyn) which comprises of buchu 
leaves infused in brandy is a preparation made by the natives of the Cape. This preparation is 
considered a supreme remedy for all chronic diseases as well as for acute diseases of the 
stomach and bladder (Sigmond, 1838; Watt and Breyer-Brandwijk, 1962; Simpson, 1998; 
Viljoen et al., 2006a). It is also used as an antibiotic for protection against infections (Forbes, 
1986). The leaves are sometimes chewed, or mixed in brandy to make a tincture to relieve 
stomach complaints or as a stomachic tonic (Gentry, 1961; Watt and Breyer-Brandwijk, 
1962; van Wyk and Wink, 2004; van Wyk et al., 2009). Buchu brandy is widely known and 
used as a diuretic and for the treatment of kidney and urinary tract diseases (Watt and Breyer-
Brandwijk, 1962; Gentry, 1961; Moolla, 2006; van Wyk et al., 2009). Buchu leaves soaked in 
vinegar (buchu vinegar or boegoe-asyn) is used to wash and clean wounds (Moolla, 2006; 
van Wyk et al., 2009). Buchu is also used to treat the symptoms of rheumatism as well as 
gout (Simpson, 1998; Moolla, 2006; Viljoen et al., 2006a; van Wyk et al., 2009; Vermaak et 
al., 2009). The essential oil of buchu is known to have therapeutic properties such as 
alleviating fever, coughs, colds and flu (Simpson, 1998; Viljoen et al., 2006a). 
 
A1.4 Chemical constituents of A. betulina 
The essential oil of buchu has been studied (Gildmeister and Treibs, 1959; Fluck et al., 1961; 
Guenther, 1964; Kaiser et al., 1975; Blommaert and Bartel, 1976; Posthumus et al., 1996). 
These studies have attributed to its flavour to 8-mercapto-p-mentha-3-one. Two monoterpene 
thiols were identified to be responsible for the odour (Fluck et al., 1961; Gentry, 1961; Watt 
and Breyer-Brandwijk, 1962; Klein and Rojahn, 1967; Lamparsky and Schudel, 1971; Kaiser 
et al., 1975; Simpson, 1998).  
 
Kaiser et al. (1975) isolated and identified 120 compounds in the commercial essential oil of 
buchu. The major compounds found were buchu camphor/diosphenol (15-30%), menthone 
and isomenthone (50-60%), limonene (±17%), pulegone and isopulegone (±7%). Viljoen et 
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al. (2006a) performed a study on the chemical composition of the commercially (Afriplex, 
South Africa) available A. betulina essential oil. They found the major constituents of buchu 
oil to be limonene (23.7%), pulegone (8.4%), menthone (29.2%) and isomenthone (14.2%).  
 
Non-volatile major compounds in buchu leaf extract were identified as hesperidin and 
diosman (El-Shafae and El-Domiaty, 2001).  
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A2 Allium sativum L. 
Allium sativum is also commonly known as garlic; ail blanc (French), Knoblauch (German), 
aglio (Italian), ajo (Spanish) and Lasan (Indian) (Ahmad and Beg, 2001; van Wyk and Wink, 
2004). Allium species are said to be among the first cultivated crops in the world and its use 
as a spice and a medicinal plant dates back to antiquity (Sato and Miyata, 2000; Benkeblia, 
2004; Rivlin, 2006).  
 
A2.1 Botanical description of A. sativum 
Allium sativum L. (Alliaceae) is a perennial shrub. It has fleshy slightly greyish leaves with 
rounded flower heads as well as numerous small bulbs, which are grouped and surrounded by 
a white papery sheath (Figure A2.1) (van Wyk and Wink, 2004).  
 
 
 
 
 
 
 
 
Figure A2.1 bulbules of A. sativum. 
 
A2.2 Geographical locality of A. sativum 
Garlic is reported to have come from the Middle East or central Asia (van Wyk and Wink, 
2004). However, the exact origin of garlic is unknown and thus only the cultivated form is 
commonly used. 
 
A2.3 Medicinal uses of A. sativum 
It has been used as a medicinal plant for over 4000 years and is still employed in folk 
medicine all over the world for the treatment of a variety of diseases (Block, 1985; Ali et al., 
2000; Corzo-Martínez et al., 2007). The oldest literature recorded, on the use of garlic as a 
medicine and a condiment is from the Sumerians is dated at 2600-2100 BC (Harris et al., 
2001). Garlic, in its various therapeutic forms i.e. powder, extracts or essential oils have been 
used in traditional medicine for various ailments by the Chinese, Egyptians, Greek, Indians, 
Koreans, Romans and the Africans (Stoll and Seebeck, 1951; Lucas, 1966; Cha, 1978; 
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Agarwal, 1996; Ankri and Mirelman, 1999; Jaber and Al-Mossawi, 2007; Abubakar, 2009). 
In Africa, garlic is used to treat abdominal discomfort, diarrhoea, otitis media, and respiratory 
tract infections (Ankri and Mirelman, 1999; Jaber and Al-Mossawi, 2007; Abubakar, 2009). 
The main or primary medicinal use of garlic is as a supportive dietary treatment of 
hyperlipidaemia (van Wyk et al., 2009). It is also used in the treatment and prevention of the 
symptoms associated with the common cold (Amagase, 2006; van Wyk et al., 2009). Garlic 
possesses antibacterial, antifungal, antiviral, antiprotozoal, anti-oxidant, anticarcinogenic and 
antimutagenic, antithrombotic and anti-arthritic effects (Sato and Miyata, 1999; Ali et al., 
2000; Harris et al., 2001; Corzo-Martínez et al., 2007; Jaber and Al-Mossawi, 2007). 
Additionally, it has and is being used for tuberculosis, heart problems, headaches, bites, 
intestinal worms, and tumours (Watt and Breyer-Brandwijk, 1962; Block, 1985; Ali et al., 
2000; Corzo-Martínez et al., 2007).  
 
A2.4 Chemical constituents of A. sativum 
Garlic contains a high amount of non-volatile organo-sulpur compounds, the primary one 
present is S-alk(en)yl-L-cysteine sulphoxides, such as alliin and γ-glutamylcysteines. Alliin is 
the main compound present in intact garlic which is degraded to allicin which is most often 
the main compound isolated in processed garlic materials (Ahmad and Beg, 2001; van Wyk 
and Wink, 2004). The main biological functions of garlic are due to the presence of their high 
organo-sulphur compounds i.e. e alliin (Augusti & Mathew, 1974; Amagase, 2006; Corzo-
Martínez et al., 2007). 
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A3 Artemisia afra Jacq. ex Willd. 
The common names of A. afra include African wormwood (English); umhlonyane, 
umhlonyane omcane (Xhosa, Zulu); lengana (Sotho, Tswana); als, alsem, wildeals 
(Afrikaans); armoise d‟Afrique (French) and Afrikanischer Wermut (German) (Hutchings et 
al., 1996; van Wyk and Wink, 2004; van Wyk et al., 2009). 
 
A3.1 Botanical description of A. afra 
A. afra (Asteraceae) is an erect multi-stemmed perennial shrub. It grows up to two metres in 
height and it is a highly aromatic plant. It is bitter tasting and has a yellow-green volatile oil 
(von Koenen, 2001). It has feathery leaves (Figure A3.1) which are finely divided and have a 
greyish-green colour (van Wyk et al., 2009). In winter, the branches die, but rapidly 
regenerate from the base, and it blossoms from January to June (Hilliard, 1977; Liu et al., 
2009; van Wyk et al., 2009). The flowers, which are borne along the branch ends, are pale 
yellowish and inconspicuous (Figure A3.2) (Hilliard, 1977; van Wyk et al., 2009). 
 
Figure A3.1 Aerial leaves of A. afra (S.F. 
van Vuuren) with single feathery leaf of A. 
afra (inset) (A.M. Viljoen). 
Figure A3.2 Pale yellowish flowers of A. 
afra (A.M. Viljoen). 
 
A3.2 Geographical locality of A. afra 
A. afra is a very common species and is indigenous to the mountainous regions in southern 
Africa (Figure A3.3) i.e. South Africa, Namibia, and Zimbabwe (Graven et al., 1992). It 
grows in the northern provinces of Gauteng and Limpopo along the eastern parts of South 
Africa as well as Swaziland and Lesotho extending up to the Western Cape of South Africa 
(Hilliard, 1977; Liu et al., 2009; van Wyk et al., 2009). It has an extensive distribution 
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northwards into tropical east Africa going as far north as Ethiopia (Gurib-Fakim, 2007; van 
Wyk et al., 2009).  
 
 
 
 
 
 
 
 
 
 
Figure A3.3 Geographical distribution of 
A. afra in South Africa (SANBI). 
 
A3.3 Medicinal uses of A. afra 
A. afra is typically given as root or leaf infusions, which are drunk or used as a gargle. Leaf 
decoctions (with sugar or honey) and an alcohol extract are taken or the steam is inhaled. 
This is achieved by covering the container as well as the head with a towel (making a tent) 
thus blocking escape of the steam and then inhaling (Watt and Breyer-Brandwijk, 1962; 
Hutchings et al., 1996; von Koenen, 2001; Thring and Weitz, 2006; van Wyk et al., 2009). It 
has a wide spectrum of uses such as in the treatment of fever, chills, whooping cough, loss of 
appetite, headache, earache, skin ulcerations, intestinal worms, colic, indigestion, flatulence, 
constipation, gout, rheumatism, malaria and bladder and kidney disorders (Watt and Breyer-
Brandwijk, 1962; von Koenen, 2001; van Wyk and Wink, 2004; Thring and Weitz, 2006; van 
Wyk et al., 2009). It is also employed to bring out the rash in measles (von Koenen, 2001).  
 
A. afra is used regularly to treat respiratory problems, specifically both upper and lower 
respiratory tract infections (von Koenen, 2001). Among them are coughs, colds, 
inflammation of the throat, bronchitis, blocked nose, pneumonia and influenza (Watt and 
Breyer-Brandwijk, 1962; Hutchings et al., 1996; van Wyk et al., 2009). 
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A3.4 Chemical constituents of A. afra 
Volatile as well as non-volatile constituents are found in A. afra. Non-volatile constituents 
from a pentane extract have revealed cerylcerotinate, nonacosane, friedeline and α- and β-
amyrin (Silbernsgel et al., 1990; Graven et al., 1992) as well as surface flavonoids (methyl 
ethers of luteolin) (Wollenweber et al., 1989; van Wyk, 2008). Ascaridole, sesquiterpene 
lactone guaianolides, scopolectin and isofraxidin have also been identified (Jakupovic et al., 
1988; Chagonda et al., 1997; Chagonda et al., 1999).  
 
Graven et al. (1992) confirms the results on the main components of the volatile oil of A. afra 
from Zimbabwe by Priprzek et al. (1982) and Graven et al (1986) i.e. α-thujone (52.5%), β-
thujone (13.1%), 1,8-cineole (13.0%) and camphor (6.6%). The study on the oil from 
Ethiopia by Worku and Rubiolo (1996) revealed the major compound to be artemisyl acetate 
(24.4-32.1%). In the Kenyan oil, 1,8-cineole was the major component at 63.37% (Mwangi et 
al., 1995) and α-thujone (52.5-54.2%) was the main component in the South African oil as 
analyzed by Lawrence (1989) and Libbey and Sturtz (1989). In the study by Chagonda et al. 
(1999), which studied the essential oil composition of cultivated A. afra, two chemotypes 
were identified i.e. cultivated from Harare and Murehwa. In the former chemotype, artemisia 
ketone (32.1-34.8%), camphor (21.8-24.4%), and 1,8-cineole (10.9-16.9%) were the 
dominant compounds. The latter sample contained 1,8-cineole (23.5-28.7%), camphor (20.2-
21.3%) and borneol (14.2-17.0%) as the major compounds. The results of this study differed 
completely with the studies by Graven et al. (1992), Lawrence (1989) and Libbey and Sturtz 
(1989) which reported α-thujone as a major constituent of the essential oil of A. afra. These 
results are congruent with the studies by Moody et al. (1994) and Garnero (1977) (Chagonda 
et al., 1999). Mangena and Muyima (1999) studied the essential oil of A. afra from Fort Hare 
in South Africa and found major constituents to be α-thujone (78.68%), β-thujone (13.3%) 
and 1,8-cineole (8.19%). Once again, results differed from that of Graven et al., (1992). 
 
In 2001, Burits et al. analyzed the essential oil of A. afra from Addis Ababa, Ethiopia using 
GC-MS. The major compounds found were camphor (26.8%), bornyl acetate (3.8%), 4-
terpineol (3.6%) and chamazulene (3.2%). Muyima et al. (2002) found camphor (15.6%), 1, 
8-cineole (13.6%) and β-thujanone (52.6%) to be the major compounds in the oil isolated 
from Fort Hare in South Africa. Viljoen et al. (2006b) studied the geographical variation by, 
GC-MS, of A. afra essential oil by comparing four natural plant populations i.e. Setibang 
(Lesotho), Giant‟s Castle (KwaZulu Natal), QwaQwa (Free State) and Kliprviersberg 
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(Gauteng). Different plants within a population were also collected. Differences in major 
compounds were noted e.g. 1,8-cineole which was present in high concentrations (50%) in 
the Gauteng samples was low (2%) in the Lesotho population. Inter-population differences 
also occurred wherein α-thujone was a major compound (77.7%) in plant sample C from 
Setibang and was not present at all in plant sample A of the same population.  
 
Thus it is evident that the volatile oil of A. afra is remarkably variable in the major and minor 
oil compounds (Graven et al., 1992; Changonda et al., 1999; Dube, 2006; Viljoen et al., 
2006b; Liu et al., 2009), with a large amount of monoterpenes and sesquiterpenes present 
(van Wyk and Wink, 2004). This variability is possibly due to the following factors: 
geographical variation; different plant parts used; drying methods; variation within the 
natural population (Liu et al., 2009) 
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A4 Eucalyptus globulus Labill. 
Common names of Eucalyptus globulus Labill. are Eucalyptus (French); Blue gum; 
Tasmanian blue gum; true blue gum; impiskayihlangulwa, umdlavusa, umdlebe (Zulu); 
bloekom (Afrikaans); Eukalyptus (German); eucalipto (Italian) and eucalypto (Spanish) 
(Hutchings et al., 1996; van Wyk and Gericke, 2000; van Wyk and Wink, 2004; Suitor et al., 
2009). 
 
A4.1 Botanical description of E. globulus  
E. globulus (Myrtaceae) is a very large tree (Figure A4.1). It has a characteristic shedding 
bark. The leaves are very glaucous, long and dimorphic as well as broad with solitary large 
white flowers (Figure A4.2) (Horn et al., 1964; van Wyk and Wink, 2004). 
Figure A4.1 Large tree of E. globulus 
(S.F. van Vuuren). 
Figure A4.2 Leaves and flowers of E. 
globulus (S.F. van Vuuren). 
 
A4.2 Geographical locality of E. globulus 
E. globulus is indigenous to Australia (Jordan et al., 1993; Dutkowski and Potts, 1999; van 
Wyk and Wink, 2004) and Tasmania. It is most widely cultivated in subtropical and 
Mediterranean regions (Takahashi et al., 2004). E. globulus was introduced into Europe, 
North and South Africa, California and the non-tropical districts of South America by Baron 
Ferdinand von Müller, a German botanist and explorer who made the qualities known all 
over the world (http://www.botanical.com/botanical/mgmh/e/eucaly14.html).  
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A4.3 Medicinal uses of E. globulus 
Among the uses for E. globulus is as a spray to repel vermin. A poultice of E. globulus is 
used to draw out an abscess. The root is said to be a purgative. The leaf is used as a febrifuge 
and a remedy for leprosy. Leaf juice is used as a tonic and antiperiodic as well as an 
antiseptic (Watt and Breyer-Brandwijk, 1962). The essential oil is applied externally for the 
relief of rheumatism and minor skin ailments (van Wyk and Wink, 2004) 
 
The main use of E. globulus in South Africa and elsewhere is as a remedy for respiratory 
complaints (such as colds and fever), and is used as an ingredient in nasal drops (Watt and 
Breyer-Brandwijk, 1962; Felhaber, 1997). The vapour from boiling the leaves is inhaled as a 
respiratory antiseptic as well as for diphtheria and croup. An infusion is drunk using a bunch 
of slightly boiled leaves in water or pouring boiling water over bruised leaves. This is used 
for the treatment of influenza. Inflammation of the lungs, chest pain and difficulty in 
breathing is treated by boiling a few leaves and then inhaling the vapours, which can induce 
sleep as well (Smith, 1895; Watt and Breyer-Brandwijk, 1962; van Wyk and Wink, 2004).  
 
It is also reported by Caceres et al. (1991) to be used in the treatment of asthma, bronchitis, 
sore throat and chest tuberculosis, whooping cough and sinusitis. E. globulus is used for the 
treatment of coughs by acting as an expectorant (Mejίa, 1927; McVaugh, 1963; Morton, 
1981; Alvarez, 1987; Orellana, 1987 in Caceres et al., 1991). In a study conducted by 
Cacreres et al. (1991), E. globulus was proven effective in inhibiting the growth of S. aureus 
and S. pyogenes. 
 
 
A4.4 Chemical constituents of E. globulus 
E. globulus has been one of the most studied of Eucalyptus species and the essential oil has 
been well characterized (Singh et al., 2000; Batista-Pereira et al., 2006; Ghalem and 
Mohamed, 2008a). The main constituent that was found was 1,8-cineole (70-80%) (Stecher et 
al., 1968; van Wyk and Wink, 2004). Other compounds include α-pinene, phellandrene, 
terpineol, citronellal, geranyl acetate, eudesmol, eudesmyl acetate, piperitone, ρ-cymene and 
limonene, camphene, β-pinene, linalool, globulol and volatile aldehydes (isovaleric) were 
found (Stecher et al., 1968; Cimanga et al., 2002; van Wyk and Wink, 2004). Tohidpour et al. 
(2010) found eucalyptol, spathulenol, and α-pinene as the major constituents of E. globulus. 
 
 259 
 Major non-volatile compounds isolated from the ethanol extract of the leaves of E. globulus 
was identified as containing β-diletones, such as 16-hydroxy-18-tritriacontanone and 4-
hydroxy-tritriacontane-16,18-dione (wax constituents), ellagic acid and its related compounds 
(Amakura et al., 2009). Other constituents include gallic acid, quercetin 3-O-β-D-
glucuronide, globuluside, cryptmeriodol, 4-epi-cryptmeridiol, 3β,13β-dihydroxyurs-11-en-
28-oic acid, β-eudesmol and macrocarpal I (Sakai et al., 2005). Amakura et al. (2009) 
identified the main constituents as gallic acid, oenothein, ellagic acid,  quercetin 3-O-β-D-
glucuronide, kaempferol 3-O-β-D-glucuronide and chlorogenic acid. Hasegawa et al. (2008) 
isolated two monoterpene conjugates of gallic acid, globulusin A and eucaglobulin from the 
hot water extract of E. globulus. 
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A5 Leonotis. randii S. Moore.  
Leonotis microphylla is a synonym of Leonotis ocymifolia (Burm.f) Iwaarson var. schinzii 
(Gürke) according to Welman in Arnold and de Wet, 2002. Leonotis randii S. Moore. is the 
synonym used by Klopper et al., (2006). Common names include wild dagga (English); 
Knopdagga, wilde-dagga, Klipdagga (Afrikaans) which translates to “rock marijuana” (Vos, 
1995) and semomonane (Watt and Breyer-Brandwijk, 1962). 
 
A5.1 Botanical description of L. randii 
Leonotis microphylla (Figure A5.1) is a perennial shrub (0.5-1m high) with densely covered 
stems, branches and leaves with long and short hispid hairs (Brown et al., 1912). It is a short 
plant displaying long flowering stems. Flowering of L. randii as shown in Figure A5.1 
dominates in the summer rainfall season between October and February (Vos, 1995). 
Figure A5.1 Flower of L. randii (S.F.van 
Vuuren). 
 
Figure A5.2 Distribution map of L. randii 
(SANBI). 
 
A5.2 Geographical locality of L. randii 
Its recorded distribution as shown in Figure A5.2 is in Gauteng (Transvaal), Free State 
(Orange Free State), and Botswana (Vos, 1995). It grows primarily in the Kalahari region of 
Gauteng (Transvaal), as shown in Figure A5.2, in the Jeppestown Ridges of Johannesburg, 
Meintjies Kop in Pretoria and in Heidelberg (Skan, 1910; Brown et al., 1912). Its habitat is 
restricted to bankenveld, sourveld, mixed bushveld, rocky outcrops and slopes (Vos, 1995). 
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A5.3 Medicinal uses of L. randii 
The Africans use an infusion of Leonotis microphylla to apply to painful spots on the skin 
and haemorrhoids. The European and the Sotho people living in South Africa drink the 
infusion for the relief of digestive disturbances with fever as well as for chest affections. The 
Kwena, a branch of the Western Sotho people and the Tswana, Western Sotho people of 
South Africa drink a decoction of the plant in large doses for coughs and colds. The Manyika, 
people from the eastern part of Zimbabwe and across the border in Mozambique; a sub-tribe 
of the Shona, people in South Africa burn the flower of L. microphylla with porcupine quills 
and then inhale the smoke to stop nose bleeds (Watt and Breyer-Brandewijk, 1962; 
http://www.britannica.com/EBchecked/topic/325884/Kwena; 
http://www.britannica.com/EBchecked/topic/607965/Tswana; 
http://www.britannica.com/EBchecked/topic/363321/Manyika). 
 
A5.4 Chemical constituents of L. randii 
According to Vos (1995), 18 compounds were identified. The essential oil comprised of: 
caryophyllene 37%; germacrene 13%; eugenol 7%; phellandrene 3%; 1,8-cineole 2% and an 
unknown compound at retention time of 34.45 mins.  
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A6 Lippia javanica (Burm.f) Spreng 
Synonyms of Lippia javanica are Lantana galpiniana Pearson, Lippia asperifolia Rich or 
Verbena javanica Burm. f. (Hutchings et al., 1996). Common names are fever tea, lemon 
bush (English); musukudu and bokhukhwane (Tswana); inzinziniba (Xhosa); umsuzwane, 
umswazi (Zulu); mumara (Shona); koors (tee) bossie, lemoenbossie, maagbossie, beukebos 
(Afrikaans); musudzungwane (Tshivenda) and lufisu (Nyakyusa) (Hutchings et al., 1996; 
Ngassapa et al., 2003; Manenzhe et al., 2004; Samie et al., 2005; van Wyk et al., 2009). 
 
A6.1 Botanical description of L. javanica 
L. javanica (Verbenaceae) is an erect woody shrub growing up to two meters in height. It has 
hairy leaves that have conspicuous veins (van Wyk et al., 2009). The leaf is described as 
being highly aromatic (van Wyk et al., 2009), having the odour of vanilla or mint (Watt and 
Breyer-Brandwijk, 1962), as well as having a strong lemon smell. Small yellowish white 
flowers (Figure A6.1) are produced in dense rounded heads (van Wyk et al., 2009). 
 
Figure A6.1 Leaves of L. javanica with 
small yellowish white flowers (A.M. 
Viljoen.) 
Figure 6.2 Geographical distribution of L. 
javanica in South Africa (SANBI). 
 
A6.2 Geographical locality of L. javanica 
L. javanica occurs over large parts of northern South Africa and it extends northward into 
tropical Africa (van Wyk et al., 2009) (Figure A6.2). Predominantly, it is found in the North-
eastern regions of South Africa and extends into Botswana, Zimbabwe, Malawi and 
Swaziland (Chagonda et al., 1993; Manenzhe et al., 2004). 
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A6.3 Medicinal uses of L. javanica 
L. javanica is predominantly used as an infusion for traditional medicine. Weak infusions are 
reportedly used as a caffeine-free tea substitute in some communities in Botswana (Watt and 
Breyer-Brandwijk, 1962; van Wyk et al., 2009; Shikanga et al., 2010; Manenzhe et al., 2004). 
Strong infusions are used topically to treat scabies and lice (van Wyk et al., 2009), it is also 
used as a calmative, anticolic, anticatarrh and as an emetic (Muchuweti et al., 2006). Pascual 
et al. (2001) documents L. javanica as being an analgesic, antipyretic, anti-inflammatory as 
well as being an antispasmodic and has antimicrobial and larvicidal/repellent properties 
(Mwangi et al., 1992; Hutchings and van Staden, 1994). It is also used to disinfect anthrax-
infected meat (Watt and Breyer-Brandwijk, 1962). The Zulu speaking people from South 
Africa drink an infusion for the treatment of gangrenous rectitis and use the plant to treat 
measles, urticaria and other rashes (Watt and Breyer-Brandwijk, 1962; van Wyk et al., 2009. 
The cooled decoction is applied as a lotion to treat skin disorders such as rashes, stings and 
bites (van Wyk et al., 2009, Muchuweti et al., 2006). It is also stuffed in the nose as a remedy 
to stop nasal haemorrhage and colds, blackwater fever, malaria (Samie et al., 2005; Ngassapa 
et al., 2003), dysenteries e.g. diarrhoea (Samie et al., 2005), tapeworm infestations (Ngassapa 
et al., 2003), abdominal pains (Ngassapa et al., 2003) and other diseases (Watt and Breyer-
Brandwijk, 1962). It is also used as a malaria remedy in South West Africa (Watt and Breyer-
Brandwijk, 1962).  
 
The Kwena and the Tswane people of South Africa use a decoction for the treatment of 
coughs and colds. Furthermore, the smoke from the burning plant is inhaled for respiratory 
conditions e.g. asthma and chronic cough (Samie et al., 2005; Muchuweti et al., 2006). The 
leaf boiled is in water and is used as a Swati (native people from South Africa and 
Swaziland) remedy for influenza and colds as well as a cough remedy by the Shangana 
(natives of Mozambique, and South Africa) (Watt and Breyer-Brandwijk, 1962). L. javanica 
leaves and stems are used by the Xhosa, natives of South Africa, as a weak infusion in milk 
or water for the treatment of coughs, colds and bronchial troubles, shortness of breath and 
chest complaints (Watt and Breyer-Brandwijk, 1962; Pascual et al., 2001). L. javanica is used 
traditionally to treat coughs, colds, bronchitis and various chest ailments. Hot leaf infusions 
are taken with milk or water.  
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A6.4 Chemical constituents of L. javanica 
Non-volatile compounds Iridoid glucosides, theveside-NA and theviridoside, were isolated 
from L. javanica by Rimpler and Sauerbier (1986). The toxic triterpenoid, Icterogenin was 
isolated and reported by Watt and Breyer-Brandwijk (1962) and cited in Hutchings and van 
Staden (1994), Pascual et al. (2001), Buckingham (2006) and Mujovo et al. (2008). 
 
Phenolic secondary metabolites have been recently studied by Olivier et al. (2010). 
Verbascoside and isoverbascoside, isolated from the aerial parts of L. javanica, are sugar 
moieties and thus render them water-soluble. They are well known for their biological 
activities (Herbert et al., 1991; Pieroni et al., 2000; Pennacchio, 2005) thus it said that the two 
compounds are probably linked to the medicinal uses of L. javanica. Traditional healers use 
the infusions of L. javanica in most cases, and thus extraction of these active constituents is 
most likely (Olivier et al., 2010). 
 
The chemical composition of L. javanica essential oil has been thoroughly studied previously 
(Mwangi et al., 1992; Velasco-Negueruela et al., 1993; Hutchings and van Staden, 1994; 
Terblanche and Kornelius 1996; Ngassapa et al., 2003; Manenzhe et al., 2004; Viljoen et al., 
2005). Neidlein and Staehle (1974) found caryophyllene, linalool and ρ-cymene as major 
components of L. javanica essential oil. Later on Mwangi et al. (1991) reported the presence 
of myrcenone, myrcene, (E) - and (Z) - tagetenone as the main characteristic components of 
the same. Terblanche and Kornelius (1996) in their review reported (Z)-tagetenone (24.9-
39.9%), (E)-tagetenone(11.4-20.6%), myrcene (4.7-8.3%), myrcenone (20.9-49.7%) as the 
main constituents. β-caryophyllene was also present (0.1-2.0%) (Fujita, 1965; Mwangi et al., 
1991; Velasco-Negueruela et al., 1993).  
 
Samples of L. javanica essential oil from Tanzania were also analyzed by Balira (1986) and 
Ngassapa et al. (2003). Balira (1986) analyzed two samples, one from Kimbiji in Dares 
Salam (A), and the other from a southern highlands region in Tanzania Iringa (B). Sample A 
contained myrcenone in high amounts i.e. 52.2%. Sample B also contained myrcenone but at 
9.6%. In the study by Ngassapa et al. (2003), two samples (A and B) were also chosen, but 
from the same location and they possessed different odours. Sample A contains limonene 
(9.6%), germacrene-D (9.0%), camphor (7.2%) and linalool (5.4%). Sample B had citral 
(geranial (21.5%) and neral (13.7%)) and limonene (11.3%). From this it is evident the two 
populations could be different chemotypes. 
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Manenzhe et al. (2004) sampled L. javanica essential oil in South Africa and found a major 
compound piperitone (74.4%), with other compounds at lower concentrations such as 
limonene (1.6%, linalool (1.8%), ο-isopropenylanisole (9.7%), α-terpineol (0.8%), Z-
Ocimenone (3.9%) and β-caryophyllene (1.0%). It was reported that the essential oil is highly 
variable, both quantitatively and qualitatively with variations present even in the same 
location (Chagonda et al., 2000). In 2005, Viljoen et al. performed a study on the 
geographical variation of L. javanica essential oil. Five natural populations each having 16 
samples were collected i.e. Swaziland, Nelspruit, Warmbaths, Long Tom Pass and Fairlands. 
Five different chemotypes were identified within the different populations. They were a 
myrcenone rich type (36-62%), a carvone rich type (61-73%), a piperitenone rich type (32-
48%), an ipsenone rich type (42-61%) and a linalool rich type (>65%).  
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A7 Osmitopsis asteriscoides (L.) Cass. 
Common names of O. asteriscoides include bellis, bels (e), belskruie (Afrikaans), and 
Mountain daisy (Bremer, 1972; Smith, 1966; van Wyk et al., 2009). 
 
A7.1 Botanical description of O. asteriscoides 
O. asteriscoides (Asteraceae) is a vigorous branched glabrous shrub growing up to two 
meters in height (Bremer, 1972). It is strongly camphor scented and has bare stems with its 
leaves crowded at the branch ends (van Wyk et al., 2009). The leaves are oblong and 
glandular displaying a large number of small glands on the surface (van Wyk et al., 2009). 
Due to these glands, this plant produces a high volume of essential oil. White flowers (Figure 
A7.1) bloom between January – December (whole year) (Bremer, 1972), and their heads are 
attractive and grouped on branch tips (van Wyk et al., 2009).   
Figure A7.1 O. asteriscoides leaves and 
flowers (A.M. Viljoen). 
Figure A7.2 Geographical distribution of 
O. asteriscoides (SANBI).
A7.2 Geographical locality of O. asteriscoides 
It is restricted to the Western Cape Province (Figure A7.2), where it thrives in open and moist 
ground but not in the shadow of trees (Bremer, 1972; Marloth, 1908). It then forms small 
“forests” and is said to be found in swampy places on the summit of Table Mountain.  
 
A7.3 Medicinal uses of O. asteriscoides 
O. asteriscoides is a traditional Cape Dutch remedy for the treatment of many ailments (van 
Wyk et al., 2009). Brandy tinctures (Spiritus bellidis) are used for coughs and hoarseness and 
the dried plant extract is applied externally for inflammation. A poultice of the leaf is applied 
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to cuts and swellings. It is very popular in the treatment of stomach troubles such as colic. 
Included in the spectrum of medicinal uses is the use for fever, influenza, body aches and 
pains, and as an embrocation in paralysis (Watt and Breyer-Brandwijk, 1962). According to 
Watt and Breyer-Brandewijk (1962), it is reported to cause sweating. Additionally, a tincture 
or an infusion is applied as a remedy for rheumatism (van Wyk et al., 2009; Viljoen et al., 
2003; Watt and Breyer-Brandewijk, 1962). 
 
A7.4 Chemical constituents of O. asteriscoides 
The essential oil of O. asteriscoides is rich in 1, 8-cineole (eucalyptol) and camphor (van 
Wyk et al., 2009). It has been previously studied by Bohlmann and Zdero, (1974); Bohlman 
et al. (1985) and Viljoen et al. (2003). O. asteriscoides has been reported to have a high 
amount of non- volatile sesquitepene lactones including osmitopsin isolated from the leaves 
(Viljoen et al., 2003; McGaw et al., 2008). 
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A8 Tetradenia riparia (Hochst.) Codd 
The common names of Tetradenia riparia include ginger bush (English); watersalie 
(Afrikaans); iboza and ibozane (Zulu) and umuravumba (Rwandanese) (Hutchings et al., 
1996; van Wyk et al., 2009). Synonyms include Iboza bainesii N.E. Br., Iboza galpinii N.E. 
Br., Iboza riparia (Hochst.) N.E. Br., Moschosma riparia N.E. Br., and Moschosma riparium 
Hochst. (Hutchings et al., 1996).  
 
A8.1 Botanical description of T. riparia 
T. riparia (Hochst.) Codd belongs to the family Lamiaceae. It is a multi-branched shrub or a 
small tree (1-3 meters in height). The leaves and stems contain glandular hairs (Figure A8.1) 
with the leaves glandular on both surfaces (van Wyk et al., 2009). Male and female flowers 
(Figure A8.2), with colours ranging from white to mauve, are born on different plants. The 
female flower spikes are densely flowered and longer (up to 80mm long) compared to the 
male spikes (20m long) (Codd, 1985; van Wyk et al., 2009). 
 
Figure A8.1 Glandular leaves of T. riparia 
(S.F. van Vuuren). 
Figure A8.2 Flowers of T. riparia  
(H. de Wet). 
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A8.2 Geographical distribution of T. riparia 
T. riparia is commonly found in the eastern parts of South Africa (Figure A8.3), on dry rocky 
slopes, wooded hillsides or on a stream bank in relatively frost-free areas (Codd, 1985; van 
Wyk et al., 2009). It extends into Namibia and Angola and then north into east tropical Africa 
and Ethiopia (Codd, 1985; van Wyk et al., 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A8.3 Botanical distribution of T. riparia (SANBI). 
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A8.3 Medicinal uses of T. riparia 
T. riparia leaf infusions and decoctions are used for respiratory diseases such as coughs, 
colds, sore throat, and influenza as well as other ailments such as mouth ulcers, stomach-
ache, diarrhoea, haemoptysis; boils, mumps fever, malaria, swollen legs (Watt and Breyer-
Brandwijk, 1962; Hutchings, 1989; Pujol, 1990; Githinji and Kokwaro, 1993; Hutchings et 
al., 1996; van Wyk et al., 2009). Crushed leaves of T. riparia are also inhaled for the 
treatment of headaches (Hutchings and van Staden, 1994). 
 
A8.4 Chemical constituents of T. riparia 
The major essential oil components found in T. riparia were α-terpineol, fenchone, β-
caryophyllene, and β-fenchyl alcohol (Campbell et al., 1997; Scott et al., 2004; van Wyk et 
al., 2009). Secondary chemical studies on T. riparia have revealed the presence of diterpenes 
which are  ibozol and 7 α-hydroxyroyleanone; the diterpenediol i.e. 8(14),15-
sandaracopimaradiene-7α,18-diol which possesses significant antimicrobial activity (De 
Kimpe et al., 1982);  α-pyrones called umuravumbolide (5,6-dihydro-6-(3-acetoxy-1-
heptenyl)-2-pyrone), tetradenolide (5,6-dihydro-6-(1,2-dihydroxyhexyl)-2-pyrone),  
deacetylmuravumbolide (5,6-dihydro-6-(3-hydroxyl-1-heptenyl)-2-pyrone) and 
deacetylboronolide (5,6-dihydro-6-(1,2,3-trihydroxyheptyl)-2-pyrone and sitosterol (Zelnik et 
al., 1978; van Puyvelde et al., 1979; van Puyvelde et al., 1986; van Puyvelde et al., 1987; 
Davies-Coleman and Rivett, 1995; Scott et al., 2004).  
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A9 Zanthoxylum capense (Thunb.) Harv. 
Synonyms of Zanthoxylum capense include Fagara capensis Thunb., F. Magaliesmontana 
Engl., Xanthoxylum (Xanthoxylon) (Waterman, 1975)  capense (Thunb.) Harv., Z. thunbergii 
DC. var obtusifolia Harv. (Hutchings et al., 1996). Common names include Small 
Knobwood, Adelaide Spice tree, and Cardamon. Other names include Wild cardamom 
(English); kleinperdepram, Paarde pram, kardamon, knop(pies)doring (Afrikaans); 
monokwane (Sotho); umlungumabele (Xhosa/Zulu); umnungamabele, amabelentombi, 
amabelezintshingezi, isimungumabele, isinungwane, umnungwane omncane (Zulu) (Smith, 
1895; Hutchings et al., 1996; van Wyk et al., 2009). 
 
A9.1 Botanical description of Z. capense 
Z. capense (Thunb.) Harv. (Rutaceae) is a tree (about 5-10m in height) with many branches. 
Thick thorns on the bark are a characteristic trait of Z. capense trees. Sharp thorns are also 
present on the stems. Several pairs of leaflets are found on the leaf (Figure A9.1) with 
translucent oil glands dotted on the edges. The tree bears fruit, which is said to contain oil, in 
clusters, which are small and orange brown in colour and resemble oranges (Watt and 
Breyer-Brandwijk, 1962). The fruit is acrid and tastes of lemon, and presents with a persistent 
burning sensation in the mouth (Watt and Breyer-Brandwijk, 1962). When ripe, the fruits slit 
open and reveal shiny black seeds inside. The flowers that are born are greenish-white and 
are inconspicuous (van Wyk et al., 2009). Root and bark decoctions have a displeasing odour 
and are said to cause sweating (Watt and Breyer-Brandwijk, 1962; Hutchings et al., 1996).  
 
A9.2 Geographical locality of Z. capense 
Z. capense is distributed widely in the eastern and northern parts of South Africa (van Wyk et 
al., 2009). Distribution also extends sporadically into the southern regions (Figure A9.2). 
 
A9.3 Medicinal uses of Z. capense 
Z. capense has a reputation of being widely used as a medicine by the African and European 
people. An infusion of the leaf lends its uses for gastric (Hutchings et al., 1996) and intestinal 
disorders as well as intestinal parasites (Watt and Breyer-Brandwijk, 1962; Hutchings et al., 
1996). The fruit has been used for flatulent colic, palsy, as a stomach remedy and for fever  
(Watt and Breyer-Brandwijk, 1962; Forbes, 1986; Hutchings et al., 1996; van Wyk et al., 
2009). The bark is taken as a tonic in persons suffering from sores (Bryant, 1970; Hutchings 
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et al., 1996) as well as a snakebite treatment. The whole plant is burned on a hot plate and the 
fumes inhaled for dizziness (Oluwole et al., 2002). 
 
Figure A9.1 Leaflets of Z. capense 
(S.F.van Vuuren). 
Figure A9.2 Geographical distribution of 
Z. capense in South Africa (SANBI). 
 
A decoction of the bark is given to cattle for gall sickness. It is also used in combination with 
other medicinal plants to treat tuberculosis, paralysis, epilepsy, infertility and impotency, 
pleurisy, as an anthelminthic, a purgative, enema, parasiticide as well as for blood purifying 
(Watt and Breyer-Brandwijk, 1962; Watt, 1967; Hutchings et al., 1996; van Wyk et al., 
2009).  
 
A decoction of the root is used as a mouthwash (Watt and Breyer-Brandwijk, 1962; Pujol, 
1990; Hutchings et al., 1996; Steyn et al., 1998; van Wyk et al., 2009) for aphthae in children 
and a lotion for acne. Powdered root taken by mouth has been used for pimples and blood 
poisoning. Powdered bark is used to treat paralysis and relieve toothache by loosening the 
tooth (Watt and Breyer-Brandwijk, 1962; Hutchings et al., 1996). The root bark as well as a 
paste of the inner stem bark is similarly used (Smith, 1895; Watt and Breyer-Brandwijk, 
1962; Pujol, 1990; Hutchings et al., 1996; van Wyk et al., 2009). Z. capense is widely used to 
disinfect anthrax-infected meat as well as in the treatment of anthrax (Watt and Breyer-
Brandwijk, 1962). 
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 Other uses of the root of Z capense include the treatment of bronchitis and for violent 
chronic coughing when used in combination with other plants (Watt and Breyer-Brandwijk, 
1962; Bryant, 1970; Hutchings et al., 1996; Steyn et al., 1998). 
 
A9.4 Chemical constituents of Z. capense 
In 1914, Juritz published the only reported chemical investigation at the time, of Z. capense 
and it was found that „a large proportion of a resinous substance was extracted as well as 
tannins and a yellow colouring substance which was not identified‟ (Steyn et al., 1998). Since 
then,  alkaloids from African Zanthoxylum capense were isolated (Calderwood et al., 1970; 
1971 in Fish and Waterman, 1972). These are skimmianine, chelerythrine, nitidine and N-
methyltetrahydropalmatine. In a study by Four compounds isolated from Z. capense were of 
interest, which were pellitorine, xanthoxylum-γ, γ-dimethylallyl ether, β-sitosterol and 
sitosterol-β-D-glucose (Steyn et al., 1998). The medicinal properties of Z. capense are said to 
be supported and explained by the presence of the secondary metabolites pellitorine and 
sitosterol-β-D-glucose (Steyn et al., 1998). 
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Appendix B – Conference/publication presentations 
 
Publications/conference presentations arising from preliminary studies* 
Co-author of the following poster: van Vuuren, S.F., Suliman, S., Dhorat, S. and AM Viljoen. 
The pharmacological interaction of commercial essential oils in combination with 
conventional antimicrobials. The 38
th
 International Symposium on Essential Oils, Austria, 
Graz, 9-13 September, 2007.  
 
Co-author of the following publication: van Vuuren, S.F., Suliman, S., and Viljoen, A.M., 
2009. The antimicrobial activity of four commercial essential oils in combination with 
conventional antimicrobials. Letters in Applied Microbiology, 48 (4), 440-446. 
 
Publications/conference presentations arising from this study* 
Suliman, S.; van Vuuren, S.F.; Viljoen, A.M. 2008. Validating the antimicrobial efficacy of 
Artemisia afra in combination with medicinal plants to treat respiratory tract infections. 
Podium presentation, Academy of Pharmaceutical Sciences of South Africa (PSSA), 2008. 
Rustenburg, 22-26 September 2008. Young scientist competition presentation. 
 
Suliman, S.; van Vuuren, S.F.; Viljoen, A.M. 2009. Antimicrobial interactions of Artemisia 
afra with other medicinal plants to treat respiratory diseases. Podium presentation,   Annual 
Meeting of the Indigenous Plant Use Forum (IPUF). Stellenbosch, 6-9 July 2009. 3
rd
 Prize 
winner of young scientist competition presentations. 
 
Suliman, S. van Vuuren, S.F.; Viljoen, A.M. 2009. The ethnobotanical study of A. afra in 
combination therapy for the treatment of respiratory tract infections. Podium presentation at 
the University of Johannesburg Post Graduated Symposium. Johannesburg, 29 October 2009.  
 
Suliman, S., van Vuuren, S.F. and Viljoen, A.M., 2010. Validating the in vitro antimicrobial 
activity of Artemisia afra in polyherbal combinations to treat respiratory infections. South 
African Journal of Botany 76, 655-661.  
 
*Abstracts can be found in Appendix C 
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Validating the antimicrobial efficacy of Artemisia afra in combination with medicinal 
plants to treat respiratory tract infections 
 
Sajida Suliman 
1
, Sandy F. van Vuuren 
1
, Alvaro M. Viljoen 
2 
1
Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of 
the Witwatersrand, 7 York Road, Parktown, 2193, South Africa. 
2
Department of Pharmaceutical Sciences, Tshwane University of Technology, Private 
Bag X680, Pretoria 0001, South Africa. 
 
Introduction: 
Artemisia afra is one of the most widely used plants in South African traditional medicine. It 
is commonly used to treat respiratory infections like coughs, colds, lung inflammation and 
often combined with plants such as Lippia javanica, Agathosma betulina, Osmitopsis 
asteriscoides, Eucalyptus globulus, Zanthoxylum capense, Leonotis microphylla, Tetradenia 
riparia and Allium sativum. The aim of this study is to provide scientific validation on the 
synergistic, additive and possibly antagonistic interactions between A. afra plant 
combinations used in traditional medicinal practices.  
 
Methods: 
In vitro minimum inhibitory concentrations (MIC) assays were used to determine 
antimicrobial efficacy of the essential oil, dichloromethane: methanol (CH2Cl2: MeOH) and 
aqueous extracts. Calculation of fractional inhibitory concentrations (FIC) and isobologram 
studies were performed to determine pharmacodynamic interactions, such as synergy, 
antagonism or additive behaviour. Thin layer chromatography (TLC) combined with bio-
autographic assays were used to visualise the antimicrobial activity.   
 
Results:  
MIC‟s results were plotted and isobolograms revealed that when Artemisia afra was 
combined with other plants, mostly additive and synergistic interactions was noted. The 
essential oil combinations mainly indicated additive interactions. With the aqueous extracts, 
synergy and antagonism was apparent. The most pronounced synergy was noted for the 
(CH2Cl2: MeOH) extract of Artemisia afra and Eucalyptus globulus. Synergy was observed 
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against M. catarrhalis, K. pneumoniae, E. faecalis and C. neoformans. TLC and bio-
autographic assay results indicate several compounds responsible for antimicrobial activity. 
  
Conclusion: 
Results obtained from antimicrobial assays for various combinations of Artemisia afra with 
other plants (as prescribed by traditional healers) show varied interactions (synergy, 
antagonism and additive) depending on the selection of plant combination.  
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Antimicrobial interactions of Artemisia afra with other medicinal plants to treat 
respiratory diseases. 
 
Suliman S.
1
, S.F. van Vuuren
1
, A.M. Viljoen
2 
1
Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of 
the Witwatersrand, 7 York Road, Parktown, 2193. 
2
Department of Pharmaceutical Sciences, Tshwane University of Technology, Private Bag 
X680, Pretoria 0001. 
 
Artemisia afra is one of the most widely used plants in South African traditional medicine. It 
is commonly used to treat respiratory infections such as coughs, colds, lung inflammation and 
often combined with plants such as Lippia javanica, Agathosma betulina, Osmitopsis 
asteriscoides, Eucalyptus globulus, Zanthoxylum capense, Leonotis microphylla, Tetradenia 
riparia and Allium sativum. The combinations were specifically analysed for any 
antimicrobial interactions. In addition, the combined use with milk, honey and salt, as 
traditionally prepared, was evaluated. Methods used included in vitro minimum inhibitory 
concentrations (MIC) assays, which were used to determine antimicrobial efficacy of the 
essential oil, dichloromethane: methanol and aqueous extracts. Calculation of fractional 
inhibitory concentrations (FIC) and isobologram studies were performed to determine 
pharmacological interactions. The most promising result was the combination of A. afra and 
A. betulina dichloromethane: methanol extract against M. catarrhalis with a FIC of 0.5. 
Isobologram results of this combination indicated synergistic, antagonistic and additive 
pharmacological behaviour against the four pathogens tested, i.e. M. catarrhalis, E. faecalis, 
K. pneumoniae and C. neoformans. Combinations of A. afra with honey, salt and milk 
showed mainly indifferent antimicrobial behaviour. An exception was noted i.e. A. afra 
(aqueous extract) combined with skim milk against M. catarrhalis, indicating additive 
behaviour with a FIC value of 0.63. Results obtained from the antimicrobial assays for 
various combinations of A. afra with other plants (as prescribed by traditional healers) show 
varied interactions depending on the selection of plant combination. 
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The ethnobotanical study of A. afra in combination therapy for the treatment of 
respiratory tract infections 
 
S. (Sajida) Suliman
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Artemisia afra is one of the most widely used medicinal plants in South Africa. It is 
commonly used to treat respiratory infections such as coughs, colds, lung inflammation and 
often combined with plants such as Lippia javanica, Agathosma betulina, Osmitopsis 
asteriscoides, Eucalyptus globulus, Zanthoxylum capense, Leonotis microphylla, Tetradenia 
riparia and Allium sativum. In addition, the combined use with milk, honey and salt is also 
traditionally prepared. These combinations were evaluated for their antimicrobial 
interactions. Methods used included in vitro minimum inhibitory concentrations (MIC) 
assays, which were used to determine antimicrobial efficacy of the essential oil, 
dichloromethane: methanol and aqueous extracts. Calculation of fractional inhibitory 
concentration (FIC) and isobolograms demonstrated pharmacological interactions. Results of 
the combinations of A. afra and L. javanica, and A. afra and O. asteriscoides essential oil, 
dichloromethane: methanol and aqueous extracts, showed mostly synergistic interactions 
against all our pathogens tested i.e. M. catarrhalis, E. faecalis, K. pneumoniae and C. 
neoformans. In the combination of A. afra and A. betulina, and A. afra and Z. capense, varied 
interactions were noted, with antagonism shown for the aqueous extracts, for all pathogens 
tested, depending on the ratio in which they were combined. When A. afra and E. globulus 
was combined mainly synergistic interactions was noted with all pathogens. Combinations of 
A. afra with honey, salt and milk showed mainly additive and indifferent antimicrobial 
behaviour. These antimicrobial interactive studies with A. afra demonstrate varied 
interactions depending on the selection of combination. 
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